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1. EXECUTIVE SUMMARY 
Introduction 
The Bio-Based Industries Joint Undertaking (BBI JU) is a public-private partnership 
(PPP)1  between the European Commission and the Bio-based Industries 
Consortium (BIC). The Council Regulation (EU) No 560/2014 sets the basis for the 
establishment of the Bio-based Industries Joint Undertaking (BBI JU).2   
BIC developed the Strategic Innovation and Research Agenda (SIRA) based on 
extensive consultation with public and private stakeholders. As per all the seven JUs, BBI 
JU awards Horizon 2020 funding for projects based on competitive calls.  Five JUs were 
already set up in 2007-2008 under the Seventh Framework Programme (FP7), whereas 
Bio-based Industries (BBI) is one of the newly established JUs under Horizon 2020 
with the specific aim of developing sustainable and competitive bio-based industries in 
Europe.  
BBI JU set out financial commitments from both the EU and from the industry members 
in order to provide funding for large-scale, longer-term and high risk/reward research. 
The objectives of BBI JU may best be achieved by the Partnerships and, most 
importantly, by bringing together of companies, universities, research centres, innovative 
SMEs and other groups and organisations around the topic of the bio-based economy, 
which is of great industrial and social relevance. BBI JU is expected to be a concrete 
example of the European Union's efforts towards strengthening its competitiveness 
through scientific excellence, industry led research, openness and innovation.  
According to Article 32(3) of the Horizon 2020 Regulation, the Commission must provide 
an in-depth assessment of all JUs. Article 11(1) of BBI JU regulation3 provides the main 
legal basis for this interim evaluation, which was carried out by a group of five 
independent experts who analysed the activities of BBI JU in the period 2014-2016. The 
evaluation takes place at an early stage, less than three years after the adoption of 
Regulation (EU) No. 560/2014, which established the BBI JU. It covers five main 
evaluation criteria: relevance, efficiency, effectiveness, coherence and EU added value.4,5 
Although at the time point of this interim evaluation none of the research projects funded 
by BBI JU had been completed, qualitative input in combination with quantitative 
information, as was available, were used to assess the effectiveness of implementation 
and the main achievements so far. 
How relevant has BBI JU been so far? 
The Bio-Based Industries Joint Undertaking (BBI JU) was initiated with the aims to attract 
more consistent private investment, promote research and innovation along whole value 
chains, to overcome fragmentation, to avoid duplication and to coordinate better 
innovation activities of bio-based industries. The institutionalized Public-Private 
Partnership (PPP) was selected among three policy options with the expectation of 
mobilizing greater project resources through significant contributions by industry.  
                                                 
1 In addition to the institutionalised PPPs, also the contractual Public-Private Partnerships (cPPPs) have a legal 
basis in Article 25 of the regulation establishing Horizon 2020. Please note that the assessment of cPPPs is not 
included in this document but will be part of the overall SWD (Staff Working Document), planned for 2017.  
2 Council Regulation (EU) No 560/2014 of 6 May 2014. 
3 Council Regulation (EU) No 560/2014 of 6 May 2014 
4 The definitions  of criteria are reported in Annex 3. 
5 Commission Staff Working Document. Better Regulation Guidelines. 19 May  2015. 
http://ec.europa.eu/smart-regulation/guidelines/docs/swd_br_guidelines_en.pdf 
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BBI JU intends to de-risk in research, demonstration and commercialization of BBI 
technologies and to respond to the challenge of creating and maintaining a competitive 
position of Europe in BBI technologies, especially in the light of the growing number of 
demonstration size facilities being implemented in US and Asia.  
Although it is still too early to assess the overall effectiveness of BBI JU in meeting these 
goals, the JU appears well aligned with the initial aims. The main positive effects of BBI 
JU in terms of competitiveness of BBI technologies come via encouragement and support 
of value chain driven cooperation across sectors (‘the structuring effect’) and via 
innovation driven mobilization of key stakeholders (‘the mobilizing effect’). 
Flagships projects are one of the distinctive measures of BBI JU: they represent an effort 
to accelerate commercialization of riskier capital-intensive BBI technologies and bring 
these to demonstration in the short term, to commercialization in the medium term and 
to wider market in the long term. Such flagship projects have already mobilized 
significant amounts of industry investments. 
Since its set up, BBI JU has reflected the evolution of the sectors and companies active in 
BIC, which nowadays embrace sectors not prominently covered in the initial stage, 
among others, representatives of the food industry and some consumer brand owners. 
This evolution is expected to have a positive impact on the development of technologies, 
since a closer involvement of a wider array of downstream sectors should lead to a more 
effective match with market requirements. 
Overall, it is recommended that BBI JU actions continue in the direction of de-risking, by 
bringing new bio-based value chains to market and by continuing the involvement of 
brand owners, end-users and sectors at the interface with customers and consumers. 
At the same time, it is of key importance that the program activities of BBI JU respond to 
relevant emerging priorities such as, for instance, resource efficiency, exploitation of CO2 
as carbon feedstock and digitalization. 
Achievements and effectiveness 
During the period 2014-2016, the project grants were allocated via four calls for 
proposals, for a total of 65 projects retained for funding. They included 6 Coordination 
and Support Actions, 20 Demonstration Actions, 6 Flagship Actions and 33 Research and 
Innovation Actions. In line with the objectives of the JU, the largest share of the 
operational budget went to actions characterized by high Technology Readiness 
Levels (TRL > 5)6:  39.5% to Demonstration Actions (TRL 6-7) and 33.2% to Flagship 
projects (TRL 8). The Research and Innovation Actions (TRL 3-5) received 25.9% of the 
funding whereas only 1.4% of the budget was invested in Coordination and Support 
Actions. As one of the main objectives of BBI JU is to avoid fragmentation and improve 
coordination, it is of high importance to invest coherently in Coordination and Support 
Actions in the second phase of the initiative. Such projects could also represent an 
important instrument for the monitoring and the analysis of the bio-based markets in 
order to optimize the programming activities and the focus of the future calls. 
The total EC contribution (in commitment appropriations) to BBI JU operational 
expenditure over 2014-2016 amounted to EUR 418.29 million and the total financial 
                                                 
6Technology Readiness Levels: TRL 1 – basic principles observed; TRL 2 – technology concept formulated; TRL 
3 – experimental proof of concept; TRL 4 – technology validated in lab; TRL 5 – technology validated in 
relevant environment (industrially relevant environment in the case of key enabling technologies); TRL 6 – 
technology demonstrated in relevant environment (industrially relevant environment in the case of key enabling 
technologies); TRL 7 – system prototype demonstration in operational environment; TRL 8 – system complete 
and qualified; TRL 9 – actual system proven in operational environment (competitive manufacturing in the case 
of key enabling technologies; or in space).  
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contribution committed by BIC at programme level, for the same expenditure and over 
the same period, amounted to EUR 0.75 million. Out of the total contributions committed 
by the two members of the JU, EUR 414.29 million was committed by BBI JU in individual 
projects selected for funding by the end of May 2017. Moreover, in the signed Grant 
Agreements signed by 31 December 2016 (i.e. those resulting from calls 2014 and 2015) 
there was an overall commitment by the private members of EUR 114,621,657.2 for in 
kind contributions to operational activities (IKOP). In the grant agreements signed later 
(i.e. those of Call 2016) the commitment by the private members amounts to EUR 
81,667,987 for in kind contributions to operational activities.  
Work programmes followed the SIRA by supporting the building up of five value chains, 
characterized, mainly, by their focus on different feedstock: lignocellulose, forestry 
biomass, agro-based biomass, organic waste. The last value chain aimed at integrating 
energy, pulp and chemicals biorefineries. So far, six flagship projects were launched to 
support the value chains characterized by the most mature technologies (lignocellulose, 
forest-based and agro-based feedstock). Since the first publication of the SIRA in 2013, 
new value chains are emerging (e.g. marine biomass) and they have attracted the 
interest of BBI JU. This shows the responsiveness of BBI to the evolving field. 
Furthermore, from 2016 the annual work programmes have moved from the biomass 
‘push’ based approach and the traditional value chains towards creating a demand for 
biomass and ‘market pull’. This approach translated into a significant number of topics, 
published in 2016, embracing different value chains. Therefore, further efforts are 
expected to support the development of technologies in these new areas. On the other 
hand, the integration of energy, pulp and chemicals biorefineries appears to have 
decreased its strategic relevance within BBI JU. 
Currently, the share of budget dedicated to Demonstration projects is significantly 
higher than originally planned in the Strategic Innovation and Research Agenda (SIRA) at 
the expense of Research and Innovation Actions and Coordination and Support Actions. 
This situation should be rebalanced through future work plans. The industrially-driven 
nature of BBI JU is clearly reflected in the pattern of budget distribution per beneficiary 
type, since the majority of the funding (70.7%) went to private entities, with a very high 
participation of SME (35.4% in terms of  participants number and 29.1% in terms of 
funding). As a comparison, SC2 and LEIT biotechnology devoted about 39% of the 
respective budgets to private entities. 
Concerning openness, BBI gone to considerable effort in communicating the BBI JU and 
its calls to stakeholders in the EU through its events, meetings and website. Overall, the 
success rate (ratio between applicants and beneficiaries) was 30.9%. The nature of BBI 
calls is fully open to the participation of any stakeholder. Although the success rate of 
proposals having BIC coordinators and BIC members is higher than for non-BIC 
coordinators and non-BIC members, the actual numbers of non-BIC coordinators and 
non-BIC members in the selected proposals are much higher.  
The geographical distribution of beneficiaries resembles those observed in the SC2 
calls and in LEIT KET Biotechnology programme, since the majority of EC funding (84%) 
goes to EU15. Although EU13 receives a much lower share of the BBI JU contribution 
than EU15, it scores better in BBI (7.9%) than in SC2 (5.5%) and in LEIT KET 
Biotechnology programme (7.2%). The unbalanced geographical distribution is also a 
consequence of the lower success rates of EU13 (19.7%) as compared to EU15 (32.6%). 
This situation, which is not specific for BBI JU but rather a common challenge in Horizon 
2020, was addressed by BBI JU through a number of initiatives organized locally and 
aiming at mobilizing the stakeholders of EU13. Nevertheless, future efforts could go 
toward developing further program strategies that take into account potentials at macro 
regional level, also in synergy with other EU initiatives (e.g. Smart Specialisation 
Strategies, S3). 
Finally, the participation of third Countries in BBI JU calls is negligible, which is 
unsurprising considering the aim to support competitiveness of EU located industries. 
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Nevertheless, in the second phase of BBI it would be important to identify some win-win 
strategies for a larger involvement of third Countries, also in the light of the reported 
growing interest of some non-EU big players towards European Bio-Based industry and 
Bioeconomy as a whole. This is a positive signal of the effectiveness of BBI JU in 
mobilizing and structuring the Bio-Based Industries as an emerging sector and creating a 
critical mass in Europe able to provide new products, technologies, solutions to 
customers in the global marketplace.  
Main achievements and effectiveness of implementation  
BBI JU became autonomous on 26 October 2015. The number of running projects has 
steadily grown from 10 projects in 2014 to 36 at the end of 2016 and to the current 65 
ongoing projects in June 2017, thereby extending beyond the formal time limit of this 
midterm evaluation. 
BBI JU has included in its legal base seven specific objectives7 to be met by the end of 
the programme period in addition to the general objectives that are common for the 
whole Horizon 2020. Moreover, there is a set of objectives common to all JUs.8 Key 
Performance Indicators (KPIs), which are regularly monitored and reported in the Annual 
Activity Reports of BBI JU, measure the progresses towards the achievement of these 
goals. Six out of seven BBI-specific KPIs are reported already well above the targets, 
whereas the seventh KPI (number of flagship projects) is well on track. The previous 
statement is made on the basis of partial data already available and taking into account 
expected (i.e. projected) results as reported in the signed Grant Agreements (no final 
reports of projects are yet available). In particular, according to the mentioned 
projections, BBI JU will establish 146 new cross-sector interconnections, 82 new value 
chains, 46 new biochemical building blocks, 106 new bio-based materials, 51 new bio-
based consumer products. Although at the time this evaluation takes place these KPIs 
are still ‘projected values‘ because no project has been concluded yet, there are already 
6 actual flagship projects that have led to a significant private sector participation and 
mobilization of private investments. Therefore, further monitoring activity and analysis 
will be required for the collection of reliable data through a methodological approach 
making a clear distinction between the actually achieved KPIs at the end of each year 
and the projected KPIs.  
The performance of BBI JU against three main Horizon 2020 KPIs – time to inform 
(TTI), time to grant (TTG) and time to pay (TTP) pre-financing – shows that it currently 
operates effectively. The 20% target for SMEs has been surpassed, which clearly 
demonstrates that the BBI JU program is contributing to the development of the bio-
based SMEs landscape in Europe. The private sector participation in the funding allocated 
is very pronounced (71%), which is a cornerstone of the BBI JU. 
Concerning the effectiveness in living up to the financial and managerial 
responsibilities, the available documents and interviews with BBI JU stakeholders indicate 
that during the conception phase of BBI JU and the organization of BBI JU regulation 
there was an underestimation of the necessity to establish clear criteria and suitable 
instruments for delivering and reporting the industry contributions. Such inaccuracy in 
the definition of clear rules led to an incomplete and fragmented picture of the actual 
financial and in kind contribution of the industry to BBI JU. 
Overall, BBI JU has created a stimulating research and innovation environment in 
Europe. BBI JU has also attracted a satisfactory level of participation of the best 
European players in the areas of the selected value chains. The development of business 
models to integrate economic actors along the whole value chain is an achievement: 
From the supply of biomass to biorefinery plants to customers and consumers of bio-
based materials, chemicals and fuels. This is also accomplished by creating new cross-
                                                 
7 With the exception of SESAR JU that is not subjected to a predefined set of KPIs. 
8 Based on Annex II (PERFORMANCE INDICATORS) to Council Decision 2013/743/EU). 
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sector interconnections and supporting cross-industry clusters. As the realization of these 
goals could not be achieved by a single member country, organization or scientific 
discipline alone, the required common European effort is justified.  
Efficiency and performance 
BBI JU’s mission is to implement the Strategic Innovation and Research Agenda (SIRA) 
developed by the Bio-based Industry Consortium (BIC) and endorsed by the European 
Commission on behalf of the European Union (EU). 
The Council regulation sets the contributions to be made by EU and BIC for the 
implementation of BBI JU. The EU’s overall contribution to administrative and operational 
costs shall be up to EUR 975 000 000. BIC shall make a total contribution of at least 
EUR 2 730 000 000. The latter consist of a financial contribution to the operational costs 
(of at least EUR 182 500 000), financial contribution to administrative costs and of in 
kind contributions (IKOP) to operational costs. The total private contribution comprises, 
also, a minimum of EUR 1 755 000 000 for implementing additional activities outside the 
work plan of BBI Joint Undertaking contributing to the objectives of BBI Initiative (IKAA). 
The two members of BBI JU, namely the EU and BIC, have long-term commitments to 
contribute both financially and - only in the case of BIC - in kind to the implementations 
of JU. However, contribution of the some inaccuracy in defining clear and applicable rules 
for the delivery of private financial contributions to operational activities as well as in 
confirming the acceptance of such established regulation, led to an insufficient financial 
contribution from BIC.  Although some measures have been designed to address and 
solve this issue, their implementations will require specific monitoring actions. Moreover, 
the delay in the drafting and approval of the IKAA plan for 2016 prevented the group of 
experts to take into account complete and updated figures on the actual delivered in kind 
contributions by industry in 2016, since the process of certification depends on IKAA 
Plans approved by the Governing Board.  
In general, the programme office appears to have implemented its activities in 
compliance with the applicable rules and procedures to support the appropriate 
management of public and private funds. The organisation, structure, decision making 
and reporting of BBI JU are in line with the legal frameworks.  
The high TRL levels of demonstration and flagship projects justify, to some extent, the 
high level of confidentiality applied to most data produced within BBI JU projects. 
Nevertheless, for implementing any mechanism aiming at better coordinating all 
initiatives dedicated to the growth of the European Bioeconomy and for searching further 
leveraging effects at the regional and macro-regional levels, it is important that the 
relevant EC directorates have prompt access to the projects’ deliverables, in compliance 
with the relevant regulations. Moreover, it is of fundamental importance to benchmark 
and monitor the effectiveness of such initiatives in assuring the EU leadership in this 
emerging sector and in implementing continuous process improvements at all levels. 
The visions of members of a successful bio based industry are well aligned, as should 
be expected with the input of members into the setting up of the BBI JU. BBI JU is in the 
process to demonstrate new value chains products and progress against KPIs and has 
advantages over other intervention modes but evidence gathering for broader 
environmental, economic and social impacts could be improved. In addition, the whole 
value chain approach could yet be strengthened by greater participation of end users and 
customers. 
Finally, BBI JU has carried out dissemination activities and a consistent number of 
dedicated events throughout Europe aimed at promoting participation into calls but also 
at mobilizing local stakeholders. Additionally, the BBI JU web site is effective in spreading 
information on calls and in organizing partnering activities. 
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EU added value and leverage effect of BBI JU 
For the achievement of the objectives set in the Article 2 of the Council Regulation (EU) 
No 560/2014, BBI JU relies on a planned budget, which is on a shared costs basis with 
industry. Every Euro of the EU funds is expected to leverage at least 2.8 Euro of private 
funds during the operation of the Joint Undertaking, which represents the highest 
leverage target among the seven JUs. Based on the in-kind and financial (in cash) 
contributions to operational costs of calls 2014 and 2015, the operational leverage effect 
by 31 December 2016 is 0.50. It must be underlined that the grants from call 2016 have 
been signed only in May 2017 and the calculations of the leverage effect take into 
account the cut-off date of 31 December 2016 (i.e. only grant agreements from calls 
2014 and 2015). When considering the available data on contributions to additional 
activities in 2014 and 2015, the additional leverage effect is 1.275. Therefore, the global 
leverage effect by 31 December 2016 is 1.779. However, this calculation does not take 
into account any private contribution to additional activities related to 2016 since the 
corresponding IKAA plan had not been approved at the time this evaluation was carried 
out. Moreover, the process of certification depends on IKAA Plans approved by the 
Governing Board. Notably, on June 2017 BIC anticipated an amount of certified IKAA for 
2016 equal to EUR 185.863 million, which is expected to affect significantly the 
quantification of the additional and global leverage effect.  Based on the certified IKAA 
for 2016 the additional leverage effect would be 2.1 while the global leverage effect 
would become 2.6. Consequently, the actual leverage effect should be re-calculated and 
published once the Governing Board approves the IKAA plan for 2016. Overall, 
intensifying private sector commitment by in-kind contributions and additional activities 
while attracting additional investments from third Countries, need to be continued as key 
tasks.  
Looking at the added value of BBI JU in a broad perspective, flagship projects with 
high TRL and their additional private investments (IKAA) would likely not have taken 
place without the intervention of BBI JU or would have had narrower and less ambitious 
scope. 
The positive effect of BBI JU is recognized also by 87.5% of the participants who, in a 
survey, affirmed that BBI JU contributes to economic growth and job creation in the EU. 
Indeed, a preliminary statistical analysis of 9 projects financed through call 2014 
indicates that a number of 689 staff is employed, with a gender distribution of 58% male 
and 42% female. As the creation of direct and indirect new jobs, both temporary and 
permanent, is taking place over extended periods of time, a standardized and constant 
reporting over the years is needed. This will provide quantitative data to judge the long-
term effect on employment in EU member states. While such a standardized and 
constant reporting can be easily introduced on the level of project coordinators for the 
duration of projects, it is more challenging to continue after the completion of projects.  
An even higher proportion of 93% of participants in the survey judged that BBI JU 
contributes to the transition from a fossil-based to a bio-based economy, while 91% 
stated that BBI JU contributes to climate change mitigation by reducing the CO2 derived 
from the use of fossil-based products. 
As the different stakeholders are fragmented in Europe, the real added value of BBI JU is 
largely in the creation of new value chains and in the acceleration of bringing together 
different sectors and industries engaged in supporting the sustainability (both 
environmental and economic) of the existing value chains.  One of the main success 
factors of BBI in 2014-2016 is represented by the structuring and mobilizing effect on 
research, industry and economy. Members of the BBI, BIC, the BBI Scientific Committee 
and the BBI State Representatives Group have acted as ambassadors for the initiative in 
their respective communities thus providing momentum.  
Some successful macro-regional initiatives boosted by BBI State Representatives 
Group (e.g. in the Mediterranean region) demonstrate that it is crucial to maximize the 
structural effect at national, regional and macro-regional levels. Therefore, it would be 
important to work jointly with regional initiatives on rural development or 
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reindustrialization of dismissed areas for catalysing revitalization through the bio-based 
industries.   
 
Coherence of BBI JU, internally and with other (EU) actions 
The objectives and activities covered under BBI JU are coherent and well-coordinated 
with the parts of the Horizon 2020 financing it: SC2 and LEIT ‘Biotechnology’. While SC2 
and LEIT Biotechnology continue to support research and innovation activities related to 
the whole Bioeconomy, BBI JU aims to strengthen the bio-based industry sector by 
industry-driven activities. It mainly finances projects with higher technology readiness 
levels and market potential than SC2 and LEIT. This is reflected in the distribution of EC 
funds per different type of action. To guarantee complementarity and support for all 
beneficiary types, SC2 and LEIT should continue to support preferentially beneficiaries 
from the academic sector (HES and REC) or request increased contributions from the 
private sector (PRC) per project. Moreover, the results of CSA projects funded under SC2 
should be taken into consideration in planning of future BBI calls. 
 
There is some overlap in the topics funded by BBI JU respect to LEIT theme:’ 
Biotechnology-based industrial processes driving competitiveness and sustainability’ and 
a better coordination is recommended. It must be noted that, due to the broad nature of 
the challenges addressed by Horizon 2020, some intersections between the different 
programmes allow for the development of comprehensive and multidisciplinary 
approaches. In order to complement the research and innovation focus of BBI JU, many 
topics covered in recent Bioeconomy-related SC2 calls of Horizon 2020 (ISIB-2014/2015 
and BB-2016/17) have been targeting the downstream side of the value chain and aimed 
at increasing public awareness and supporting markets’ development. They also integrate 
crosscutting activities, such as communication, technology transfer and dissemination 
activities. Overall, there is evidence that the interlink with other parts of Horizon 2020, 
such as SC5 'Climate action, environment, resource efficiency and raw materials', are 
softer.  
Pursuing in the efforts towards an effective coordination of the programming activities 
would ensure an improved coherence of BBI JU. For instance, the objectives and 
activities financed by BBI are closely linked to those of SPIRE (Sustainable Process 
Industry through Resource and Energy Efficiency) PPP. Notably, particular attention has 
been put on the sub key action KA 1.4: ‘Advancing the role of sustainable 
biomass/renewables as industrial raw material’ to avoid overlap or duplication.  
In order to achieve an effective coordination it is crucial that EC directorates and the 
Scientific Committee are consulted in the earlier phases of the programming activities, 
which are currently carried out mainly by BIC members. Moreover, it is important that 
programming strategies are fully effective in catching trends and opportunities that 
will pave the way for EU leadership in new emerging technological areas. 
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2. INTRODUCTION 
2.1. Purpose of the evaluation 
This report addresses the interim evaluation of the Joint Undertaking on Bio-Based 
Industries (‘BBI Joint Undertaking),9 a body established under the Treaty on the 
Functioning of the European Union, and in particular Article 187 and the first paragraph 
of Article 188 thereof and entrusted with the implementation of a public-private 
partnership referred to in Article 209 (‘Model Financial Regulation for public-private 
partnership bodies’) of Regulation (EU, Euratom) No 966/2012.  
According to Article 11 of Council Regulation (EU) No 560/2014 establishing the Bio-
based Industries Joint Undertaking (BBI JU), the Commission shall carry out, by 30 June 
2017, with the assistance of independent experts, an interim evaluation of BBI Joint 
Undertaking.10   
The provisions on public-private partnership (Article 25 of Council Regulation (EU) No 
1291/2013) comprise a wide range of topics that need to be addressed by the evaluation 
(e.g. governance structure, contractual arrangements between members, coherence and 
complementarity with other parts of Horizon 2020, etc.). Moreover, the co-legislator 
explicitly requires, as part of the Horizon 2020 Interim Evaluation, an in-depth 
assessment on whether the public-private partnership is implemented in an open, 
transparent and efficient way, as stipulated in Article 32(2) of Council Regulation (EU) 
No 1291/2013. These requirements necessitate the evaluation to cover both the 
operations of BBI JU as well as organisation and outputs produced by the research 
projects funded by BBI JU.  
The analysis complies with the requirements of the revised evaluation guidelines of the 
Better Regulation Package11 and covers the five main evaluation criteria - relevance, 
efficiency, effectiveness, coherence and EU added value.12 
The results of this evaluation will be used to inform the European Parliament and the 
Council, national authorities, the research community and other stakeholders on the 
outcome of BBI JU under Horizon 2020. Based on the conclusions of the interim 
evaluation, the Commission may also act in accordance with Article 4(5)13 of Council 
Regulation No 560/2014 or take any other appropriate action.  
                                                 
9 The Bio-Based Industries Joint Undertaking (BBI JU) is a public-private partnership between the European 
Commission and Bio-based Industries Consortium (BIC). BIC developed the SIRA based on extensive 
consultation with public and private stakeholders. The SIRA describes the main technological and innovation 
challenges that need to be overcome in order to develop sustainable and competitive bio-based industries in 
Europe and identifies research, demonstration and deployment activities to be carried out by a Joint Technology 
Initiative. Such programmatic content is implemented, although non exclusively, by the BBI JU, which is the 
object of this evaluation. Concerning Joint Technology Initiatives, in May 2007,  the Commission adopted the 
first proposals for Joint Technology Initiatives. It was the first time that public-private partnerships, involving 
industry, the research community and public authorities, were proposed at European level to pursue ambitious 
common research objectives. Joint Technology Initiatives are a mechanism for performing research at EU level 
and support large-scale multinational research activities in areas of major interest to European industrial 
competitiveness and issues of high societal relevance. 
10 The Commission shall prepare a report on that evaluation, which shall include conclusions of the evaluation 
and observations by the Commission. The Commission shall send that report to the European Parliament and to 
the Council by 31 December 2017. The results of the interim evaluation of the BBI Joint Undertaking shall be 
taken into account in the in-depth assessment and in the interim evaluation referred to in Article 32 of 
Regulation (EU) No 1291/2013.  
11 Commission Staff Working Document. Better Regulation Guidelines. 19 May  2015. 
http://ec.europa.eu/smart-regulation/guidelines/docs/swd_br_guidelines_en.pdf 
12 The definitions  of criteria are reported in Annex 3. 
13 The Commission may terminate, proportionally reduce or suspend the Union’s financial contribution to the 
BBI Joint Undertaking or trigger the winding-up procedure referred to in Article 20(2) of the Statutes if those 
members or their constituent entities do not contribute, contribute only partially or contribute late with regard 
to the contributions referred to in paragraph 2 of this Article. The Commission decision shall not hinder the 
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The results of this evaluation will also be used to improve the implementation of BBI 
Initiative under Horizon 2020, contribute to the formulation of BBI JU Annual Work Plans 
2018-2020 and assessing if industry delivered on its expected contribution. 
2.2. Scope of the evaluation 
This Interim Evaluation of BBI Joint Undertaking (2014-2016) takes place at an early 
stage, less than three years after Regulation (EU) No 560/2014 was adopted, which 
established the Biobased Industries Joint Undertaking. 
Although at the time point of this interim evaluation none of the research projects funded 
by BBI JU has been completed, qualitative input in combination with quantitative 
information available were used to assess the effectiveness of implementation and the 
main achievements so far. 
The evaluation report covers seven evaluation questions proposed by the 'Terms of 
Reference for the independent Expert Group set up by the DG RTD of the European 
Commission in order to carry out the Interim Evaluation of the BBI Joint Undertaking 
('Terms of Reference')' and more specifically: 
 
1. Background to the initiative, objectives and relevance 
2. Implementation of BBI Joint Technology Initiative 
3. Main achievements and effectiveness of implementation 
4. BBI Joint Undertaking's performance in 2014 – 2016 
5. EU added value 
6. Coherence 
7. Synthesis, conclusions and recommendations 
3. BACKGROUND TO THE INITIATIVE 
3.1. Description of the initiative and its objectives 
Based on the experience acquired with JUs under FP7, BBI JU has been set up by the 
European Commission as part of a new generation of public and private 
partnerships. The aim was increasing the scale and impact of research and innovation 
investments on the bio-based industries by combining private sector investment with 
European public funding.  
The objective of BBI Initiative is to implement a programme of research and 
innovation activities in Europe that will support the establishment of sustainable bio-
based value chains and assess the availability of renewable biological resources, which 
can be used for the production of bio-based materials. This objective is to be achieved by 
supporting research, demonstration and deployment activities using resources from 
the public and private sectors. The objectives of BBI JU are to contribute to the 
implementation of Horizon 2020 and to the objectives of BBI Initiative through the 
organisation of calls for proposals for supporting research, demonstration and 
deployment activities in an open, transparent, effective and efficient way.   
The transnational, trans-sectorial and complex nature of BBI JU builds on a wide 
range of projects that contribute to the advancement of bio-based industries. These 
projects have been funded by the EU in the past and now require pooling complementary 
knowledge and financial resources across sectors and borders.  
More specifically, according to Article 1 of BBI JU Statutes, the Undertaking shall carry 
out the following tasks:  
                                                                                                                                                        
reimbursement of eligible costs already incurred by the members by the time of the notification of the decision 
to the BBI Joint Undertaking. 
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(a) Guarantee the establishment and sustainable management of BBI Initiative 
programme;  
(b) Mobilise the public and private sector resources needed;  
(c) Establish and develop close and long-term cooperation between the Union, industry 
and the other stakeholders;  
(d) Ensure the efficiency of BBI Initiative;  
(e) Reach the critical mass of research effort to embark on a long-term programme;  
(f) Monitor progress towards the achievement of the objectives of BBI Joint Undertaking;  
(g) Provide financial support to research and innovation indirect actions mainly through 
grants;  
(h) Engage in information, communication, exploitation and dissemination activities by 
applying mutatis mutandis Article 28 of Regulation (EU) No 1291/2013, including making 
the detailed information on results from calls for proposals available and accessible in a 
common Horizon 2020 e-database;  
(I) liaise with a broad range of stakeholders including research organisations and 
universities. 
The BBI Initiative aims at more resource efficient and sustainable low-carbon economy 
and increasing economic growth and employment, in particularly in rural areas, by 
developing sustainable and competitive bio-based industries in Europe based on 
advanced biorefineries that source their biomass sustainably. A key success factor 
thereby is collaboration between stakeholders throughout Europe and along the 
entire bio-based value chains, including primary production and processing industries, 
consumer brands, SMEs, research and technology centres and universities.  
For maximum impact, BBI JU should develop close synergies with other Union 
programmes in areas such as education, environment, competitiveness and SMEs, 
as well as with the Cohesion Policy funds, Rural Development Policy and with the 
European structural and investment funds (ESIF). Indeed, such synergies can 
specifically help to strengthen local, regional and national research and innovation 
capabilities.  
The background and the initiative itself are described and assessed in more detail in 
sections 7.1.1-7.1.4 (Evaluation question 1). In addition, an Intervention Logic diagram 
in line with the ‘Better regulation package’ is presented there.  
3.2. Baseline 
The evaluation itself will mainly assess the progress of the BBI JU against its specific 
targets and KPIs. However, in a wider context it is important to understand the baseline 
situation of the bio-based industry and its operating environment before the 
establishment of the BBI JU and how the industry and the operating environment have 
evolved since the establishment of the BBI JU. For that purpose, the impact assessment 
preceding the setup of BBI JU gives wider baseline information against which the 
progress can be reflected when assessing the relevant evaluation questions.    
The impact assessment (IA) accompanying the European Commission proposal for a 
Council Regulation on the BBI JU was published in 2013.14 During the process for the 
preparation of the IA, the Commission consulted a wide range of stakeholders 
representing industry, research communities, Member States, regions and the public. The 
IA was prepared by DG RTD with the support of other Commission services.  A group of 
                                                 
14 Commission Staff Working Document Executive Summary Of The Impact Assessment 
Accompanying The Document Proposal For A Council Regulation On The Bio-Based 
Industries Joint Undertaking. SWD/2013/0248 Final. 
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external reviewers assisted the Commission with the data collection and analysis of the 
IA. 
In the impact assessment, the baseline situation was assessed, and the following 
conclusions were drawn:  
 The European economy currently heavily relies on petrol and other fossil 
resources for energy and products, while it is critical that the EU meets its 
climate change targets for 2020 and moves towards a competitive low carbon 
economy in 2050. Bio-based industries can contribute by partially substituting 
fossil resources with renewable ones to produce bio-based products and 
biofuels.  
 Bio-based industries currently only represent about 3% of the EUR 2 trillion in 
annual turnover and 1% of the 22 million jobs generated by the European 
Bioeconomy, but bio-based industries are expected to grow more rapidly and 
substantially than more traditional Bioeconomy sectors. Setting up supply 
chains for biomass and networks of local and regional biorefineries also creates 
new jobs and sources of revenue for rural communities. 
 In view of growing global competition, further investments in research, 
demonstration and deployment of bio-based industries are needed to strengthen 
further Europe's competitive position.  
 New solutions are needed to sustainably increase available local biomass (e.g. 
by using residues, waste). Reliable and cost-competitive supply chains will need 
to be developed. 
 The conversion of non-edible biomass in ‘advanced’ biorefineries is more difficult 
than for food crops in ‘conventional’ biorefineries. New efficient and cost-
competitive processes must be developed. In addition, Demonstrating and 
deploying advanced biorefineries is crucial to compete with well-established 
(petro-) chemical industries, which requires rapid up scaling and several 
technological breakthroughs and cross-sectorial industrial synergies. 
 Supporting demand-side actions are needed for the uptake of bio-based 
products: R&I can support the uptake of bio-based products in consumer 
markets and green procurement, e.g. by developing standards, labels and life 
cycle assessments.  
 Several market failures are currently causing lack of investment in R&I for 
bio-based industries and need to be addressed: High risk and cost of 
demonstration and deployment, knowledge spillovers, nascent and fragmented 
industrial sector, transaction cost, policy framework and uncertainty around 
resource availability. 
According to the impact assessment, the need for EU intervention was summarised as 
follows: 
 Member States and Regions have supported R&I for bio-based industries with a 
wide range of Bioeconomy initiatives and cross-border collaborations have been 
explored, but not to a sufficient extent to attain the critical mass needed to 
attract consistent private investment, promote R&I along whole value chains, 
avoid fragmentation and duplication, or improve coordination. 
 A strong EU level push will be critical to securing long-term investments, 
mitigating risks and reaching critical mass needed to bring the right partners to 
the table and resolve the technological and innovation problems bio-based 
industries face, particularly in the areas of demonstration and deployment.  
The Impact Assessment discusses three policy options for organising R&I on bio-based 
industries under Horizon 2020: The ‘Business as Usual’  (BAU) option based on standard 
Horizon 2020 instruments only; the ‘Contractual PPP’  (c-PPP) option based on a 
contractual agreement between the European Commission and industry; and the 
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‘Institutional PPP’  (i-PPP) option involving creating a Joint Technology Initiative (JTI). 
From these three, the i-PPP was the preferred option based on the impact assessment, 
especially as it was considered on its stronger capacity to mobilise greater project 
resources due to the significant contribution by industry. 
The situation before setting up BBI JU is described also in Section 7.1.2. 
4. EVALUATION QUESTIONS 
As stipulated in Articles 32(3) and 25(3) of Council Regulation (EU) 1291/2013, the 
interim evaluation of the public-private partnerships (thus including BBI JU) should focus 
on the following main aspects: 
 
 Openness: The extent to which the JUs enable world-class research that helps 
Europe drive in to a leadership position globally, and how they engage with a 
wider constituency to open the research to the broader society.  
 Transparency: The extent to which the JUs keep an open non-discriminatory 
attitude towards a wide community of stakeholders and provide them with easy 
and effective access to information. 
 Effectiveness: The progress towards achieving the objectives set, including 
how all parties in the public-private partnerships live up to their financial and 
managerial responsibilities.  
 Efficiency will consider the relationship between the resources used by an 
intervention and the changes generated by the intervention.  
 
The above evaluation aspects were addressed under different evaluation questions that 
are integrated in the overall evaluation framework. More specifically, the seven questions 
addressed by the Expert Group were: 
1. Background to the initiative, objectives and relevance 
2. Implementation of BBI Joint Technology Initiative 
3. Main achievements and effectiveness of implementation 
4. BBI Joint Undertaking's performance in 2014 – 2016 
5. EU added value 
6. Coherence 
7. Synthesis, conclusions and recommendations 
5. METHOD/PROCESS FOLLOWED 
5.1. Process/Methodology 
The interim evaluation was carried out with the assistance of a group of independent 
experts15. This report is based on their findings. The group is composed of 6 external 
experts, including a Chair and a Rapporteur, selected from a list that is continuously 
updated through an open call for applications.16 The independent experts were selected 
because they have a range of skills in the relevant fields covered by this evaluation.  
The experts critically examine the rationale, design and current state of implementation 
of the programme. The activities carried out by the experts included the collection, 
analysis and evaluation of data, including both quantitative and qualitative evidence 
that address the evaluation questions articulated in the Terms of Reference.  
                                                 
15http://ec.europa.eu/transparency/regexpert/index.cfm?do=groupDetail.groupDetail&groupID=3456&NewSear
ch=1&NewSearch=1 
16 Call addressed to individuals for the establishment of a database of prospective independent experts to assist 
Commission services with tasks in connection with Horizon 2020 — the Framework Programme for Research 
and Innovation (OJ C342 of 22 November 2013) 
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The evaluation questions were designed to respond to a specific set of evaluation issues. 
The experts formulated their qualitative assessment based on robust evidence and 
supported by quantitative analysis. 
The overall design of the evaluation was based on a mixed methods approach 
comprising: 
 
 Desk research which covered the legal base for Horizon 2020 and BBI JU, work 
programmes and documents produced as part of the Strategic Programming 
process, BBI Annual Work Plans and Budgets (2014 to 2017), Annual Activity 
Reports (2014 to 2015, and draft AAR 2016), minutes of meetings of BBI JU 
governing and advisory bodies, impact studies etc.. 
 Composition analysis which entailed a quantitative analysis of CORDA data 
relating to BBI JU proposals and projects, such as the number and type of 
participants, contribution, etc.. 
 Statistical analysis of data stored in the CORDA database and its reliability 
checks. 
 Analysis and interpretation of the results of the survey of BBI JU beneficiaries, 
which implies a questionnaire proposed by the Commission services.   
 Open dialogue and cooperation with EC, BIC and BBI officers for identifying 
extra sources for specific information and for the continuous updating of new 
data and documents (e.g. call statistics, draft AAR 2016) delivered by BBI JU 
and the EC throughout the period of the evaluation activity. 
 Sharing information and preliminary findings within regularly scheduled 
meetings of the experts. Meetings were focused on specific topics (e.g. KPIs, 
industry contributions to BBI JU) but they also had the objective to discuss the 
methodology of structuring and collecting data (e.g. identification of relevant 
sources of information or stakeholders to be interviewed).  
 Interviews with stakeholders involved in BBI Initiative, both from EC, BIC and 
BBI JU itself (e.g. selected project coordinators, project officers, and members 
of GB). The Expert Group has developed and agreed with the Commission 
services the procedure and the plan of the interviewees. All questions were 
forwarded to interviewed persons in advance. 
 Comparison, where relevant, with the impact of other EC initiatives as, for 
instance, SC2 and LEIT.         
 Comparison with other JUs, although restricted to the KPIs common for all JUs. 
 
The Rapporteur prepared the interim drafts of the report based on all members' written 
contributions and of relevant documents and material identified by Expert Group 
members. These drafts were revised following the feedback of the Commission staff, 
which also supported the production of the report by making available relevant factual 
evidence and by facilitating the establishment of bilateral contacts with BBI JU and BIC. 
The Rapporteur attended, in conjunction with Commission staff, a meeting of the 
Rapporteurs involved in the interim evaluations of the different Joint Undertakings under 
Horizon 2020 (7 in total), to ensure to the extent possible consistency between the seven 
evaluations running in parallel.  
 
Working Approach  
The Expert Group had to consider that no running project financed by BBI JU had been 
completed yet at the time of the evaluation activity, but rather most of them had just 
started.  In that respect, the Annual Work Programmes represented a point of relevance, 
as well as the definition and monitoring of the KPIs. Moreover, the Expert Group collected 
 18 
relevant quantitative and qualitative information from interviews with BBI stakeholders, 
combining and linking the different sources of information. 
In some cases the necessary data and information were incomplete (e.g. in kind 
contributions delivered by industry), and the problems were reported to the Commission 
staff, so that a solution was achieved upon the discussion of the issue. 
Attention was paid to the participation to BBI JU (in both proposals and projects), 
especially in terms of geographical distribution (see section 7.1). 
An ‘Intervention Logic Diagram’ (method recommended by the ‘Better Regulation’ 
package) was drafted to summarise the basis and rationale for the programme 
intervention, showing also the causal relationships and the expected outcomes and 
impacts of programme activities. 
 
Modus operandi  
The Expert Group executed the requirements specified under each task as mentioned 
above via a combination of collective and individual work carried out remotely and 
structured around regular meetings. The evaluation tasks were carried out through a 
constant sharing and discussion of the work among the experts. A Yammer group for on-
web communication between experts was started. 
At the kick-off meeting (14 November 2016) the Commission, in agreement with the 
Chair, specified the working methods of the Expert Group with a view to ensuring that 
the capacities of the Expert Group members are best utilized to allow in-depth analysis of 
all the areas covered by the Terms of Reference. 
More importantly, after the kick off meeting (14 November 2016),17 a regularly scheduled 
number of meetings took place, which had, as a first objective, the distribution of specific 
tasks and responsibilities among experts (22 December 2016). Minutes were made 
available to the experts and uploaded on Yammer to keep record of decisions and 
progresses. 
The tasks corresponding to questions 1-4 were assigned to Task Leaders (TLs), who, 
however, did not have the single responsibility for the analysis of the assigned question. 
Rather, all experts contributed to any evaluation question. The TLs were responsible for a 
preliminary check of the documents available on CORDA and for the identification of 
further needs in terms of data/documents or contacts to be established with relevant 
stakeholders (meeting of 18 January 2017).  
It must be underlined that since one of the experts receded from the assignment due to 
health reasons, the work that had been originally planned to be addressed by a group of 
six experts was redistributed by the end of January 2017 within the remaining working 
group composed of five experts. Nevertheless, the necessary decisions and actions were 
taken in the due time to minimise the impact, thus allowing the regular delivery of 
analysis results (meeting of 31 January 2017).  
 
 
 
 
 
                                                 
17 
http://ec.europa.eu/transparency/regexpert/index.cfm?do=groupDetail.groupDetail&groupID=3456&NewSearc
h=1&NewSearch=1 
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Table 1: Meetings attended by the experts 
Date of the 
meeting 
Location Minutes Participants 
14 November  
2016 
Kick-off Meeting, 
Brussels  
Available on CORDA Experts, EC 
22 December  
2017 
Teleconference Uploaded on 
Yammer  
Experts 
31 January 2017 Teleconference Notes circulated 
among experts 
Experts 
9 February 2017 Teleconference Uploaded on 
Yammer 
Experts 
2 March 2017 Rapporteurs meeting, 
Brussels  
EC minutes + l 
notes circulated 
among experts 
Rapporteur,  EC 
13 March 2017 Teleconference Uploaded on 
Yammer 
Experts 
27 March 2017 Teleconference Uploaded on 
Yammer 
Experts 
29 March 2017 BBI Interviews, 
Brussels 
Notes circulated 
among experts 
Experts,  BBI 
30-31 March 
2017 
Two-day Meeting, 
Brussels 
Available on CORDA Experts, EC 
12 April 2017  Teleconference Uploaded on 
Yammer 
Experts 
2 May  Teleconference Uploaded on 
Yammer 
Experts 
22 May  Teleconference Uploaded on 
Yammer 
Experts 
29-30 May 2017 Final Two-Day 
Meeting, Brussels 
Draft circulated by 
the EC 
Experts, EC, BBI 
2 June 2017 Teleconference Notes via e-mail Experts 
 
In order to facilitate the experts’ work and to provide some common references for the 
evaluation activity, a workflow was constructed where each question was dissected into 
articulated sub-questions. The list of documents present on CORDA was translated into a 
table and each folder/file was labelled for enabling the experts to apply a fast citation 
mode.  
Finally, cross-references between different questions were identified and highlighted, 
since the same documents are often relevant to different questions but from 
complementary perspectives. The  modus operandi and the progresses of the evaluation 
work were shared with EC Officers during the rapporteurs’ meeting of 2 March 2017. The 
Rapporteur created PowerPoint presentations to summarize the discussions held during 
teleconference meetings of the Experts. Moreover, the same meeting represented the 
occasion for refining the timeline for the delivery of preliminary drafts of the Mid-term 
evaluation report and served for coordination, by comparing notes with peer rapporteurs 
of Expert groups of the other six Joint Undertaking Mid-term evaluations active in 
parallel. 
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5.2. Limitations – robustness of findings 
Most of the data not available at the time of the launch of the evaluation activity (14 
November 2016) were promptly provided to the experts as soon as made available to the 
EC (e.g. Draft AAR 2016, IKOP analysis, results of on-line survey, statistical analysis of 
call 2016) with only few exceptions (e.g. rules for reporting IKOP and IKAA Report for 
2016, see section 7.3). Regarding evaluation question 2 (section 7.2), statistics analysis 
on budget and participation patterns according to value chains has been provided by the 
EC to the Expert group; furthermore, a separate presentation including projects from 
2016 call has been delivered by BBI just after the second Expert Group meeting.   
Regarding evaluation question 3 (section 7.3), it must be noted that the reported Key 
Performance Indicators KPI3 and KPI7 represent cooperation and flagship projects 
achieved already in 2016, whereas the other KPIs are projected to be achieved by 2020, 
because the projects are not yet completed. In order to provide an actual mid-term 
picture of the progress already achieved until 2016 also in respect to the second type of 
KPIs, the Expert Group has selected a number of projects to be analysed in more detail. 
The experts have put together a list of questions for project coordinators and then they 
have organized some interviews.  
The experts have carried out interviews also with representatives of BBI JU, the 
European Commission, BIC, the Chair of the States Representatives Group and Chair of 
the Scientific Committee. 
 
6. IMPLEMENTATION STATE OF PLAY (RESULTS) 
After the establishment and initial operation of BBI Joint Undertaking, for which the 
Commission was responsible according to Article 19 of BBI Council Regulation, BBI JU 
reached the operational capacity to implement its own budget on 26 October 2015 (see 
section 7.1). Driven by the multi-annual Strategic Innovation and Research Agenda 
(SIRA, 2013)18, describing the main technological and innovation challenges to be 
overcome in order to develop sustainable and competitive bio-based industries in Europe, 
BBI JU has set up solid tools for establishing Annual Work Plans. These outline the scope 
and details of research, innovation, demonstration and deployment activities to be 
carried out and prioritised for the calls for proposals (see section 7.2), the governance 
and activities and an annual budget (see section 7.3).  
 
Effectiveness of the initiative on the leverage of investments  
BBI JU is expected to leverage private resources by EU funds at a level that 
cannot be achieved by traditional instruments of Horizon 2020, which lack the 
strategic long-term approach regarding programming and financing (see section 7.3.2.3). 
In that respect, the budget of BBI JU reflects very ambitious goals in terms of substantial 
private investments. The private resources invested by the industry can be in kind 
contributions and in cash contributions. 
In kind contributions19 are one of the main forms of private contributions used by BBI 
JU.  Similar mechanisms for delivery private contributions are applied in all different JUs 
                                                 
18http://ec.europa.eu/research/participants/data/ref/h2020/other/legal_basis/jtis/bbi/bbi-sira_en.pdf 
http://ec.europa.eu/research/participants/data/ref/h2020/other/legal_basis/jtis/bbi/bbi-sira_en.pdf 
 
19 In kind contributions consist of the costs incurred by the members other than the Union or their constituent 
entities in implementing indirect actions less the contribution of the BBI Joint Undertaking and any other Union 
contribution to those costs (IKOP), or of costs incurred by the members other than the Union or their 
constituent entities in implementing additional activities outside the work plan of the BBI Joint Undertaking 
contributing to the objectives of the BBI Initiative (IKAA). 
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acting within the Horizon 2020 framework. Council Regulation No 560/2014 provides the 
limits regarding the in kind contributions (see section 7.3) to the operational costs 
(IKOP)20  as well the in kind contributions consisting of the costs incurred by them in 
implementing additional activities (IKAA).21 Furthermore, a commitment of BIC to 
contribute also financially (‘in cash’) to operational costs represents a distinct feature of 
BBI JU (see Section 7.3).22 
As underlined before, this Interim Evaluation of BBI Joint Undertaking (2014-2016) takes 
place at a very early stage, less than three years after the establishing of BBI JU, when 
no project has been concluded yet and only preliminary figures are available concerning 
leverage of investments. Nevertheless, the analysis of the documents provided by both 
the EC and BBI JU, as well information acquired through the direct consultation of some 
actors involved in the whole cycle of BBI JU financial and managerial activities, have 
pointed out that, at the time of this interim evaluation, there are still some difficulties in 
the interpretation of the regulation and modalities for delivery the different forms of 
private contribution planned in BBI JU statutes. 
One first issue is related to the interpretation of the regulation concerning the delivery of 
the financial contribution to operational costs by BIC. Other difficulties have been 
found for the establishment of the methodologies for planning, reporting and certification 
of both IKOP and IKAA, which has led to delays in the adoption of IKAA plans, and to 
uncertainties related to the reporting and certification of IKOP and IKAA23.  As regards 
IKOP, the current evaluation bases its assessment on contributions committed not only 
by BIC or its constituent entities but also by any other participant in BBI JU projects. 
More detailed analyses of the above mentioned difficulties as well as of the envisaged 
solutions are reported in sections 7.3 and 7.4. 
  
                                                 
20 Article 12.3 (c) of BBI JU Statutes. 
21 Article 4.2 (b) of Council Regulation No 560/2014.   
22 Article 12.4 of BBI JU Statutes. 
23 According to Commission Delegated Regulation (EU) No 1268/2012 of 29 October 2012 “The no-profit and 
co-financing principles should be revised in line with the clarifications and simplification measures introduced in 
the Financial Regulation. In particular, for the sake of clarity, it is necessary to establish detailed rules on the 
types of receipts to be retained for the no-profit principle as well as the forms of external co-financing and in 
kind contributions. ”   
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 7. ANSWERS TO THE EVALUATION QUESTIONS 
7.1 Evaluation question 1: Background to the initiative, objectives and 
relevance 
Public-private partnerships are one of the Horizon 2020 implementation modalities, 
where all involved members commit themselves to support the development and 
implementation of pre-competitive research and innovation activities of strategic 
importance to the Union's competitiveness and industrial leadership or to address specific 
societal challenges.24  
BBI JU is one of the several Horizon 2020 public-private partnership initiatives (see 
section 7.4). In order to assess the background, objectives and relevance of BBI JU both 
the overall context of public-private partnerships under Horizon 2020 and the specific 
context of the bio-based industries research and innovation need to be considered. They 
are included here in the assessment of evaluation question 1 by the expert group.  
As defined in Annex 3 of the Terms of Reference for the Expert Group, stakeholder 
interviews addressed the wider operating environment before and after setting up BBI JU 
via the following questions. 
 
What is the competitive position of the BBI Technologies in the short, medium 
and long terms? 
In the stakeholder interviews, the competitive position of BBI technologies, processes 
and concepts was discussed with representatives of the industry and the Commission 
officials. The interviewees largely agreed that before setting up of BBI JU the competitive 
position of Europe in BBI technologies was challenged by many of the demo size facilities 
being implemented in US and Asia. Well aligned with this initial challenge one of the key 
focus areas of BBI JU was to de-risk demonstration and commercialization of BBI 
technologies. The interviewees also largely agreed that the main positive effect of BBI JU 
in terms of competitiveness of BBI technologies comes via value chain driven cooperation 
across sectors, which helps scale up the technologies towards market applications. BBI 
JU is valuable especially for the long-term effect of bringing technologies to market and 
market replication. It is also an important signal effect for boosting the long-term 
development. Flagships are one aspect to bring the key BBI technologies to 
demonstration in the short term, to commercialization in the medium term and to market 
replication in the long term. In capital-intensive bio-based industries, technology 
commercialization takes time since it needs to be done with a staged approach. 
What changes have occurred from a technology development point of view (e.g. 
complementary/competitive technology) and in the global economic/financial 
context of this sector since the initiation of the BBI JU programme and what are 
their likely effects? 
The economic/financial aspects discussed by the interviewees included especially oil 
prices. Since setting up the BBI JU the oil price has reduced drastically, and the prices of 
agricultural commodities have somewhat reduced.  
 
 
 
 
 
                                                 
24Art 25.1 of the Council Regulation (EU) No 1291/2013 establishing Horizon 2020 
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Figure 1. Prices of oil and agricultural commodities. 
 
 
 
Oil price is affecting competitiveness of BBI technologies indirectly. Reducing oil prices 
make it harder for the bio-based value chains to be economically competitive. Slightly 
reduced prices of agricultural commodities can also have an indirect effect. In addition, 
many of the interviewees brought up sectoral evolvement. After setting up the BBI JU the 
sectors active in BIC have evolved to include also for example the food industry and 
increasing amount of brand owners. From technology development point of view the BBI 
technologies can be developed to better match the market requirements and be 
competitive in the marketplace when a wider array of downstream sectors are closely 
involved in the development work.  
One technological development that has occurred in the recent years is the development 
of carbon dioxide based chemicals and fuels production to first commercial facilities. If 
carbon dioxide based chemicals and fuels can be produced in techno economical feasible 
routes in the future it is likely that those applications will grow rapidly and indirectly 
affect the competitiveness of the BBI technologies. Based on the concept the effect on 
competitiveness of the BBI technologies can be positive or negative. If carbon dioxide is 
produced as a side product from bio-based processing chains, and utilized as a feedstock 
for chemicals and fuels, it can have a positive effect on overall competitiveness of bio-
based technologies. If carbon dioxide based chemicals can be produced in a cost 
competitive manner from other than bio-based sources, it can affect competitiveness of 
bio-based production routes negatively.  
In addition, digitalization is a mega trend that is transforming whole sectors and 
industries and needs to be considered also as a direct or indirect aspect affecting the 
competitiveness of BBI technologies. It can directly improve the competitiveness of bio-
based technologies through enabling e.g. better optimization of supply chains and 
processing concepts. It can also indirectly affect competitiveness of bio-based 
technologies by changing market demand and consumption patterns. 
 
7.1.1 Policy framework, context and background information 
The Bioeconomy Strategy 
The Commission Communication ‘Innovating for sustainable growth: A Bioeconomy for 
Europe’ aims to pave the way to a more sustainable use of renewable resources for 
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industrial purposes, while ensuring environmental protection. The Bioeconomy thereby 
also contributes significantly to the objectives of the Europe 2020 flagship initiatives 
‘Innovation Union’ and ‘A Resource Efficient Europe’.25  
The Bioeconomy strategy includes an Action Plan with three pillars: 
1) Investments in research, innovation and skills; 
2) Reinforced policy interaction and stakeholder engagement;  
3) Enhancement of markets and competitiveness in Bioeconomy.  
Action 10 of pillar 3 is to ‘Promote the setting up of networks with the required logistics 
for integrated and diversified biorefineries, demonstration and pilot plants across Europe, 
including the necessary logistics and supply chains for a cascading use of biomass and 
waste streams. Start negotiations to establish a research and innovation PPP for bio-
based industries at European level (by 2013).’  This sub-action point sets the concrete 
foundation for setting up BBI JU. 
 
Industrial policy 
Concerning industrial policy there are several relevant policy aspects backing up the need 
for establishing BBI JU. Bio-based products were identified as one key market area 
already in the Commission Communication of 21 December 2007 entitled ‘A lead market 
initiative for Europe’.26 The Lead Market Initiative, or LMI, firstly identifies promising 
emerging markets to be supported by concerted policy action and then designs a 
process to better streamline legal and regulatory environments and accelerate the 
growth of demand. Bio-based products were defined in the LMI as products that are 
made from renewable, biological raw materials such as plants and trees. The policy 
elements of the LMI – environmental regulations, standardization, labelling and 
encouraging Member States to set up demonstration plants – were expected to have a 
role to play, together with the Common Agriculture Policy. 
Later, the Commission Communication of 10 October 2012 entitled ‘A Stronger European 
Industry for Growth and Economic Recovery’ emphasises the strategic importance of bio-
based industries for the future competitiveness of Europe.27 Bio-based product markets 
are included as one priority action line there, and the specific actions for the Commission 
include:  
- Implementation of the Bioeconomy Strategy 
- Fostering markets for biobased products; 
- Speeding up the development of standards and their international recognition; 
- Promoting labelling and green public procurement; 
- Working with the industry to develop detailed proposals for a Bioeconomy PPP 
(2013-14 onwards). 
Both key policy aspects from the industrial policy point of view, the LMI and the renewed 
industrial policy, are in alignment with BBI JU PPP, and support its relevance. 
 
Public-private partnerships 
The European Commission has included public-private partnership initiatives under 
Horizon 2020, supporting the setting up of BBI JU from an institutional point of view (Art. 
                                                 
25 COM(2014) 339 final 10.6.2014, COM(2011)0571  
26 COM(200) 0860 final  
27 COM(2012) 582 final, Brussels, 10.10.2012 
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25 of Council Regulation (EU) No 1291/2013).28 The Innovation Investment Package was 
proposed in a Communication from the Commission in 2013 and was approved by the EU 
Member States in 2014.29 The package includes Joint Technology Initiatives that organise 
their own research and innovation agenda and award funding for projects based on 
competitive calls.  
BBI JU is one of the seven JTIs set up as Joint Undertakings (JUs). JUs are ‘Union bodies’ 
under Articles 208 and 209 of the EU Financial Regulation.30 The European Commission, 
as a co-founding member, is responsible for start up the JUs. Once the JUs have built up 
their legal and financial framework and demonstrated their operational capacity to 
implement their own budgets, they are granted autonomy. 
 
Setting up of BBI JU 
BBI JU has been established by Council Regulation (EU) No 560/2014 of 6 May 
2014. The background documents setting the scene include the Commission proposal, 
the impact assessment and the executive summary of the impact assessment.31  
The members of BBI JU are defined in the Statutes (which are annexed to the Council 
regulation) as the European Union, represented by the Commission, and the Bio-based 
Industries Consortium Aisbl32 (the ‘BIC’). The latter is a non-profit organisation 
established under Belgium law, with its permanent office in Brussels, Belgium33, which 
represents the industry group that supports BBI JU. Its members cover the entire bio-
based value chain and consist of large industries, small and medium-sized enterprises 
(SMEs), regional clusters, European trade associations and European Technology 
Platforms. Any interested stakeholders along the bio-based value chain may apply for 
membership. 
As described in the Council Regulation on establishing BBI JU, in 2013 BIC developed a 
vision paper and a Strategic Innovation and Research Agenda (SIRA),34 based on 
extensive consultation with public and private stakeholders.35 The SIRA describes the 
main technological and innovation challenges that need to be overcome in order to 
develop sustainable and competitive bio-based industries in Europe and identifies 
research, demonstration and deployment activities to be carried out by BBI JU.  
The bodies of BBI JU are defined in the Statutes set out in the Annex to the Council 
regulation as the Governing Board, the Executive Director, the Scientific Committee and 
the States Representatives Group. The bodies and their roles are briefly summarised in 
Table 2.36 
 
 
                                                 
28 Regulation (EU) No 1291/2013 final of the European Parliament and of the Council of 11 December 2013 
establishing Horizon 2020 - the Framework Programme for Research and Innovation (2014-2020) and repealing 
Decision No 1982/2006/EC Text with EEA relevance 
29 COM/2013/0494 Public-private partnerships in Horizon 2020: a powerful tool to deliver on innovation and 
growth in Europe (10/07/2013) 
30 Regulation (EU, Euratom) No 966/2012 of the European Parliament and of the Council of 25 October 2012 on 
the financial rules applicable to the general budget of the Union and repealing Council Regulation (EC, Euratom) 
No 1605/2002 
31 COM/2013/0496, 10/07/2013, SWD/2013/0247, SWD/2013/0248. 
32 http://biconsortium.eu 
33 upon acceptance of these Statutes, by means of a letter of endorsement. 
34 It must be noted that the SIRA was revised in 2017 but only the document published in 2013 was taken into 
account for the present evaluation. 
35 http://ec.europa.eu/research/participants/data/ref/h2020/other/legal_basis/jtis/bbi/bbi-sira_en.pdf 
36 Council Regulation (EU) No 560/2014 of 6 May 2014. 
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Table 2: Bodies of BBI JU 
Body Role  
Governing 
board 
Composed of five representatives of the Commission, on behalf of 
the Union; and five representatives of the members other than the 
Union (thus of BIC), at least one of which is a Small and Medium 
Enterprise (SMEs) representative. The Governing Board has overall 
responsibility for the strategic orientation and the operations of BBI 
Joint Undertaking and supervises the implementation of its activities. 
The Commission, within its role in the Governing Board, seeks to 
ensure coordination between the activities of BBI Joint Undertaking 
and the relevant activities of Horizon 2020 with a view to promoting 
synergies when identifying priorities covered by collaborative 
research.   
Executive 
Director 
The Executive Director is the chief executive responsible for the day-
to-day management of BBI Joint Undertaking in accordance with the 
decisions of the Governing Board. The Executive Director is the legal 
representative of BBI Joint Undertaking, accountable to the 
Governing Board. The Executive Director implements the budget of 
BBI Joint Undertaking. The Executive Director sets up a Programme 
Office for the execution, under his or her responsibility, of all support 
tasks arising from this Regulation. 
Scientific 
Committee 
Advisory body of BBI Joint Undertaking. The Scientific Committee 
consists of no more than fifteen members. It elects a chairperson 
from among its members. The members reflect a balanced 
representation of worldwide-recognised experts from academia, 
industry, SMEs, non-governmental organisations and regulatory 
bodies. Collectively, the Scientific Committee members have the 
necessary scientific competencies and expertise covering the 
technical domain needed to make science-based recommendations to 
BBI Joint Undertaking. 
States 
Representatives 
Group 
Advisory body of BBI Joint Undertaking. The States Representatives 
Group consists of one representative of each Member State and of 
each country associated to Horizon 2020. It elects a chairperson 
among its members. The States Representatives Group meets at 
least twice a year. Its chairperson convenes the meetings. The 
Executive Director and the chairperson of the Governing Board or 
their representatives attend the meetings. The chairperson of the 
States Representatives Group may invite other persons to attend its 
meetings as observers, in particular representatives of regional 
authorities within the Union, representatives of civil society or 
representatives of SME associations. 
 
The financial contributions to be made by members of the JU are set in the Council 
regulation as follows.37 The Union’s38 overall contribution to BBI JU to cover 
administrative costs and operational costs shall be up to EUR 975 000 000. The 
contribution of the Union shall be paid from the appropriations in the general budget of 
the Union allocated to the Specific Programme implementing Horizon 2020.39 The 
                                                 
37 Council Regulation (EU) No 560/2014 of 6 May 2014 
38 EU contribution including EFTA 
39 established by Decision 743/2013/EU, in accordance with point (c)(iv) of Article 58(1) and Articles 60 and 61 of 
Regulation (EU, Euratom) No 966/2012 for bodies referred to in Article 209 of that Regulation 
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members of BBI Joint Undertaking other than the Union shall make, or arrange for their 
constituent entities to make, a total contribution of at least EUR 2 730 000 000. The 
latter consist of a financial contribution to the operational costs (of at least EUR 182 500 
000 at programme level), financial contribution to administrative costs and of in kind 
contributions (IKOP). The total private contribution comprises, also, a minimum of EUR 1 
755 000 000 for implementing additional activities outside the work plan of BBI Joint 
Undertaking contributing to the objectives of BBI Initiative (IKAA). A more detailed 
explanation of the budget is available in section 7.3.2. Other Union funding programmes 
may support the in kind costs in compliance with the applicable rules and procedures. In 
such cases, Union financing shall not be a substitute for the in kind contributions from 
the members other than the Union or their constituent entities.  
According to the Council regulation the administrative costs of BBI JU shall not exceed 
EUR 58 500 000 and shall be covered by means of financial contributions divided equally 
on an annual basis between the Union and the members other than the Union. If part of 
the contribution for administrative costs is not used, it may be made available to cover 
the operational costs of BBI Joint Undertaking. 
Further analysis of roles, financial aspects and other institutional aspects of setting up 
BBI JU are reported in section 7.3.2. 
 
Expected synergies 
As described earlier, this mid-term evaluation will assess how the intervention works 
within Horizon 2020 between BBI JU and regular Horizon 2020 calls. The synergies, in 
this context, require good complementarity between the actions undertaken and projects 
supported, towards implementation of Horizon 2020 and its specific programmes, 
especially SC2 and LEIT. These aspects are considered in the further sections (evaluation 
question 2 and onwards). 
According to the Council regulation, BBI JU should develop close synergies with other 
Union programmes in areas such as education, environment, competitiveness and SMEs, 
and with the Cohesion Policy funds and Rural Development Policy. Horizon 2020 should 
also promote synergies with the European Structural and Investment Funds (ESIF). 
Therefore, BBI Joint Undertaking is expected to develop close interactions with the ESIF, 
which can specifically help to strengthen local, regional and national research and 
innovation capabilities in the area of BBI JU. 
As the procedures for supporting the expected synergies are not described in detail 
in the statutes or the other key background documents of BBI Initiative, the expert group 
assessed this aspect in the interviews of the Commission officials and BBI JU and BIC 
representatives.  
In the interviews, it was pointed out that there was a lack of official procedures for 
implementing the expected synergies with programmes on education, environment, 
competitiveness, SMEs, cohesion policy funds, rural development policy and European 
structural and investments funds. However, the work programmes and annual work 
programmes include references to possible complementary actions.  It was also 
commented that the BBI JU projects are governed by Horizon 2020 rules, making it 
challenging to have project level support also from structural funds, for example. 
Therefore, the synergies with structural funds and other funding instruments outside 
HORIZON 2020   need to be sought by parallel projects or on the multi-project level, or 
programme level.  
 
7.1.2 Situation before approval and setup of BBI JU 
In FP7, Bioeconomy research and innovation was funded within Theme 2 ‘Food, 
Agriculture and Fisheries, and Biotechnology’ (FAFB). It was divided into four main 
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thematic areas with an overall budget of EUR 1.9 billion, which represents an increase of 
46% over the corresponding research in FP6.40 The allocations to the thematic areas in 
FP7 were biotechnology 32%, agriculture 31%, food 27%, fisheries and aquaculture 9%. 
According to the ex-post evaluation of FP7 in the biotechnology area, which thematically 
is the closest to BBI JU scope, there was a shift in the later years towards industrial 
biorefinery projects, and product development away from research on novel sources of 
biomass, which was emphasised in the first years of FP7.  
Within the biotechnology area, the main activity areas had similar budget allocations. 
Primary production and novel sources of biomass and marine and fresh-water 
biotechnology received over EUR 200 million.41 Research and innovation projects on 
biorefinery and industrial biotechnology, which emphasise the middle and end parts of 
the value chains, received together close to EUR 200 million. The more crosscutting 
research on policies, emerging trends and environmental technology received together 
around EUR150 million. The biotechnology area grew very substantially over the life of 
the programme. Allocated funding more than doubled in absolute terms and increased 
from 24% of FAFB funding in 2007-2008 to 41% in 2012-2013.42 
While the funding of biotechnology research and innovation in Europe has grown 
significantly, this has not been matched by a corresponding implementation into the 
relevant industrial sectors in Europe. Therefore, a concerted effort by all stakeholders 
was envisioned to mobilise and structure the emerging and promising new sector 
of the bio-based industries in Europe towards building up Europe as the leading house 
of a future-oriented and sustainable Bioeconomy.   
The shift towards a value chain attitude and a market approach started already in FP7. 
Then, BBI initiative moved further towards solving the key problems identified in the 
various strategy and policy documents on development of the bio-based industries. BBI 
JU intends to increase a holistic value chain approach, to lower the risk for increasing 
industrial investment, and to shift the focus more towards demonstration and 
deployment.  
In the interviews with Commission officials and BBI JU and BIC representatives, some 
aspects of the situation before setting up BBI JU were highlighted. A first relevant aspect 
was that in 2012-2014, the EU had a more knowledge- and technology-oriented view on 
the bio-based industries, while the US and Asia were providing market and financial 
support for deployment, providing ground for production investments. Back at that time, 
some Member States had developed Bioeconomy strategies already, but also those were 
mainly focused on knowledge and technology. Furthermore, the political support was 
mainly for biofuels, whereas for other sectors of the bio-based industries the support 
focused on R&D level. Thus, there was an identified gap from knowledge to 
production, as reported, for example, in the Key Enabling Technologies report of the 
European Commission.43 
Considering this background, the industry was willing to join forces and develop BBI PPP 
with a target to move towards increasing deployment, market awareness and regional 
involvement across sectors and value chains.  
                                                 
40 European Commission (2014). An ex-post evaluation of the rationale, implementation and impacts of EU 
Seventh Framework Programme (2007-2013), Cooperation Theme 2: Food, agriculture and fisheries, and 
biotechnology. Report to the European Commission. 
41 European Commission (2014). An ex-post evaluation of the rationale, implementation and impacts of EU 
Seventh Framework Programme (2007-2013), Cooperation Theme 2: Food, agriculture and fisheries, and 
biotechnology. Report to the European Commission. 
42 European Commission (2014). An ex-post evaluation of the rationale, implementation and impacts of EU 
Seventh Framework Programme (2007-2013), Cooperation Theme 2: Food, agriculture and fisheries, and 
biotechnology. Report to the European Commission. 
43 Communication From The Commission To The European Parliament, The Council, The European Economic And Social 
Committee And The Committee Of The Regions “A Stronger European Industry for Growth and Economic Recovery 
Industrial Policy” Communication Update. COM/2012/0582 final. 
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In the interviews, the change of situation before and after creating BBI JU was 
characterised mainly through two main aspects: BBI JU has provided a structuring 
effect, bringing together the sectors and actors towards deployment of new value 
chains, and it has mobilised increasing investments on developing innovations for the 
bio-based industries. 
 
7.1.3 Introduction to BBI JU and the problems it intended to solve 
Specific objectives of BBI JU 
The specific objectives of BBI JU laid down by Article 2 of Council Regulation (EU) 
560/2014 of 6 May 2014 are: 
‘(a) to contribute to the implementation of Regulation (EU) No 1291/2013 and in 
particular Part III of Decision 2013/743/EU;  
(b) to contribute to the objectives of BBI Initiative of a more resource efficient and 
sustainable low-carbon economy and increasing economic growth and employment, in 
particularly in rural areas, by developing sustainable and competitive bio-based 
industries in Europe based on advanced biorefineries that source their biomass 
sustainably, and in particular to: (i) demonstrate technologies that enable new chemical 
building blocks, new materials, and new consumer products from European biomass 
which replace the need for fossil- based inputs; (ii) develop business models that 
integrate economic actors along the whole value chain from supply of biomass to 
biorefinery plants to consumers of bio-based materials, chemicals and fuels, including by 
means of creating new cross-sector interconnections and supporting cross-industry 
clusters; (iii) set up flagship biorefinery plants that deploy the technologies and business 
models for bio-based materials, chemicals and fuels and demonstrate cost and 
performance improvements to levels that are competitive with fossil-based alternatives.’  
Objectives of BBI JU are in line but also complementary with other parts of Horizon 2020 
in particular ‘Leadership in nanotechnologies, advanced materials, biotechnology and 
advanced manufacturing and processing’  (LEIT) and ‘Improving food security, 
developing sustainable agriculture, marine and maritime research and the Bioeconomy’  
(Societal Challenge 2).  
 Moreover, 15% of the Union contribution to BBI JU is financed by the LEIT program and 
the remaining 85% is financed by the SC2 program. 
 
Challenges BBI JU intends to overcome 
The challenges addressed by BBI JU and the related targets are summarised in Table 3. 
Table 3: Challenges addressed by BBI JU 
 
Targets Challenges intended to be overcome 
Improved synergies in innovation Dispersion of technical competences 
Lacking of critical mass  
Reducing risk for private investment Market failures that discourage private 
investment into pre-competitive research, 
demonstration and deployment activities 
for bio-based industries 
Risk for private research and innovation 
investment in the development of 
sustainable and competitive bio-based 
products and biofuels 
Improving reliable knowledge base and Limited data publicly available on real 
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functioning of biomass supply chains resource availability, considering building 
sustainable and competitive value chains 
Limited availability of reliable biomass 
supply considering building sustainable 
and competitive value chains 
Increasing investment in development of 
the bio-based industry sector 
Insufficient investment in the 
development of a sustainable bio-based 
industry sector in Europe considering 
being a key player in research, 
demonstration and the deployment of 
advanced bio-based products and biofuels 
Establishment of new sustainable value 
chains 
Insufficient collaboration between 
stakeholders along the entire bio-based 
value chains, including primary production 
and processing industries, consumer 
brands, SMEs, research and technology 
centres and universities considering being 
a key player in research, demonstration 
and the deployment of advanced bio-
based products and biofuels 
 
The problems summarised above are aligned with the key policy documents and 
strategies, the Bioeconomy Strategy and the industrial policy, and the main findings of 
the impact assessment.  
 
7.1.4 Intervention logic 
The intervention logic diagram is presented as defined in the evaluation guidelines of the 
Better Regulation package, summarising the evaluation work of the expert group on 
drivers and needs, inputs, activities, expected outputs, expected results and expected 
impacts of the BBI JU and showing how different measures were expected to interact 
with each other according to the key background documents, including the Bioeconomy 
strategy, Council Regulation on BBI JU and BBI JU SIRA. 
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Table 4: Intervention logic.
  
INPUTS FOR 
BBI-JU
ACTIVITIES OF BBI-JU OUTPUTS OF BBI-JU RESULTS OF BBI-JU IMPACTS OF BBI-JU
EC financial 
contribution to 
BBI JU
RIAs (Objective in SIRA 30%): 
TRL 3-5, Bridging 
technological and concept-
level gaps in bio-based value 
chains. Dedicated projects on 
the development of specific 
technologies and concepts 
needed to realise the value 
chains, and proving the 
principles in pilot installations.
Approaches for sustainable and efficient production, mobilisation and 
use of biomass
Development of supply chains of  biomass (forest and agro based), byproducts and bio-based waste 
streams, e.g. production in marginal land, cost-efficient mobilisation, supply chain synergies. 5 to 10 new/innovative 
species varieties; 10% higher mobilisation of forest biomass by innovative technologies; 10% higher biomass yield by 
combining innovative cultivation methods with the regional most suitable crop rotation; Higher efficiency of fertiliser use 
(focus on N, P, K) by 15% increase of harvested biomass per unit of fertiliser; 15% increase in the water use 
efficiency by adapted crop rotations and management practices. 
Reduced dependency on fossil 
materials and fuels and 
increased use of European 
biomass sources, including better 
use of underutilised land and bio 
waste streams
Industrial 
contribution to 
BBI JU (in 
cash and in 
kind, including 
IKOP)
Demo projects (Objective in 
SIRA 30%): 
TRL 4-6, Demonstration of bio-
based processes and value 
chains integrating the actors 
along the value chain 
Development of new resource, energy and cost efficient processes, 
technologies and concepts for holistic utilization of European 
biomass into new chemical building blocks, materials and new 
consumer products in advanced biorefineries and bringin existing 
value chains to new levels by optimised use of feedstock and by-
products
Shift to novel resource-efficient processing methods for biomass and bio-based products, e.g. increasing 
yields over processing chain, holistic raw material utilization, improved energy integration across the value chain
Reduction in CO2 emissions. 
Reduced resource intensity of 
processing and improved 
resource efficiency (in terms of 
energy, materials, chemicals, 
water).
Additional 
activities by 
the industry 
linked to but 
outside of BBI 
JU projects 
(IKAA)
Flagships (Objective in SIRA 
34,75%): 
TRL 7-8, Bringing bio-based 
value chains into readiness for 
commercial deployment by 
setting up flagship biorefinery 
plants and integrating the 
actors along the value chain
 
Development of bio-based products (chemical building blocks, 
materials, consumer products) and biologically active compounds 
(BBI-JU KPIs: 5 new building blocks based on biomass of European 
origin validated at demonstration scale, further increasing to 10 in 
2030, 50 new bio-based materials (eg. such as specialty fibres, 
plastics, composites and packaging solutions, 30 new demonstrated 
‘consumer’ products based on bio-based chemicals and materials) 
New bio-based products, value chains,  businesses and investments e.g. in new bio-based chemicals and 
materials. The new bio-based products resulting from the BBI will on average have an at least 50% reduction on 
green house gas emission compared to their fossil alternatives. 5 new building blocks based on biomass of European 
origin validated at demonstration scale, further increasing to 10 in 2030; 10 functionalised chemicals and materials 
developed, with demonstration of their economic feasibility, lower environmental footprint and societal benefits; 5 
successfully demonstrated concepts for valorisation of proteins from plant residues; 50 new bio-based materials (eg. 
such as specialty fibres, plastics, composites and packaging solutions); 30 new demonstrated ‘consumer’ products 
based on bio-based chemicals and materials;
5 new biodegradable, compostable or recyclable bio based products and materials for short life application. 
Improved competitiveness and 
growth of European bio-based 
industries
CSAs (Objective in SIRA 
3,25%):  addressing the cross-
cutting challenges and 
supporting the value chains to
become reality
Scale-up and demonstration of new bio-based value chains including 
development of associated business models and demonstration of 
performance against fossil alternative chains (BBI-JU KPIs: At least 
10 new bio-based value chains, At least 5 flagships resulting from the 
BBI producing new bio-based materials, chemicals and fuels which 
have proven to become cost-competitive to the alternatives based on 
fossil resources (at least 1 per value chain)
Market uptake for new bio-based building blocks and new consumer products, e.g. by green public 
procurement. 
Strengthening rural economies and 
high-skilled job increase. 
10 new regional biorefinery 
clusters raised: biorefinery 
demonstrations, with regional 
biomass supply, 10 conversion of 
existing and unused facilities into 
biorefineries 
Programme management
Stakeholders engagement and demand-side measures supporting 
market development of bio-based products
Improved awareness and perception of bio-based products, consumer acceptance
Improved nutrient cycle, reduced 
toxicity and other environmental 
benefits, e.g. through bio-waste 
utilization
Supporting development of regulation, standards and certifications for 
biomass, processing and bio-based products
Development of sustainability assessment of bio-based value chains
New cross-sector interconnections (BBI-JU KPI: 36 new cross-sector 
interconnections in bio-based economy clusters)
DRIVERS/NEEDS
Bioeconomy strategy 
and action plan: 
drivers / needs include 
1) feeding the increasing 
population, 
2) depletion of natural 
resources, 
3) impacts of increasing 
environmental 
pressures, 
4) climate change. 
The strategy has three 
pillars responding to 
these drivers for these in 
the area of bioeconomy: 
Investments in research, 
innovation and skills; 
Reinforced policy 
interaction and 
stakeholder 
engagement; 
Enhancement of 
markets and 
competitiveness.
BBI-JU Regulation: 
PPP to support the 
establishment of 
sustainable and competitive 
bio-based industries and 
value chains in Europe. 
Integration of biomass 
producing and processing 
sectors in order to reconcile 
food security and natural 
resource scarcity and 
environmental objectives 
with the use of biomass for 
industrial and energy 
purposes
BBI-JU SIRA: 
1) demonstrate technologies that 
enable new chemical building 
blocks, new materials, and new 
consumer products from 
European biomass which replace 
the need for fossil-based inputs; 
2) to develop business models 
that integrate economic actors 
along the whole value chain from 
supply of biomass to biorefinery 
plants to consumers of  bio-
based materials, chemicals and 
fuels, including by means of 
creating new cross-sector 
interconnections and supporting 
cross-industry clusters; 
3) set up flagship biorefinery 
plants that deploy the 
technologies and business 
models for bio-based materials, 
chemicals and fuels and 
demonstrate cost and 
performance improvements to 
levels that are competitive with 
fossil-based alternatives. 
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7.2 Evaluation question 2: Implementation of BBI Joint Technology 
Initiative44 
Concerning BBI JU organization, its staff is organized as reported in Figure 2. 
 
Figure 2: Organisational structure of BBI JU. 
 
 
 
While the BBI JU full staff complement is as set out in Figure 2, recruitment has been 
ongoing. Staffing complements reported in annual reports.  
- 0 (in start-up phase and initiating recruitment) as recorded in 2014 annual 
report45 
- 13 as recorded in 2015 annual report46 
- 20 as recorded in 2016 annual report 47 
The data analysed in this section reflects the progresses in the implementation of BBI 
JU initiative as of May 2017 concerning the portfolio of projects selected for funding (65 
projects in total). The deadline for the last call for proposals from which the portfolio was 
selected was 8 September 2016. The grant agreements with the projects from this call 
were signed on May 201748. 
The purpose of this section is to provide the statistical analysis of the state of play 
and provide information about different participation patterns and the distribution of 
funds. Comparison of some participation patterns with those of two other Horizon 2020 
programmes:  
                                                 
44 The SIRA developed by BIC describes the main technological and innovation challenges that need to be 
overcome in order to develop sustainable and competitive bio-based industries in Europe and identifies 
research, demonstration and deployment activities to be carried out by a Joint Technology Initiative. Such 
programmatic content is implemented, although non exclusively, by BBI JU, which is the object of this 
evaluation. 
45 BBI JU Annual Activity Report 2014 
46 BBI JU Annual Activity Report 2015 
47 BBI JU Annual Activity Report 2016 
48 The analysis extends the ToR limit of 31 December 2016. 
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1) Societal Challenge 2: Food Security, Sustainable Agriculture and Forestry, Marine and 
Inland Water Research and the Bioeconomy (SC2)  (statistics for all calls including SME 
instrument)49; and  
2) LEIT KET Biotechnology programme (LEIT) (statistics for all calls including SME 
instrument) 50 is presented. 
This section provides necessary background information for the evaluation of 
effectiveness of implementation, BBI performance, EU added value and coherence that 
follows this chapter. 
 
7.2.1 Presentation of an overview of calls launched and implemented during the 
period 2014-2016 
The analysis presented in this report concerns the calls launched and implemented by 
BBI JU during the period 2014-2016. In this period, the project grants were allocated via 
four calls for proposals as listed in Table 5. The calls were launched for 65 call topics, to 
which 222 proposals were submitted in total. The total success rate (ratio of all 
funded to all submitted proposals) was 29%. This is significantly higher than the 
success rate for the main calls in SC2 (21.5)  51and the success rate in LEIT KET 
(19.9%).52  
The total EC contribution (in commitment appropriations) to BBI JU operational 
expenditure over 2014-2016 amounted to EUR 418.29 million and the total financial 
contribution committed by BIC at programme level, for the same expenditure and over 
the same period amounted to EUR 0.75 million. Out of the total contributions committed 
by the two members of the JU, EUR 414.29 million were subsequently committed by the 
BBI JU in individual projects selected for funding. BBI JU will use the rest (EUR 4.75 
million) of the EU (including EFTA) contribution to BBI JU operational expenditure in 
2014-2016 in calls for proposals in subsequent years. 
In CORDA statistics, the financial contribution of industry to operational costs is included 
in the projects’ budget (EC net requested project contribution). Therefore, the total 
budget in all below presented statistics equals to EUR 414.29 million, which 
corresponds to EUR 413.54 million of EU (incl. EFTA) contribution plus EUR 0.75 
million of industry financial contribution to operational costs at programme 
level in 2016. 
BBI JU selected 65 projects for funding: 6 Coordination and Support Actions (BBI-CSA), 
26 Innovation Actions (IA) (thereof 20 Demonstration Actions (BBI-IA-DEMO) and 6 
Flagship Actions (BBI-IA-FLAG)), and 33 Research and Innovation Actions (BBI-RIA) 
(Table 6). In terms of funding, 72.7% of the BBI JU
53
 contribution (EUR 301.18 million) 
was dedicated to Innovation Actions (39.5% to DEMO and 33.2% to FLAG projects); 25.9% 
(EUR 107.1 million) went to RIAs and 1.4% (EUR 5.85 million) to CSAs (Table 7).  
 
 
 
 
                                                 
49 DG RTD, unit F.1. Statistics on SC2 programme including SME instrument, (cut-off January 2017); 
50 DG RTD, unit D.2. Statistics on LEIT KET Biotechnology programme including SME instrument, (Cut-off 31 
March 2017). 
51 DG RTD, unit F.1. Statistics on SC2 programme including SME instrument, (Cut-off 31 March 2017). 
52 DG RTD, unit D.2. Statistics on LEIT KET Biotechnology programme including SME instrument, (Cut-off 31 
March 2017). 
53 The BBI JU contribution to calls 2014-2016 of EUR 414.29 million comprises EUR 413.54 million of 
EUcontribution (out of the total EUR 418.29 million that has been committed by the EU) and EUR 0.75 million of  
industry contribution 
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Table 5. Calls overview 2014-2016. 
 
Call Contribution 
awarded  to 
funded 
projects (in 
million 
EUR)* 
No. of 
topics 
No. of 
submitted 
proposals 
No. of 
funded 
projects  
Success rate 
per call 
(funded/sub
mitted 
proposals) 
H2020-BBI-PPP-
2014-1 
49.65 16 38 10 26.3% 
H2020-BBI-JTI-
2015-01  
73.74 3 9 3 33.3% 
H2020-BBI-PPP-
2015-02 
105.30 19 73 23 31.5% 
H2020-BBI-JTI-
2016  
185.60 27 102 29 28.4% 
Total 414.29* 65 222 65 29.3% 
Source: CORDA analysis; * EUR 413.54 million of EU (incl. EFTA) contribution + EUR 
0.75 million industry financial contribution to operational costs at programme level in 
2016 
Table 6. Project numbers per call and per type of action (2014-2016) 
 
Calls Project types 
  BBI-
CSA 
BBI-IA-
DEMO 
BBI-IA-
FLAG 
BBI-
RIA 
Grand 
Total 
H2020-BBI-PPP-2014-
1 
0 2 1 7 10 
H2020-BBI-PPP-2015-
1-1 
0 0 3 0 3 
H2020-BBI-PPP-2015-
2-1 
3 9 0 11 23 
H2020-BBI-JTI-2016 3 9 2 15 29 
Grand Total 6 20 6 33 65 
In percentage 
H2020-BBI-PPP-2014-
1 
0.0% 20.0% 10.0% 70.0% 100.0% 
H2020-BBI-PPP-2015-
1-1 
0.0% 0.0% 100.0% 0.0% 100.0% 
H2020-BBI-PPP-2015-
2-1 
13.0% 39.1% 0.0% 47.8% 100.0% 
H2020-BBI-JTI-2016 10.3% 31.0% 6.9% 51.7% 100.0% 
Grand Total 9.2% 30.8% 9.2% 50.8% 100.0% 
Source: CORDA analysis. 
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Table 7. Contribution per call and per type of action (in EUR million) (2014-
2016) 
 
Calls Project types 
  
BBI-
CSA 
BBI-IA-
DEMO 
BBI-IA-
FLAG 
BBI-
RIA 
Grand 
Total* 
H2020-BBI-PPP-2014-
1 0.00 19.72 17.00 12.94 49.65 
H2020-BBI-PPP-2015-
1-1 0.00 0.00 73.74 0.00 73.74 
H2020-BBI-PPP-2015-
2-1 2.96 62.67 0.00 39.67 105.30 
H2020-BBI-JTI-2016 2.89 81.21 47.01 54.49 185.60 
Grand Total 5.85 163.59 137.75 107.10 414.29* 
In percentage 
H2020-BBI-PPP-2014-
1 0.0% 39.7% 34.2% 26.1% 100.0% 
H2020-BBI-PPP-2015-
1-1 0.0% 0.0% 100.0% 0.0% 100.0% 
H2020-BBI-PPP-2015-
2-1 2.8% 59.5% 0.0% 37.7% 100.0% 
H2020-BBI-JTI-2016 1.6% 43.8% 25.3% 29.4% 100.0% 
Grand Total 1.4% 39.5% 33.2% 25.9% 100.0% 
 
Source: CORDA analysis;* EUR 413.54 million of EU (incl. EFTA) contribution + EUR 0.75 
million industry financial contribution to operational costs at programme level in 2016. 
 
Concerning the programming procedures, there is no doubt that inputs from industries 
in Europe on the work programme are the distinctive feature of JUs. Nevertheless, the 
dynamic developments in the creation of new bio-based industries offer additional 
opportunities for shaping the work programmes, including new approaches and new 
directions which a single member country, organization or scientific discipline could not 
realize and which require a common European effort. Therefore, a balanced consideration 
of all dimensions of the EU added value and a more active (in contrast to ‘reactive’) 
involvement of the EC could be beneficial to industry, science and society in building the 
Innovation Union. 
 
7.2.2 Participation patterns by country and region: trends and specificities  
A summary of the geographical participation in BBI calls and projects is presented in 
Tables 8 and 9. The tables are divided by the country groups (EU15, EU13, Associated 
Countries and Third Countries). The individual countries in each group are listed in 
alphabetic order.  
The countries with the highest funding received and numbers of participations are 
Germany (EUR 71.64 million; 99 participations), Italy (EUR 51.07 million; 76), 
Netherlands (EUR 48.09 million; 87), France (EUR 36.02 million; 66) and Spain (EUR 
33.38 million; 85). The same countries score highest in terms of coordinators’ numbers 
(DE: 7, IT: 8, NL: 10, FR: 6 and ES: 12). Interestingly, UK, the country scoring highest 
in terms of participation and budget received in the main SC2 calls, falls behind in BBI, 
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with only EUR 18.52 million received and 48 participations. The UK success rate is 
surprisingly low (only 23.8%) compared to EU15 average (31.3 %). All countries that 
rank highest in BBI calls belong to EU15 (Member States of the EU prior to the accession 
of ten candidate countries on 1 May 2004). 
From the EU13 (Member States that joined the EU in 2004 or later), Slovakia (EUR 21.5 
million received and 10 participations) and Poland (EUR 5.46 million; 11) are the most 
active. Interestingly, Slovakia is also among the top five countries in terms of success 
rate (66.7%).  
Norway leads in terms of funding received as well as participation numbers among the 
Associated Countries (EUR 29.52 million; 14), followed by Iceland (EUR 2.16 million; 
5) and Switzerland (EUR 0.76 million; 12). 
Although there was some interest in BBI calls among Third Countries (21 applications 
in total), eventually no applicant from this country group received funding. 
EU15 accounts by far for the most participation and the most funding committed in BBI 
in the period 2014-2016. EU15 has 671 participations in total, which account for 89% 
of all participations, and this group receives EUR 348.12 million (84% of the total). 
Most of the project coordinators (62; 93.9%) come from this country group. The 
participants from EU13 countries account for only 6% (45 participations) of the total 
and receive only 7.9% of the EC funding (EUR 32.90 million), very similar to the 
Associated Countries (EUR 33.28 million). So far there is only one project coordinator 
from EU13 (from Poland), and the success rate of 19.7% is far below that of EU15 
(32.6%) or even Associated Countries (27.9%).  
 
Table 8. Participation by country: No. of applications, applicants, participations, 
participants, coordinators, contribution in millions of Euro and success rates 
(2014-2016). 
 
Cou
ntry 
Total 
applica
tions 
Total 
applic
ants 
Total 
particip
ations 
Total 
partici
pants 
Total 
coordina
tors* 
Contribut
ion**  
Success rate 
(participation/ap
plications) 
EU15 
AT 92 65 22 21   5.32 23.9% 
BE 143 88 59 47 4 26.57 41.3% 
DE 278 186 99 80 7 71.64 35.6% 
DK 66 40 15 14 1 4.73 22.7% 
EL 60 42 8 6 1 3.80 13.3% 
ES 266 174 85 65 12 33.38 32.0% 
FI 112 63 43 29 6 14.41 38.4% 
FR 153 111 66 58 6 36.02 43.1% 
IE 50 33 14 12 2 15.92 28.0% 
IT 288 172 76 61 8 51.07 26.4% 
NL 192 115 87 67 10 48.09 45.3% 
PT 80 56 13 13   3.30 16.3% 
SE 75 45 36 28 3 15.37 48.0% 
UK 202 145 48 41 2 18.52 23.8% 
EU13 
BG 8 8         0.0% 
CY 8 8 1 1   0.41 12.5% 
CZ 20 19         0.0% 
EE 7 6 1 1   0.11 14.3% 
HR 32 25 9 6   2.52 28.1% 
HU 17 15 7 7   1.61 41.2% 
LT 10 9 1 1   0.37 10.0% 
LV 24 19 1 1   0.33 4.2% 
MT 3 2         0.0% 
PL 41 32 11 10 1 5.46 26.8% 
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RO 23 21 3 3   0.46 13.0% 
SI 21 17 1 1   0.13 4.8% 
SK 15 15 10 10   21.50 66.7% 
Associated countries (AC) 
BA 1 1         0.0% 
CH 33 26 12 12   0.76 36.4% 
FO 2 2 1 1   0.50 50.0% 
IL 12 9         0.0% 
IS 10 8 5 4 1 2.16 50.0% 
ME 1 1         0.0% 
MK 2 1         0.0% 
NO 37 25 14 12 2 29.52 37.8% 
RS 15 13 2 2   0.25 13.3% 
TN 5 5         0.0% 
TR 14 13 4 4   0.08 28.6% 
UA 4 4         0.0% 
Third countries 
AR 1 1         0.0% 
AU 2 1         0.0% 
BR 1 1         0.0% 
CA 2 2         0.0% 
CL 1 1         0.0% 
CN 4 4         0.0% 
CR 1 1         0.0% 
DZ 1 1         0.0% 
EG 1 1         0.0% 
KE 1 1         0.0% 
KZ 1 1         0.0% 
RU 1 1         0.0% 
SM 1 1         0.0% 
US 2 2         0.0% 
VN 1 1         0.0% 
Tota
l 2443 1659 754 618 66 414.29** 30.9% 
Source: CORDA analysis;  
*3 coordinators are in charge of multiple projects; FIBIC (FI): 2 prom., IMECAL (ES):2 
project, VTT (FI): 2 projects. duplicates were not removed; 1 project SmartLi has 2 
coordinators 
* *EUR 413.54 million of EU (incl. EFTA) contribution + EUR 0.75 million industry 
financial contribution to operational costs at programme level in 2016 
 
Table 9. Participation patterns by country group: No. of applications, applicants, 
participations, participants, coordinators, BBI JU contribution (in million Euro) 
and success rates (2014-2016) 
 
Country 
group 
Total 
applic
ations 
Total 
applica
nts 
Total 
participat
ions 
Total 
participants 
Total 
coordinat
ors* 
Contribut
ion**  
Success 
rate 
(participati
on/applica
tions) 
EU 15 2057 1335 671 542 62 348.12 32.6% 
EU13 229 181 45 41 1 32.90 19.7% 
EU 28 2286 1516 716 583 63 381.01 31.3% 
AC 136 108 38 35 3 33.28 27.9% 
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Third 
countri
es 21 20 0 0 0 0.00 0.0% 
Total 2443 1644 754 618 66 
414.29*
* 30.9% 
In percentage 
EU 15 84.2% 81.2% 89.0% 87.7% 93.9% 84.0%   
EU13 9.4% 11.0% 6.0% 6.6% 1.5% 7.9%   
EU 28 93.6% 92.2% 95.0% 94.3% 95.5% 92.0%   
AC 5.6% 6.6% 5.0% 5.7% 4.5% 8.0%   
Third 
countri
es 0.9% 1.2% 0.0% 0.0% 0.0% 0.0%   
Total 
100.0
% 100.0% 100.0% 100.0% 100.0% 100.0%   
Source: CORDA analysis 
*3 coordinators are in charge of multiple projects; FIBIC (FI): 2 projects, IMECAL (ES):2 
projects, VTT (FI): 2 projects; duplicates were not removed; 1 project SmartLi has 2 
coordinators 
* *EUR 413.54 million of EU (incl. EFTA) contribution + EUR 0.75 million industry 
financial contribution to operational costs at programme level in 2016 
 
7.2.3 Participation patterns broken down by type of beneficiary organisation 
(universities, research organisations and industry including large companies 
and SMEs) 
Participation patterns broken down by type of beneficiary organisation are presented in 
Tables 10 and 11. 
The selected proposals under BBI JU represent 754 participations, mobilising 618 distinct 
participants corresponding to an average of 1.2 participations per participant. The 
majority of participants are private-for-profit entities (PRC) (406, i.e. 65.7%). PRC 
include large companies and SMEs. Please note, that CORDA does not distinguish 
between these two types of organisations, which would be useful in order to better 
estimate SMEs participation in different programmes.  
The percentage of PRC is very high in BBI compared to the main SC2 calls. It is also 
significantly higher than in LEIT programme (49%)54. 15.9% of BBI call participants are 
Research organisations (REC), and 11.8% are Higher and Secondary Education 
Establishments (HES). These figures are significantly lower than in the main SC2 calls. In 
LEIT, HES and REC constitute 24 and 17%, respectively55. Public bodies in BBI (PUB) 
account for 1%, and the remaining 5.7% are other types of actors.  
 
Table 10. Participation patterns by beneficiary type: No. of applications, 
applicants, participations, participants, coordinators, BBI JU contribution (in 
million Euro) and success rates (2014-2016). 
 
                                                 
54 DG RTD, unit D.2. Statistics on LEIT KET Biotechnology programme including SME instrument, (Cut-off 31 
March 2017). 
55 DG RTD, unit D.2. Statistics on LEIT KET Biotechnology programme including SME instrument, (Cut-off 31 
March 2017)  
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Type of 
beneficiary 
No. of 
applicati
ons 
No. of 
applican
ts 
No. of 
participati
ons 
No. of 
participa
nts 
Total 
coordina
tors 
Contribu
tion*  
Success 
rate: 
participati
on/applic
ation 
Higher or 
Secondary 
Education 
Establishme
nt (HES) 538 312 96 73 8 44.80 17.8% 
Research 
Organisation
s (REC) 459 241 146 98 24 66.30 31.8% 
Public 
bodies 
(PUB) 29 27 6 6 0 0.63 20.7% 
Private for 
profit 
entities 
(PRC) 1311 1003 466 406 29 292.76 35.5% 
Other (OTH) 106 76 40 35 5 9.81 37.7% 
Total 2443 1659 754 618 66 414.29* 30.9% 
In percentage 
Higher or 
Secondary 
Education 
Establishme
nt (HES) 22.0% 18.8% 12.7% 11.8% 12.1% 10.8%   
Research 
Organisation
s (REC) 18.8% 14.5% 19.4% 15.9% 36.4% 16.0%   
Public 
bodies 
(PUB) 1.2% 1.6% 0.8% 1.0% 0.0% 0.2%   
Private for 
profit 
entities 
(PRC) 53.7% 60.5% 61.8% 65.7% 43.9% 70.7%   
Other (OTH) 4.3% 4.6% 5.3% 5.7% 7.6% 2.4%   
Total 100.0% 100.0% 100.0% 100.0% 100.0% 100.0%   
Source: CORDA analysis;* EUR 413.54 million of EU (incl. EFTA) contribution + EUR 0.75 
million industry financial contribution to operational costs at programme level in 2016 
 
In terms of funding, 70.7% (EUR 292.76 million) of the contribution goes to PRC, 
16% (EUR 66.3 million) to REC, 10.8% (EUR 44.8 million) to HES, 0.2% (EUR 0.63 
million) to PUB, and 2.4% (EUR 9.81 million) to other organisations. This pattern 
significantly differs from the main SC2 calls, were the highest percentage of the budget 
goes to REC (33.1%) and HES (27%), whereas the private sector (PRC) receives only 
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around 27.2% of the total contribution56. In LEIT PRC, receive the highest share of 
funding (39.2%), followed by HEC (30.6%) and REC (24.6%)57 
Success rates vary considerably for different types of actors. They also differ from those 
in the main SC2 calls. 35.5% of private-for-profit entities in proposals are funded in BBI, 
compared to 17.4% in main SC2 calls58 and 15.3% in LEIT59. HES success rates (17.8%) 
are lower than in SC2 (19.4%) and in LEIT (23.4%). REC’s success rates (31.8%) are 
similar to LEIT (33.1%) but higher than in SC2 (26.8%). In contrary, public bodies 
succeed more often in LEIT (64%) and SC2 (42.3%) than in BBI (20.7%). Total success 
rates in BBI (30.9 %) are significantly higher than those in SC2 (21.5%) and in LEIT 
(19.9%). 
BBI calls have a very good SME participation (Table 11). 35.4% (219 of the total 
618 beneficiaries) participating in BBI projects conform to SME status. 738 SMEs have 
participated so far in applications (30.2% of total) and had a very good success rate 
(36.4%), higher than the total success rates in BBI calls (30.9%). They have received 
so far EUR 120.35 million, which corresponds to 29.1% of the total contribution. It 
should be noted though, that the share of SMEs is calculated based on applicants’ self-
assessment done at the proposal submission.  
 
Table 11. Participation patterns of SMEs compared to all other participants 
(non-SMEs): No. of applications, applicants, participations, participants, 
coordinators, BBI JU contribution and success rates (2014-2016). 
 
Type of 
benefici
ary 
No. of 
applica
tions 
No. of 
applica
nts 
No. of 
participa
tions 
No. of 
particip
ants 
Total 
coordina
tors 
Contributio
n*  
Success 
rate 
(participa
tion/appli
cation) 
SMEs** 738 519 269 219 19 120.38 36.4% 
Non-
SMEs 1705 1140 485 399 47 293.91 28.4% 
Total 2443 1659 754 618 66 414.29* 30.9% 
In percentage 
SMEs 30.2% 31.3% 35.7% 35.4% 28.8% 29.1%   
Non-
SMEs 69.8% 68.7% 64.3% 64.6% 71.2% 70.9%   
Total 100.0% 100.0% 100.0% 100.0% 100.0% 100.0%   
Source: CORDA analysis;* EUR 413.54 million of EU (incl. EFTA) contribution + EUR 0.75 
million industry financial contribution to operational costs at programme level in 2016. 
** Based on the self-assessment done by applicants 
 
Table 12. Participation patterns per project type: No. of applications, applicants, 
participations, participants, coordinators, BBI JU contribution (in million Euro) 
and success rates (2014-2016). 
                                                 
56 DG RTD, unit F.1. Statistics on SC2 programme including SME instrument, (cut-off January 2017); 
57 DG RTD, unit D.2. Statistics on LEIT KET Biotechnology programme including SME instrument, (Cut-off 31 
March 2017)  
58 DG RTD, unit F.1. Statistics on SC2 programme including SME instrument, (cut-off January 2017); 
59 DG RTD, unit D.2. Statistics on LEIT KET Biotechnology programme including SME instrument, (Cut-off 31 
March 2017)  
 41 
 
Proje
ct 
type 
No. of 
applicatio
ns 
No. of 
applica
nts 
No. of 
participa
tions 
No. of 
partici
pants 
Total 
Coordi
nators 
EC 
contributio
n*  
Success rate 
(participatio
n/applicatio
n) 
CSA 77 52 39 30 6 5.85 50.6% 
DEMO 692 457 233 183 20 163.59 33.7% 
FLAG  215 163 56 51 6 137.75 26.0% 
RIA 1459 987 426 354 34 107.10 29.2% 
Total 2443 1659 754 618 66 414.29* 30.9% 
In percentage 
CSA 3% 3% 5.2% 4.9% 9.1% 1.4%   
DEMO 28% 28% 
30.9
% 29.6% 30.3% 39.5%   
FLAG  9% 10% 7.4% 8.3% 9.1% 33.2%   
RIA 60% 59% 
56.5
% 57.3% 51.5% 25.9%   
Total 100% 100% 
100.0
% 100.0% 100.0% 100.0%   
Source: CORDA analysis;* EUR 413.54 million of EU (incl. EFTA) contribution + EUR 0.75 
million industry financial contribution to operational costs at programme level in 2016 
 
7.2.4 Participation patterns and budget share per value chain 
Table 13 outlines the number of projects, participants and distribution of EU funds 
according to the value chain. Table 14 presents the number of projects according to 
value chain and type of action whereas Table 15 shows the distribution of funds 
according to value chain and type of action.  
One of the main objectives of BBI JU outlined in SIRA (2013) is accelerating the building 
of bio-based value chains (VC). Five value chains of very high importance for further 
development of the Bioeconomy were proposed and were supposed to be strengthened 
especially by large demonstration and flagship projects: 
 
VC1: From lignocellulosic feedstock to advanced biofuels, bio-based chemicals 
and biomaterials: realising the feedstock and technology base for the next generation 
of fuels, chemicals and materials. 
VC2: The next generation forest-based value chains: utilization of the full potential of 
forestry biomass by improved mobilization and realization of new added-value products 
and markets. 
VC3: The next generation agro-based value chains: realizing the highest sustainability 
and added value by improved agricultural production and new added value products and 
markets. 
VC4: Emergence of new value chains from (organic) waste: From waste problems to 
economic opportunities by realizing sustainable technologies to convert waste into 
valuable products. 
VC5: The integrated energy, pulp and chemicals biorefineries: Realizing sustainable 
bio-energy production, by backwards integration with biorefinery operations isolating 
higher added value components. 
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Each VC was supposed to lead to at least one flagship project, covering full value chain, 
namely demonstrating the feasibility of feedstock supply, market application and market 
uptake. 
So far six flagship projects were launched, three in VC1, one in VC2 and two in VC3 
(Table 14). Lignocellulose, forest-based and agro-based value chains existed before BBI 
and thus it is not surprising that they present the highest technology readiness level and 
launching of the flagship projects in those areas was possible. However, so far the 
distribution of projects and funds according to value chain seem to be somewhat 
unbalanced.   
Table 13. Number of projects, participants and BBI JU contribution per value 
chain (2014-2016). 
 
Value Chain No. of projects 
No. of 
participations 
Contribution 
(EUR million)* 
VC1 (Lignocellulose) 14 171 142.64 
VC2 (forest-based) 10 139 64.20 
VC3 (agro-based) 11 135 85.43 
VC4 (organic waste) 6 74 31.86 
across VCs 19 172 68.63 
Aquatic Biomass 5 63 21.54 
Total 65 754 414.29* 
In percentage 
VC1 (Lignocellulose) 22% 23% 34.43% 
VC2 (forest-based) 15% 18% 15.50% 
VC3 (agro-based) 17% 18% 20.62% 
VC4 (organic waste) 9% 10% 7.69% 
across VCs 29% 23% 16.56% 
Aquatic Biomass 8% 8% 5.20% 
Total 100% 100% 100.00% 
Source: CORDA analysis and a table with project distribution according to VC received 
from BBI office;* EUR 413.54 million of EU (incl. EFTA) contribution + EUR 0.75 million 
industry financial contribution to operational costs at programme level in 2016 
 
Table 16 shows the planned (SIRA, 2013) and actual distribution of funding over the 
value chain demonstrators. Lignocellulose (VC1) received so far 40% of planned funds for 
DEMO and FLAG projects compared to 48% planned. Forest based (VC2) has received 
17% compared to 15% planned and agro-based (VC3) 24%, while originally only 15% of 
funds were planned for this sector. Organic waste value chain (VC4) was supported only 
by 7% of the total budget while SIRA had foreseen 15%. No flagship project in this VC 
was launched so far. This sector is emerging and it is not as well established as VC1-
VC3; however, efforts should be made to support the development of technologies that 
will convert waste into valuable products. 
The integrated energy, pulp and chemicals biorefineries value chain (VC5) apparently has 
decreased its strategic relevance for BBI, taking account of the activities being financed 
in other parts of Horizon 2020, in particular to maximise synergies and avoid overlaps 
with SC2 ‘Energy’. Thus no funding was dedicated to projects in this VC.  On the other 
hand, new value chains have emerged, such as Aquatic Biomass. Inclusion of new value 
chains indicates responsiveness of BBI to the emerging market needs. Furthermore, from 
2016 the annual work programmes have refocused and moved away from the biomass 
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‘push’ based approach and the traditional value chains, towards creating a demand for 
biomass and ‘market pull’. This approach is reflected in the high number of ‘across VC’ 
call topics starting in AWP2016 as well as relatively high number of CSA topics in 2016 
(4) that are meant to support further development of the biobased sector through 
clustering, networking and open innovation. It should be noted, that CSA projects have 
still received lower than planned share of the funds (Table 12: 1.4% compared to 
planned 3.25% in SIRA). This could be used as an opportunity, and future CSA projects 
could support market analysis for bio-based products and processes and thus support 
‘market pull’. Constant monitoring and analysis of the bio-based markets is of extremely 
high importance for the development of the future calls. Efforts should be made to 
support development of completely new value chains. Towards the end of the BBI 
programme, more DEMO and especially FLAG projects demonstrating the feasibility and 
economic viability of completely new bio-based value chains should be launched. 
 
Table 14. Number of projects according to value chain and type of action (2014-
2016). 
 
Value Chain RIA DEMO FLAG CSA Total 
VC1 
(Lignocellulose) 
5 6 3   14 
VC2 (Forest-based) 6 3 1   10 
VC3 (Agro-based) 4 5 2   11 
VC4 (Organic 
waste) 
4 2     6 
across VCs 9 4   6 19 
Aquatic Biomass 5       5 
Total 33 20 6 6 65 
In percentage 
VC1 
(Lignocellulose) 
15% 30% 50% 0% 22% 
VC2 (Forest-based) 18% 15% 17% 0% 15% 
VC3 (Agro-based) 12% 25% 33% 0% 17% 
VC4 (Organic 
waste) 
12% 10% 0% 0% 9% 
across VCs 27% 20% 0% 100% 29% 
Aquatic Biomass 15% 0% 0% 0% 8% 
% Total 100% 100% 100% 100% 100% 
Source: CORDA analysis and a table with project distribution according to VC received 
from BBI office 
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Table 15. Budget share (EC incl. EFTA and industry financial contribution to 
operational costs *) per value chain and project type (2014-2016). 
 
Value Chain RIA DEMO FLAG CSA Total 
VC1 
(Lignocellulose) 
22.36 48.97 71.31 0.00 142.64 
VC2 (Forest-based) 13.02 23.74 27.43 0.00 64.20 
VC3 (Agro-based) 13.12 33.30 39.00 0.00 85.43 
VC4 (Organic 
waste) 
10.22 21.64 0.00 0.00 31.86 
across VCs 26.84 35.94 0.00 5.85 68.63 
Aquatic Biomass 21.54 0.00 0.00 0.00 21.54 
Total 107.10 163.59 137.75 5.85 414.29* 
In percentage 
VC1 
(Lignocellulose) 
21% 30% 52% 0% 34% 
VC2 (Forest-based) 12% 15% 20% 0% 15% 
VC3 (Agro-based) 12% 20% 28% 0% 21% 
VC4 (Organic 
waste) 
10% 13% 0% 0% 8% 
across VCs 25% 22% 0% 100% 17% 
Aquatic Biomass 20% 0% 0% 0% 5% 
% Total 100% 100% 100% 100% 100% 
Source: CORDA analysis and a table with project distribution according to VC received 
from BBI office;* EUR 413.54 million of EU (incl. EFTA) contribution + EUR 0.75 million 
industry financial contribution to operational costs at programme level in 2016 
 
Table 16. Comparison of planned and actual distribution of funding over the 
value chain demonstrators. 
 
Planned in SIRA* Current state** 
Value Chain  
Distribution of 
funding (DEMO + 
FLAG) 
Value Chain  
Distribution of 
funding (DEMO + 
FLAG) 
VC1 (Lignocellulose) 48% VC1 (Lignocellulose) 40% 
VC2 (Forest-based) 15% VC2 (Forest-based) 17% 
VC3 (Agro-based) 15% VC3 (Agro-based) 24% 
VC4 (Organic waste) 15% VC4 (Organic waste) 7% 
VC5 (Energy, Pulp & 
Chemicals) 7% 
across VCs 
12% 
Aquatic Biomass  0% Aquatic Biomass 0% 
Total 100% Total 100% 
Sources: *SIRA, 2013 ** CORDA analysis and a table with project distribution according 
to VC received from BBI office, May 2017; 
 45 
 
7.2.5 Competition for funding: success rates in terms of successful proposals, 
activity types of applicants and budget share 
The global success rate (total participations/applications) in BBI calls equals to 30.9% 
and is higher than in other parts of SC2 and in LEIT (section 7.2.9). In terms of country 
groups, EU13 (Member States that join EU since 2004) has lower success rate than EU15 
(only 19.7% and funding share of 7.9%).  
As to beneficiary type, private for profit entities (PRC) and other organisations (OTH) 
have highest success rates, 35.5% and 37.7%, respectively. On the other hand, higher 
and secondary education establishments (HES) and public bodies (PUB), have rather low 
success in BBI calls, 17.8% and 20.7%, respectively. Research organisations (REC) 
succeed in 31.8% of applications. This pattern significantly differs from main SC2 calls, 
where PRC have lower success rates compared to other organisation types, which may be 
due to the more applied and market driven nature of the challenge (section 7.2.9).  
SMEs have very good success rate in BBI, 36.4%, as well as good share of total funding, 
29.1% (please note, the SMEs’ share is calculated based on participants’ self-
assessment). 
In terms of project type (see Table 12) CSAs have notably higher success rates 
(50.6%) than all other project types and rather low percentage of total applications 
(3%). RIAs are evidently the most popular actions and attract 60% of all applications. 
  
Figure 3: BBI JU contribution (EUR million and percentage of total) per project 
type. Total equals to EUR 414.29 million of which EUR 413.54 million is EU (incl. 
EFTA) contribution and EUR 0.75 million is industry financial contribution to 
operational costs at programme level in 2016. 
 
 
 
 
The largest part of the contribution goes to demonstration (DEMO) and flagship projects 
(FLAG), 39.5% (EUR 163.59 million) and 33.2% (EUR 137.75 million Euro), respectively 
(Fig. 1). Only 25.9% of the funding goes to research and innovation actions (RIA), 
although those projects attract 57.3% of participants (354 out of 618).  In SIRA 30% of 
funds were planned for DEMO, 34.75% for FLAG, 30% for RIA and 3.25% for CSA. 
Currently, the share of budget dedicated to DEMO projects is significantly higher than 
originally planned at the expense of RIA and CSA projects. This should be taken into 
consideration in the future work plans. 
CSA 
5.85 
1% 
DEMO 
163.59 
40% 
FLAG  
137.75 
33% 
RIA 
107.10 
26% 
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Overall, 517 out of the 72960 beneficiaries taking part in funded projects are non-BIC 
members, which is a signal of the openness and attractiveness of the JU.61 
In call 2016, the success rates among proposals having a BIC Coordinator are very 
high (47.4 %), compared to proposals with non-BIC Coordinators (23.8%)62. Success 
rates in projects with at least one BIC member (38.1%) are also higher than in those without a 
BIC member (24.8%).
63
 
Interestingly, when analysing the type of participation of BIC members in funded 
projects, the percentage of associated BIC members has increased significantly from 
2014 to 2016.64 While the percentage of full BIC member taking part in funded projects 
was slightly higher in 2014 and 2015 calls, in 2016 the associated BIC-member that 
benefitted from a BBI JU contribution was 64 % of the total BIC members (68 associated 
BIC members taking part in funded projects by 2016 calls versus 39 full BIC-members). 
These figures indicate a significant and growing mobilization of non-industrial BIC 
members.  
 
7.2.6 Average grant size in terms of budget and number of beneficiaries  
The average BBI grant size is 6.37 million Euros and an average project includes 
11.6 participants. This varies depending on the project type. CSA projects are the 
smallest, 0.98 million Euro and 6.5 participants. FLAG projects are the largest in terms 
of funding (EUR 22.96 million on average) and RIA projects have the highest average 
participant number (12.9). 
 
Table 17. Number of projects, sum of contribution (in million Euros) and 
average project size, in terms of contribution and participants’ number, per 
project type (2014-2016) 
 
Project 
type 
No. of 
project
s 
No. of 
project
s (in 
%) 
Sum of 
Project BBI 
contribution
*  
Sum of 
Project 
contributio
n (in %) 
Average 
Project 
contributio
n  
Average 
number of 
participan
t 
CSA 6 9% 5.85 1.4% 0.98 6.5 
DEMO 20 31% 163.59 39.5% 8.18 11.7 
FLAG  6 9% 137.75 33.2% 22.96 9.3 
RIA 33 51% 107.10 25.9% 3.25 12.9 
All 
project
s 
65 100% 414.29* 100.0% 6.37 11.6 
Source: CORDA analysis;* EUR 413.54 million of EU (incl. EFTA) contribution + EUR 0.75 
million industry financial contribution to operational costs at programme level in 2016. 
 
                                                 
60 Data provided by BBI JU, cut-off date 31 December 2016. Discrepances with figures reported in tables 7-12 
are due to the fact that, as specified in the notes, in those cases duplications of applicants and beneficiaries 
were not taken into account. 
61 BBI JU statistics. 
62 BBI, 2016. Results Call 2016. Presentation. 
63 BBI, 2016. Results Call 2016. Presentation. 
64 Data provided by BBI JU through an e-mail by the EC on 23 June 2017. 
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7.2.7 How do these trends compare with the SC2 and LEIT KET Biotechnology 
programmes? 
As presented in Figure 4, the geographical distribution of funds in BBI resembles those in 
the main SC2 calls and in LEIT KET Biotechnology programme. Similar as in main part of 
the programme and in LEIT, the majority of EC funding (84%) goes to EU15. Although 
EU13 receives a much lower share of the BBI JU contribution than EU15, it scores better 
in BBI (7.9%) than in main SC2 (5.5%) and in LEIT KET Biotechnology programme 
(7.2%). We also observe a big discrepancy between the success rates of EU15 (32.6%) 
and EU13 (19.7%) (Fig. 3).  
The BBI programme office has made a lot of efforts to reach the audience from less 
represented Member States. This is reflected in a high number of events (e.g. Info 
Days) organised in EU13 starting from 2015. The trend regarding EU13 should be further 
monitored and the correlation between the outreach efforts and participation should be 
continuously looked at. The fact that EU13 receives higher percentage of the EC funds 
than in main calls is a good signal. However, it is a cumulative figure: The participation 
and success rates among different EU13 countries are very uneven. While Slovakia, 
Poland, Hungary and Croatia already participate (7 to 11 participations) and have good 
success rates (from 27% Poland to 67% Slovakia65), there are countries which have not 
participated in calls at all yet (Bulgaria, Czech Republic and Malta), or very insignificantly 
(Cyprus, Estonia, Latvia, Lithuania, Slovenia – only 1 participation each). Success rates 
in those countries are also very low, from zero to around 14%. Efforts should be made to 
mobilise potential applicants in all countries that are underrepresented by now. 
Furthermore, care should be taken that topics relevant for those countries are taken up 
in the calls. 
It should also be noted that overall, the success rates in BBI (30.9%) are much higher 
than in main SC2 (21.5%) and in LEIT (19.9%) (Fig.3). This could be due to high 
specificity of the BBI programme, in which the industrial and research community is 
actively involved (via BIC) in drafting the topics of the AWPs, together with the EC. In 
addition, the BBI calls target technologies with higher TRL than SC2 and LEIT, and the 
number of potential applicants may thus be lower than in the main calls. Furthermore, 
the BBI programme is still in the early phase and the bioindustry sector is currently 
emerging.  
Figure 4: Contribution per country group in BBI, SC2 (including SME instrument) 
and LEIT KET Biotechnology (including SME instrument) calls as percentage of 
total. 
 
                                                 
65 Three beneficiaries from Slovakia are mmbers of the BIOSKOH consortium (Flagship project) 
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Source: BBI: CORDA analysis (cut-off May 2017); SC2; DG RTD, unit F.1. Statistics on 
SC2 programme including SME instrument, (cut-off January 2017); LEIT KET. DG RTD, 
unit D.2. Statistics on LEIT KET Biotechnology programme including SME instrument, 
(Cut-off 31 March 2017) 
 
Figure 5: Success rate per country group BBI, SC2 (including SME instrument) 
and LEIT KET Biotechnology (including SME instrument). 
 
Source: BBI: CORDA analysis (cut-off May 2017); SC2; DG RTD, unit F.1. Statistics on SC2 programme 
including SME instrument, (cut-off January 2017); LEIT KET. DG RTD, unit D.2. Statistics on LEIT KET 
Biotechnology programme including SME instrument, (Cut-off 31 March 2017)  
 
The pattern of budget distribution per beneficiary type significantly differs from that in 
SC2 and in LEIT. The majority of the EC funding in BBI (70.7%) goes to private entities, 
(see Fig. 6). In SC2 private entities receive only 27.2%. In LEIT Biotechnology private 
sector (PRC) is a main beneficiary, however it receives much lower budget share 
compared to BBI (39.2%) Higher or secondary education establishments and research 
organisations combined (HES + REC); receive 26.8% of the total contribution in BBI and 
55.2 and 60.1% in LEIT KET Biotechnology and SC2, respectively.  
HES have also very low success rates in BBI (only 17.8%). The goal of BBI JU was to 
support an emerging Bioeconomy sector and to stimulate the development of European 
bioindustries, therefore in BBI the majority of the budget (72.7%) is dedicated to large 
demonstration and flagship projects with a high Technology Readiness Level. The 
supported projects should be as close to real market applications as possible. Because of 
that, the programme is better suited to industrial applicants than to academia. However, 
there is very high interest in the BBI calls among applicants from research and education 
(almost 1000 applications received, see Table 10). Participation of research partners is 
still expected and those partners should be encouraged to participate. Intra-sectorial 
collaborations, between research and industry are extremely important for the further 
development of this young sector and the input from scientific partners is needed to 
generate most innovative solutions. For example, it is expected that synthetic biology, 
which for the time being is a purely academic domain, will be a very important driver in 
further development of Bioeconomy. Therefore, care should be taken that in the future 
calls emerging trends, such as synthetic biology and platform technologies (e.g. 
bioinformatics), are well covered. The proposed amendment to the Council Regulation,66 
                                                 
66 The Commission adopted the proposal at the end of February 2017. Proposal of 22.2.2017 for a COUNCIL 
REGULATION amending the COUNCIL REGULATION (EU) No 560/2014 of 6 May 2014 establishing the Bio-
based Industries Joint Undertaking.   2017/0024 
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which is expected to allow financial contribution to operational costs at the project level, 
should facilitate the realisation of such projects, and thus in the second half of BBI more 
calls for RIAs in emerging trends should be published. BBI is an instrument dedicated to 
private sector and to avoid duplication of efforts, the support for other beneficiary types, 
especially academia and other research organisations (HES and REC) should be 
strengthen in other parts of HORIZON 2020   related to Bioeconomy and biotechnology. 
Figure 6: Contribution per beneficiary type in BBI, SC2 (including SME 
instrument) and LEIT KET Biotechnology (including SME instrument) calls as 
percentage of total. 
 
Source: BBI: CORDA analysis (cut-off May 2017); SC2; DG RTD, unit F.1. Statistics on 
SC2 programme including SME instrument, (cut-off January 2017); LEIT KET. DG RTD, 
unit D.2. Statistics on LEIT KET Biotechnology programme including SME instrument, 
(Cut-off 31 March 2017). 
Figure 7: Success rate per beneficiary type in BBI, SC2 (including SME 
instrument) and LEIT KET Biotechnology (including SME instrument) calls. 
 
 
Source: BBI: CORDA analysis (cut-off May 2017); SC2; DG RTD, unit F.1. Statistics on 
SC2 programme including SME instrument, (cut-off January 2017); LEIT KET. DG RTD, 
unit D.2. Statistics on LEIT KET Biotechnology programme including SME instrument, 
(Cut-off 31 March 2017). 
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7.3 Evaluation Question 3: Main achievements and effectiveness of 
implementation 
7.3.1 Main achievements 
The five value chains, chosen at the beginning of BBI JU and described in the original 
SIRA, have been described already in section 7.2.4 and are well selected with their 
respective focus enabling the creation of new value chains.    
The number of running projects has steadily grown from 10 projects in 2014 to 36 at 
the end of 2016 and to the current 65 ongoing projects in June 2017. 
Various levels and groups of Key Performance Indicators (KPIs) have been 
established to monitor the progresses of BBI JU. The level 1 KPIs assess the contribution 
to the overall strategic objectives of the bio-based economy in Europe. Monitoring level 1 
KPIs does not fall within the scope of this agenda, as the BBI Initiative is one of the 
instruments supporting Bioeconomy in Europe. It makes only indirect contributions to the 
level 1 KPIs, especially through its flagship projects. Successfully operating flagship 
biorefineries may lead to many similar installations springing up across Europe. Further 
rollout of BBI technological successes also depends on having the right policies, 
legislation and incentives in place and on factors such as the oil price and CO2 targets. 
Level 2 KPIs measure the Initiative’s progress towards the specific research and 
innovation targets for 2020 (output and outcome). The topics in the BBI annual work 
plans will include expected impacts under the relevant level 2 KPIs. Level 3 KPIs are 
included in all projects funded by the BBI joint undertaking and monitor their success.  
The performance of BBI JU against three main Horizon 2020 KPIs – time to inform (TTI), 
time to grant (TTG) and time to pay (TTP) pre-financing – operates efficiently well within 
the Horizon 2020 targets.  
The Horizon 2020 20% target for SMEs in LEIT and the Societal Challenges67 has been 
surpassed, as 29% of the EC funding 2014-2016 goes to SMEs. This clearly demonstrates 
that the BBI JU programme is contributing to the development of the bio-based industry 
landscape in Europe. SMEs are well represented in projects retained for funding, with a 
success rate of 31% and with 36% of all beneficiaries in retained proposals being SMEs. 
The objectives for gender balance,68 fostering gender balance in Horizon 2020 research 
teams and ensuring gender balance in decision-making, are reasonably implemented 
with respect to BBI JU groups, although there is room for improvement in the Governing 
Board with only 2 female members out of the 10-member board.  
The private sector participation, a cornerstone of the BBI JU, is very pronounced in the 
funding allocated, with 71% of all beneficiaries. Higher education establishments are 
however represented just with about 12% despite a high mobilisation.  
It must be underlined that the seven Key Performance Indicators specific for the BBI JU 
are defined in the ‘BBI Key Objectives’ in the current SIRA, in the Commission proposal 
for the Council Regulation and in the Impact Assessment.      
  
                                                 
67 Article 22(3) Horizon Regulation 
68 H2020 Programme Guidance on Gender Equality in Horizon 2020, Version 2.0, 22 April 2016 
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Figure 8: Samples of images provided by some BBI JU projects: a) Exilva factory by 
Borregard (partner of Flagship Project EXILVA); b) Borregard advanced biorefinery 
developed within the Flagship project EXILVA; c) Agricultural residues from a Slovakian 
field to be used as feedstock for the Flagship project BIOSKOH; d) Biochemtex (partner 
of Flagship Project BIOSKOH) Crescentino biorefinery plant, in northern Italy, where the 
technology used in the BIOSKOH project is currently demonstrated; e) Novozymes 
(Partner of Flagship Project BIOSKOH) enzymes production site; f) Cardoon field for 
Flagship Project FIRST2RUN  g) Biorefinery Plant for Flagship Project FIRST2RUN;  h) 
Pilot Plant for Flagship Project FIRST2RUN; i) Processing underutilized low value sugar 
beet pulp into value added products within the DEMO-project; j) Demo Plant developed, 
built and operated  by Royal Cosun; k) Pilot Plant built by Royal Cosun for supporting 
activities under DEMO project PULP2VALUE;  l) New Royal Cosun Innovation Centre 
building to support biobased innovations projects such as PULP2VALUE;  m) Fermentation 
at Bio Base Europe Pilot Plant (partner of RIA project CARBOSURF);  n) Pilot facility for 
RIA project CARBOSURF at project partner Bio Based Europe Pilot Plant. 
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Table 18: Key Performance Indicators specific for BBI JU and as reported in 
draft AAR2016. 
 
KPI Target Comments 
1 36 New cross-sector interconnections in BBI JU projects by 2020 has 
been surpassed with 146 projected for 2020 for new cooperation 
between companies and other actors from different sectors, which 
interconnect/ cooperate thanks to BBI JU projects to build new 
value chains.  
2 10 New (or optimised) bio-based value chains created by 2020 have 
been surpassed with 82 for new value chains (from raw material to 
product application) projected for 2020 to be realised with BBI JU 
projects. A value chain is considered new when at least one of its 
segments is new: the feedstock, the processing, the end product or 
its application. 
3 200 Cooperation projects through cross-industry clusters are 
being approached in 2016 by 36 grants signed, whereby the 
differentiation between cross-industry clusters and cross-sectorial 
clusters is not fully clear. 
4 5 New bio-based building blocks based on biomass of European 
origin by 2020 have not been sufficiently ambitious. It is projected 
to be easily surpassed in 2020 by 46 new bio-chemical building 
blocks developed thanks to BBI JU projects. These are either 
identical to non-renewable building blocks and have not 
(successfully) been made on (pre)commercial scale yet or are new 
building blocks that have better performance than fossil-based 
counterparts in comparable applications or are novel molecule, 
breakthrough building blocks that have no fossil-based counter-
parts.  
5 50 New bio-based materials by 2020 will also been easily surpassed 
in 2020 by the expected 106 new bio-based materials developed 
thanks to BBI JU projects. They will replace fossil-based materials 
that have proven to have an equal or overall better sustainability by 
Life Cycle Assessment (LCA), improved material efficiency, and 
reduced GHG emission, biodegradability, recyclability or other 
improved functionalities during use or reuse.  
6 30 New demonstrated ‘consumer’ products based on bio-based 
chemicals by 2020 will be surpassed in 2020 by the projected 51 
new bio-based ‘consumer products’ that are meeting a clear market 
demand, fulfil all technical requirements, are economically viable 
and will have an overall better sustainability score than its current 
alternative (by LCA, improved material efficiency, reduced GHG 
emission, biodegradability, recyclability and/or other improved 
effects during use or reuse). 
7   5 Target of 5 for KPI 7: Flagships resulting from the BBI is very well 
on track, with the 4 grant agreements already signed at 31 
December 2016 by the BBI JU on flagships, first of the kind 
biorefineries operating at a commercial stage and more to be built 
in Europe with project consortia. By June 2017, the number of 
signed flagship projects has increased to 6, thus already surpassing 
the target. 
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Figure 9: Level 2 KPI Numbers for Targets and Results of BBI JU at 31 
December 2016. 
 
 
 
Overall, the BBI JU has created a stimulating research and innovation environment in 
Europe. From the signed Grant Agreements it emerges that the projects are expected to 
deliver the following ‘projected’ results: 146 new cross-sector interconnections, 82 new 
value chains, 46 new bio-chemical building blocks, 106 new bio-based materials, 51 new 
bio-based ‘consumer products’. Moreover, there are already 6 actual grant agreements 
for flagships that demonstrate a pronounced private sector participation in funding 
including SME participation well above the target.  
Six of seven level 2 BBI-specific projected KPIs for 2020 are well above the targets and 
the seventh KPI is showing progress. Further attention and analysis will be needed to 
include quantitative comparison of data presented in section 7.2 with KPIs. Yearly 
comparisons to KPIs will be done once the statistics are complete. For a better and 
quicker data collection and verification, the methodological approach should make use of 
a clear distinction between the actually achieved KPI at the end of year and the projected 
KPI after the BBI programme is complete. 
 
7.3.2 Effectiveness of implementation 
7.3.2.1 Achievement of the objectives set in Article 2 of the Council Regulation 
establishing BBI JU 
The objective of the BBI Initiative is the development of sustainable and competitive bio-
based industries in Europe for a more resource efficient and sustainable low-carbon 
economy boosting economic and employment growth, in particularly in rural areas. The 
concepts are very well addressed by the ongoing projects (Figure 10) in the different 
value chains of the BBI JU and their cross-sectoral growth opportunities.  
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Figure 10: Cumulative number of ongoing projects since 2014 and per year. 
 
 
 
The ongoing projects are well on track towards technologies enabling the preparation of 
new chemical building blocks, new materials and new consumer products from European 
biomass, which will overcome the need for fossil-based inputs. The development of 
business models to integrate economic actors along the whole value chain is, based on 
the analysis of ongoing projects and interviews, an achievement. BBI JU is connecting 
stakeholders throughout the value chain up to brand owners and end-users. This includes 
creating new cross-sector interconnections and supporting cross-industry clusters, e.g. in 
the DEMO project BIOFOREVER (BIO-based products from FORestry via Economically 
Viable European Routes) or MACRO CASCADE (Cascading Marine Macroalgal Biorefinery). 
They are focussed on lignocellulosic, forest- and agro-based feedstock but they are also 
organizing new value chains from organic waste. As already indicated from the 
progresses in KPIs, the setup of flagship projects is very well on track. Based on the 
analysis of ongoing projects within the value chains, selections have been 
carefully done towards technologies and business models for bio-based materials, 
chemicals and fuels that aim at demonstrating cost and performance improvements to 
levels that are competitive with fossil-based alternatives.  
 
7.3.2.2 Assessment of the programme administration lifecycle and setting up a 
research agenda from definition of the work programme and publication of calls 
to evaluation, selection, negotiation, contract/ budget engagement 
The annual work plans have been set up to address the cross-sectoral challenges and 
support the value chains to become reality. 
The number of topics related to the budget of the call has been growing steadily from 
2014 to 2016, as can be seen from the overview of the annual work plans. The scope and 
details of research and innovation activities, call and project management rules, 
governance, internal control framework and budget are professionally described.  
With the establishment of the BBI offices in Brussels and the launch of the BBI JU staff 
recruitment, BBI JU has become operational by 26 October 2015. Together with BIC and 
the EC, BBI JU has managed to publish the annual work programme according to a 
schedule (the publication of the call in April and the deadline in September) that allows 
sufficient time for the proposal design and the construction of consortia, thus enabling 
the mobilization of players in the bio-based industries. In the case of the annual work 
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plan 2015, the timing was tight as two calls were published in May and August. The two 
main objectives in 2014 were the preparatory actions for BBI JU autonomy and the 
implementation of call 2014. The subsequent call in 2015 was launched by the EC but 
BBI JU, which became autonomous in autumn 2015, carried out its evaluation and Grant 
Agreement preparation (GAP) independently. Therefore, call 2016 was launched and 
implemented by BBI JU alone. 
The nature of BBI calls is fully open to the participation of any stakeholder. The success 
rate of proposals having BIC coordinators and BIC members is higher than for non-BIC 
coordinators and non-BIC members, while the actual numbers of non-BIC coordinators 
and non-BIC members in the selected proposals are much higher, with the exception of 
non-BIC coordinators in the flagship call 2015.1.  
Table 19: Overview BIC Members versus non-BIC Members in calls 2014-2016 
Calls Applicants, 
beneficiaries,  
coordinators 
BIC 
Members 
Non-BIC 
Members 
Success Rates 
Call         
2016 
Applicants 20.1% 79.9% BIC members had a 38.07% 
success rate in selected 
proposals                            
non-BIC members had a  
24.81% success rate in 
selected proposals 
Beneficiaries in 
selected proposals 
27.8% 72.2% 
Coordinators in 
proposals 
18.0% 82.0% Success rate of proposals 
having a BIC COO: 47.36% 
Success rate of proposals 
having a non-BIC COO: 23.8% 
Coordinators in 
selected proposals 
31.0% 69.0% 
Call 
2015.2 
Applicants 20.0% 80.0% BIC members had a 51.5% 
success rate in selected 
proposals                            
non-BIC members had a  
30.96% success rate in 
selected proposals                       
Beneficiaries in 
selected proposals 
30.0% 70.0% 
Coordinators in 
proposals 
26.0% 74.0% Success rate of proposals 
having a BIC COO: 52.6% 
Success rate of proposals 
having a non-BIC COO: 
24.07% 
Coordinators in 
selected proposals 
43.5% 56.0% 
Call 
2015.1 
Applicants 24.0% 76.0% BIC members had a 36% 
success rate in selected 
proposals                           
non-BIC members had a 20% 
success rate in selected 
proposals 
Beneficiaries in 
selected proposals 
36.0% 64.0% 
Coordinators in 
proposals 
55.5% 44.5% Success rate of proposals 
having a BIC COO: 60% 
Success rate of proposals 
having a non-BIC COO: 0% 
Coordinators in 
selected proposals 
100.0%      0% 
Call             
2014 
Applicants 18.1% 81.9% BIC members had a 42.4% 
success rate in selected 
proposals                            
non-BIC members had a 
23.15% success rate in 
selected proposals                   
Beneficiaries in 
selected proposals 
28.9% 71.1% 
Coordinators in 
proposals 
no data no data Success rate of proposals 
having a BIC COO: no data 
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Coordinators in 
selected proposals 
no data no data 
Success rate of proposals 
having a non-BIC COO : no 
data 
 
Overall, BBI JU has attracted a satisfactory level of participation of the best European 
players in the areas of the selected value chains and non-BIC members make up the 
majority of participants and coordinators in the selected proposals. This demonstrates 
the openness of the BBI JU, while the higher success rate of BIC-members versus non-
BIC members is a sign that BIC-membership provides an advantage for the proposal 
preparation.    
 
7.3.2.3 How all parties in the public-private partnerships lived up to their 
financial and managerial responsibilities? 
The programme office of BBI JU has been responsible for managing the 
administrative budget since its autonomy was granted at the end of October 2015. For 
the achievement of objectives set in the Article 2 of the Council Regulation (EU) No 
560/2014, BBI JU relies on a planned budget, which is on a shared costs basis with 
industry, as reported in Table 20. 
Every Euro of the EU funds is expected to leverage at least 2.8 Euro of private funds 
during the operation of the Joint Undertaking. A qualitative and quantitative analysis of 
the effective leverage effect assessed at the time of this midterm evaluation is reported 
in section 7.5.  
 
Table 20: Expected contributions of the two members to BBI JU budget (in 
Euro) as from the Council Regulation. 
 
Max EU contribution Minimum Total 
Contribution by BIC 
Total   approximated  
BBI JU budget69 
975 000 000 2 730 000 000 3 705 000 000 
 
Split of BIC contribution 
Contribution by 
BIC to operational costs  
Minimum in kind additional 
activities (IKAA) by BIC 
975 000 00070 
(of which at least 182 500 000 financial in cash 
contribution at programme level) 
1 755 000 000 
 
Operational costs should be covered by means of financial contributions coming 
from EU and BIC and by in kind contributions to operational costs (IKOP) by BIC 
and BIC’s members, consisting of the costs incurred by them in implementing indirect 
actions less the contribution of BBI Joint Undertaking and any other Union contribution to 
those costs. 
As shown by Table 20, a large contribution of BIC to BBI JU is in the form of in kind 
additional activities (IKAA) consisting of the costs incurred outside the work plan of the 
                                                 
69 Administrative costs should not exceed EUR 58 500 000 and shall be covered proportionally by EU and BIC on 
an annual basis. 
70 The amount of EUR 975 000 000 is extrapolated by subtracting the IKAA contribution (EUR 1 755 000 000)  
from the total minimum expected private contribution ( EUR 2 730 000 000).  
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BBI JU. These activities may consist, for example, in establishing additional large 
demonstration and flagship plants, thus contributing to the before mentioned objectives 
of BBI Initiative.71 Notably, Article 4 of the Council Regulation specifies that for 
evaluating the contribution of BIC, in kind costs have to be certified by external 
independent auditors. 
Table 21, reports an overview of BBI JU budget for 2014-2016. Budget 2016 reflects a 
reactivation equal to about EUR 28 million, which derives from unused operational budget 
during 2014-15 activities. The table includes also EFTA contribution but does not 
comprise IKAA,72 since such activities are outside the work plan. 
 
Table 21: Annual budget 2014-1673.  
 
Commitment appropriations Amended 
Budget 
2016  
Budget 2015  Effective 
Budget 
201474 
EU contribution  158,082,50
0  
201,908,289  
 
50,684,807 
of which Administrative  1,946,263  1,412,37  684,807 
of which Operational  156,136,237  200,495,917  50,000,000 
EFTA contribution  4,315,652  5,941,622  1,500,000 
of which Administrative 53,133 47,042 0 
of which Operational 4,262,519 5,894,580 1,500,000 
Industry financial (in cash) 
contribution  
2,943,315  1,572,886  0 
of which Administrative  2,193,315  1,572,886  0 
of which Operational  750,000  0  0 
Reactivation of unused 
appropriations (2015 and2014)  
28,954,403  
 
0  0 
TOTAL REVENUES  
 
194,295,87
0 
209,422,797 52,184,807 
 
A more detailed picture of the different contributions to operational costs of the two BBI 
JU partners is reported in Table 22. EU contribution and private IKOP are extracted from 
the Grant Agreements (GAs) signed by 31 December 2016,75 whereas the private 
financial (in cash) contribution to operational costs was committed at program level 
according to 2016 budget.  Moreover, the table reports the IKAA delivered and certified 
at 31 December 2016. Notably, IKAA76 were already delivered at 31 December 2016 
                                                 
71 Other Union funding programmes may support those costs in compliance with the applicable rules and 
procedures. In such cases, Union financing shall not be a substitute for the in kind contributions from the 
members other than the Union or their constituent entities.  
72 Costs incurred by private partners in implementing additional activities outside the work plan of the BBI Joint 
Undertaking but still contributing to the objectives of the BBI Initiative.  
73 BBI JU Annual Work Plan and Budget 2015, 2016. 
74 This budget, which is not the initial adopted BBI JU budget 2014, reflects the contributions that were actually 
made to BBI JU in 2014 by its constituencies. 
75 Central database CORDA 
76 Costs incurred by private partners in implementing additional activities outside the work plan of the BBI Joint 
Undertaking but still contributing to the objectives of the BBI Initiative.  
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whereas the other committed contributions will be delivered throughout the duration of 
the financed projects.77 IKAA activities must be set out in an annual additional 
activities plan that has to indicate the estimated value of those contributions.  
 
Table 22: Contribution to operational costs of EU and BIC (in EUR) and in kind 
private contributions for implementing additional activities outside the work 
plan of the BBI Joint Undertaking but still contributing to the objectives of the 
BBI Initiative. 
 
Contributions of EU and BIC to operational costs78  IKAA actually 
delivered by BIC 
members and  certified 
79  
Total  EU 
contribution 
Committed in the 
GAs 
Total committed 
IKOP of private 
partners in the 
signed GAs80 
Committed private 
financial 
contribution (in 
cash)81 
 
228.690.682,1 114.621.657,2 750.000 291.482.000 
 
It must be underlined that Table 22 does not include any IKAA for 2016 because, as 
mentioned in section 7.3, some difficulties have been found for the establishment of the 
methodology for planning, reporting and certifying IKAA. Those difficulties have 
prevented the delivery of the conclusive figures necessary to make a complete 
quantitative evaluation of the industry’s contribution and, conversely, of the leverage 
effect of BBI JU.82  However, as mentioned in section 7.3, in June 2017 BIC anticipated 
an amount of certified IKAA for 2016 equal to EUR 185.863 million. 
BIC has to report each year by 31 January to the Governing Board of the BBI 
Joint Undertaking on the value of the contributions to administrative, operational (both 
in cash and IKOP) costs as well as  IKAA made in each of the previous financial 
years.  
 
As already mentioned in section 6, some difficulties were inherited from the legal base 
and the start-up phase of the organisation:  
a. The interpretation of the regulation concerning the delivery of financial (in 
cash) contribution to operational costs by BIC; 
b. The lack of methodology for in-kind additional activities (IKAA) planning and 
reporting; 
c. The lack of a documented reporting procedure for in-kind contributions to 
operational costs (IKOP).  
 
                                                 
77 At this stage, the latest expected end date of a project is 31 August 2021 
78 As extracted from data made available to the group of experts by May 2017.  
79 IKAA Report for 2014-2015 (CIRCA data base). It must be noted that IKAA report for 2016 was not available 
at the time this analysis was performed. However, in June 2017 BIC anticipated an amount of certified IKAA for 
2016 equal to EUR 185.863 million, which, however, was not accounted in the table reported herein. 
80 Calculated by subtracting the total EU contribution from the total committed costs (EUR 343.312.339,30) 
81 BBI JU Annual Work Plan and Budget 2016, page 96. 
82 More specifically, the discussion arises in the context of 'traditional' activities (e.g. bio-refinery) which have 
only a partial 'innovative component'. A typical example could be a traditional bio-refinery which has among its 
traditional lines of production, one that produces a new bio-based product. In these cases, the EC considers 
that only a portion of the activity can be considered AA while BIC would prefer that the entire activity is 
considered AA. 
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As regards the financial contribution by BIC, there is an issue related to the 
interpretation of the Council Regulation establishing BBI JU. Article 4 of Council 
Regulation 560/2014, read together with Article 12 of BBI Statutes, implies that the 
financial contribution from BIC should be entered into BBI JU’s operational budget (i.e. 
delivered at programme level). Although BIC endorsed the current text of the Council 
Regulation, after its entry into force and following its implementation, its members have 
explained that delivering financial contributions at programme level would not offer them 
any guaranteed benefit in exchange (e.g. results of the projects and related intellectual 
property rights). In addition to this, taking into account the open and transparent nature 
of the BBI calls for proposals, financial contributions delivered at programme level could 
benefit competitors participating in projects funded by BBI JU. It must be also underlined 
that the ‘in cash contribution’ issue83 is specific of BBI JU among the existing JTIs.84  
The consequence of these difficulties is a lack of financial (in cash) contribution of BIC 
to operational costs. This made the EC impose a partial suspension of the Union 
contribution to operational costs for 2017. In line with article 4(5) of the Council 
Regulation, the EC has taken the steps to suspend EUR 50 million out of the planned EUR 
131 million EC contributions to BBI JU operational costs in 2017, leading to a EUR 81 
million contributions in 2017. This partial suspension of part of the budget to later stages 
leaves BIC the possibility of still honouring its financial (in cash) commitments in the 
course of the initiative. 
The EC proposed an amendment to the Council Regulation (EU) No 560/2014 
establishing BBI JU, with the aim to enable the delivery of in cash contributions to 
operational costs at project level as well, thus making the expected financial resources 
available in the BBI field. Moreover, the proposed amendment would also allow industry 
to overcome the concerns mentioned above.  
The Council Regulation also requires an annual additional activities plan to indicate 
the estimated value of IKAA, which are BIC’s own contributions to the costs incurred in 
implementing additional activities outside the work plan but still contributing to the 
objectives of BBI Initiative. A procedure for the planning, reporting and certification of 
the in kind contribution for the additional activities has been agreed at a working level 
between services of BIC, the BBI JU and the EC. Due to the fact that the process of 
certification of IKAA is dependent on approved IKAA plans, an IKAA Report of certified 
value was submitted only for 2014-2015 while for 2016 this was not yet possible. 
Notably, the group of experts did not have access to data on private contribution to 
additional activities related to 2016 since the corresponding IKAA plan had not been 
approved yet at the time this evaluation was carried out. However, in June 2017 BIC 
anticipated an amount of certified IKAA for 2016 equal to EUR 185.863 million. As such, 
the timely approval of IKAA plans is of major importance for all monitoring activities as 
well as for an evaluation of the leverage effect of BBI Initiative.85  
It must be noted that due to the fact that additional activities by the industry are often 
reported in conjunction with the annual reporting cycle of the projects and that the 
reported additional activities require a certification process before been taken into 
account in calculation of the leverage effect, there is always a delay before overall 
leverage effect can be calculated. Furthermore, as additional activities can often be 
related to piloting and demonstration activities and they can therefore be realized only 
more towards the end of the project cycles, the focus of investment on additional 
activities can naturally be later in the programme cycle than the upfront investments on 
operational activities. 
The reporting of in kind contributions to operational costs (IKOP), which are 
introduced in the accounts of BBI JU after the signature of each grant agreement, 
                                                 
83 Financial (in cash) contribution to operational costs 
84 Only IMI JU conceives the possibility that private partners contribute in cash to the implementation of 
activities, although at both programme and project level. 
85 Based on the anticipated certified IKAA for 2016 the additional leverage effect would be 2.1 while the global 
leverage effect would become 2.6. 
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involves different processes than reporting and certification of IKAA. As regards IKOP, 
the members other than the EU can choose to report and certify fewer costs than the 
Council Regulation allows them to (i.e. only non-reimbursed eligible costs rather than 
total costs). And if they decide to do so, they can use the Certificate on Financial 
Statements (CFS) for the purposes of certification. An advanced draft guidance for 
reporting and certification is currently under discussion by the members. It should 
provide clear guidelines for BIC and its members on how to report and certify their IKOP. 
Specific and quantitative evaluation of the contribution of BBI JU members will be 
included in section 7.4 (Evaluation question 4: BBI Joint Undertaking's performance in 
2014 – 2016). 
 
7.4 Evaluation Question 4:  BBI Joint Undertaking's performance in 2014 - 
2016 
7.4.1. BBI JU mission and governance 
7.4.1.1What is the regulatory framework of setting up the BBI JU? 
The Council Regulation (EU) No 560/201486 establishing the Bio-based Industries Joint 
Undertaking was published in the Official Journal of the European Union on 7 June 2014 
by the Council of the European Union. It has regard to the Treaty on the Functioning of 
the European Union, and in particular Article 18787and the first paragraph of Article 18888 
thereof, to the proposal from the European Commission, to the opinion of the European 
Parliament and to the opinion of the European Economic and Social Committee.  
Relevant precursors are Decision No 1982/2006/EC of the European Parliament and of 
the Council89, Council Decision 2006/971/EC90 and Regulation (EU) No 1291/201391 of 
the European Parliament and of the Council for Horizon 2020 – The Framework 
Programme for Research and Innovation (2014-2020), in short Horizon 2020. Union 
involvement in those public-private partnerships may, in accordance with Regulation (EU) 
No 1291/2013, take the form of financial contributions to joint undertakings, which have 
been established on the basis of Article 187 of the Treaty on the Functioning of the 
European Union (TFEU) pursuant to Decision No 1982/2006/EC.92 Support may be 
provided to joint undertakings established in the framework of Horizon 2020 in 
accordance with Regulation (EU) No 1291/2013 and Council Decision 2013/743/EU under 
the conditions specified in that Decision. The model financial Regulation No 110/201493 
for public-private partnership bodies has been published in the Official Journal of the 
European Union on 7 February 2014 by the European Commission.  
                                                 
86 COUNCIL REGULATION (EU) No 560/2014 of 6 May 2014 establishing the Bio-based Industries Joint 
Undertaking 
87 Article 187 ‘The Union may set up joint undertakings or any other structure necessary for the efficient 
execution of Union research, technological development and demonstration programmes’ 
88 Article 188 'The Council, on a proposal from the Commission and after consulting the European Parliament 
and the Economic and Social Committee, shall adopt the provisions referred to in Article 187.’ 
89 Public-private partnerships in the form of Joint Technology Initiatives were initially provided for in Decision 
No 1982/2006/EC of the European Parliament and of the Council 
90 Council Decision 2006/971/EC ( 3 ) identified specific public-private partnerships to be supported 
91 REGULATION (EU) No 1291/2013 OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL of 11 December 
2013 establishing Horizon 2020 - the Framework Programme for Research and Innovation (2014-2020) and 
repealing Decision No 1982/2006/EC 
92 DECISION No 1982/2006/EC OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL of 18 December 2006 
concerning the Seventh Framework Programme of the European Community for research, technological 
development and demonstration activities (2007-2013) 
93 COMMISSION DELEGATED REGULATION (EU) No 110/2014 of 30 September 2013 on the model financial 
regulation for public-private partnership bodies referred to in Article 209 of Regulation (EU, Euratom) No 
966/2012 of the European Parliament and of the Council 
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The Governing Board of the BBI JU adopted its financial rules94 on 14 October 2014, 
having regard to the Treaty on the Functioning of the European Union, to Council 
Regulation (EU) No 560/2014 on the BBI JU and in particular Article 595 thereof, to the 
Statutes annexed to the Council Regulation (EU) No 560/2014 on the BBI JU and in 
particular Article 7(3)(c)96 thereof, to Regulation (EU, Euratom) No 966/201297 of the 
European Parliament and of the Council of 25 October 2012 on the financial rules 
applicable to the general budget of the Union and repealing Council Regulation (EC, 
Euratom) No 1605/20023, and in particular Article 20998 thereof. 
As described in the annual activity reports 2014, 2015 and 2016 and confirmed by 
interviews with representatives of BBI JU,99 the programme office appears to have 
implemented its activities in compliance with the applicable rules and procedures set out 
above to support the appropriate management of public and private funds. This was done 
under the authority of the Executive Directors as Chief Executive responsible for the day 
to-day management of the BBI JU, and in accordance with the decisions of the Governing 
Board. 
 
The management of BBI JU programming and grant processes is governed by the 
Horizon 2020 legislation and in particular:  
 
 Council Regulation (EU) No 560/2014 of 6 May 2014, establishing the Bio-based 
Industries Joint Undertaking; 
 Horizon 2020 Framework Programme — Regulation (EU) No 1291/2013 of the 
European Parliament and of the Council of 11 December 2013 establishing Horizon 
2020 - The Framework Programme for Research and Innovation (2014-2020) (OJ 
347, 20.12.2013, p. 104);  
 Rules for Participation (RfP) — Regulation (EU) No 1290/2013 of the European 
Parliament and of the Council of 11 of December 2013 laying down the rules for 
the participation and dissemination in Horizon 2020 – the Framework Programme 
for Research and Innovation (2014-2020) (OJ L 347, 20.12.2013, p.81);  
 Specific programme implementing Horizon 2020 - Council Decision 2013/743/EU 
of 3 December 2013 establishing the specific programme implementing Horizon 
2020 - the Framework Programme for Research and Innovation (2014-2020) and 
repealing Decisions 2006/971/EC, 2006/972/EC, 2006/973/EC, 2006/974/EC and 
2006/975/EC. 
  COMMISSION DELEGATED REGULATION (EU) No 623/2014 of 14 February 2014,  
                                                 
94 FINANCIAL RULES OF THE BIO-BASED INDUSTRIES JOINT UNDERTAKING, October 2014 
95 «COUNCIL REGULATION (EU) No 560/2014 of 6 May 2014 establishing the Bio-based Industries Joint 
Undertaking ’Financial rules : Without prejudice to Article 12 of this Regulation, the BBI Joint Undertaking shall 
adopt its specific financial rules in accordance with Article 209 of Regulation (EU, Euratom) No 966/2012 and 
Commission Delegated Regulation (EU) No 110/2014’ 
96 COUNCIL REGULATION (EU) No 560/2014 of 6 May 2014 establishing the Bio-based Industries Joint 
Undertaking  ‘The Governing Board shall in particular carry out the following tasks: (c) adopt the financial rules 
of the BBI Joint Undertaking in accordance with Article 5 of this Regulation’ 
97 REGULATION (EU, EURATOM) No 966/2012 OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL of 25 
October 2012 on the financial rules applicable to the general budget of the Union and repealing Council 
Regulation (EC, Euratom) No 1605/2002, Article 209: Model Financial Regulation for public-private partnership 
bodies ‘The bodies having legal personality set up by a basic act and entrusted with the implementation of a 
public-private partnership shall adopt their financial rules. Those rules shall include a set of principles necessary 
to ensure sound financial management of Union funds. The Commission shall be empowered to adopt a model 
financial regulation by means of a delegated act in accordance with Article 210 which shall lay down the 
principles necessary to ensure sound financial management of Union funds and which shall be based on Article 
60. The financial rules of those bodies shall not depart from the model financial regulation except where their 
specific needs so require and with the Commission's prior consent.’ 
98 COMMISSION DELEGATED REGULATION (EU) No 110/2014 of 30 September 2013 on the model financial 
regulation for public-private partnership bodies referred to in Article 209 of Regulation (EU, Euratom) No 
966/2012 of the European Parliament and of the Council 
99 Bio-based Industries Joint Undertaking (BBI JU) ANNUAL ACTIVITY REPORTs 2014, 2015 and 2016 
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7.4.1.2 What is BBI JU mission? 
The BBI JU is the body entrusted with the implementation of the public-private 
partnership established by Council Regulation No 560/2014 between the European Union, 
represented by the European Commission (EC), and the Bio-based Industries Consortium 
(BIC).  
BBI JU aims to bring together all relevant stakeholders to establish innovative bio-based 
industries as a competitive sector in Europe, ranging from primary production, large 
industry, small and medium-sized enterprises (SMEs), clusters, trade associations, 
academia, regional technology offices, research and technology organizations  to end-
users. This aims to build a better network in the bio based materials and chemicals 
sector enabling collaborative investments in infrastructure and accelerating adoption of 
these technologies. 
BBI JU’s mission is to implement the Strategic Innovation and Research Agenda (SIRA) 
developed by the Bio-based Industry Consortium (BIC) and endorsed by the European 
Commission on behalf of the European Union (EU). BBI JU operates its programme as the 
catalyst to enable the EU and industry to align their strategy and vision while respecting 
the principles of openness, transparency and excellence required for funding under the 
Horizon 2020 framework programme, through the annual calls for proposals organised by 
BBI JU.  
The Council Regulation (EU) No 560/2014 of 6 May 2014 establishing the BBI JU defines 
the following tasks:  
 
 Ensure the establishment and sustainable management of the BBI Initiative.   
 Mobilise the public and private sector resources needed, establish and develop 
close and long-term cooperation between the Union, industry and the other 
stakeholders.  
 Ensure the efficiency of the BBI Initiative.  
 Reach the critical mass of research effort to embark on a long-term programme.  
 Monitor progress towards the achievement of the objectives of the BBI JU.  
 Provide financial support to research and innovation indirect actions mainly 
through grants. 
 Engage in information, communication, exploitation and dissemination activities.  
 Liaise with a broad range of stakeholders including research organisations and 
universities and any other task needed to achieve the objectives. 
The Bio-based Industries Joint Undertaking shall have the following objectives: 
 
 To contribute to the implementation of Regulation (EU) No 1291/2013 and in 
particular Part III of Decision 2013/743/EU. 
 To contribute to the objectives of the BBI Initiative of a more resource efficient 
and sustainable low-carbon economy and increasing economic growth and 
employment, in particularly in rural areas, by developing sustainable and 
competitive bio-based industries in Europe based on advanced biorefineries that 
source their biomass sustainably, and in particular to: 
o demonstrate technologies that enable new chemical building blocks, new 
materials and new consumer products from European biomass which 
replace the need for fossil- based inputs; 
o develop business models that integrate economic actors along the whole 
value chain from supply of biomass to biorefinery plants to consumers of 
bio-based materials, chemicals and fuels, including by means of creating 
new cross-sector interconnections and supporting cross-industry clusters;  
o set up flagship biorefinery plants that deploy the technologies and business 
models for bio-based materials, chemicals and fuels and demonstrate cost 
and performance improvements to levels that are competitive with fossil-
based alternatives. 
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The specific objectives were elaborated based on the technological and innovation 
challenges and in consultation with the BIC (currently comprising >40 companies, 
several trade associations and European Technology Platforms (ETPs), research and 
technology organizations, universities and SMEs.100 As some aspects of the proposed 
activities are also supported under other parts of Horizon 2020 and PPPs (e.g. SPIRE) 
attention was paid to avoid duplication. 
Legal authority to act is set out in Delegation agreement101 that from 2015 entrust tasks 
for the duration of the JU. 
 
7.4.1.3 Does the JU operate in accordance with its intended governance 
structure? 
The BBI JU as described in annual reports and interviews operates with a governing 
board comprising five representatives of the BIC and five representatives of the European 
Commission  
In detail, the responsible persons since the inception of the BBI JU have been: 
Executive Directors: 
 Barend Verachtert – Interim Executive Director until 30 September 2015 
 Philippe Mengal - Executive Director from 1 October 2015  
The Governing Board, which comprises a balance of EC members & BIC members, has 
been chaired by: 
 Rudolf Strohmeier, Deputy Director-General ‘Research Programmes’, DG RTD 
(Chairman until 9 December 2015)  
 Marcel Wubbolts, Chief Technology Officer, DSM (Chairman from 9 December 
2015 until 31 December 2016) 
 
The BIC industrial board members are intended to represent not their company but 
their sector (SME, chemical, biochemical, etc.) providing appropriate input on a neutral 
basis and not promoting projects benefiting or the interests of their company. BIC 
members are also consulted through surveys and the general assembly. 
Scientific Committee (SC), States Representative Group (SRG) as advisory bodies, 
supports this organization. 
Governing board minutes are recorded while decisions, documents are also 
documented in the annual reports, which illustrate the incremental process of assembling 
the JU and organization. These bodies of the BBI JU and composition of the governing 
board are in alignment with the structure required in articles 4 and 5 of Council 
regulation 560/2014.102 
The Governing Board adopted the following documents and decisions in 2014:  
 Rules of Procedure of the BBI JU Governing Board  
 Selection procedure and criteria for the nomination of the members of the BBI JU 
Scientific Committee 
 Work Programme 2014  
 Guide for Applicants, Rules for Participation and other call documents  
 Model Grant Agreement  
 Organisational structure  
 Financial Rules  
 Annual budget 2014  
 Appointment of DG Budget as Accounting Officer for BBI  
 Rules on the reimbursement of SRG members  
                                                 
100 http://biconsortium.eu/membership/members-full and http://biconsortium.eu/membership/associate-
members 
101 DELEGATION AGREEMENT BBI JU Bio based Industries Joint Undertaking October 2015  
102 COUNCIL REGULATION (EU) No 560/2014 of 6 May 2014.  
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 Annual Work Plan, Budget and Staff establishment plan 2015 
The Governing Board adopted the following decisions in 2015:  
 Funding of indirect actions pursuant to the 2014 call for proposals 
 Amendment of the AWP 2015 
 Adoption of the Annual Activity Report (AAR) 2014 
 Second amendment of the AWP 2015 
 Appointment of the Executive Director 
 Adoption of the Internal Control Standards of the BBI JU 
 Approval of the date on which BBI JU will have the capacity to implement its own 
budget 
 Funding of Indirect Actions pursuant to the 2015.1 Call for Proposals 
 Adoption of BBI JU AWP and Budget for 2016 
The main decisions taken by the GB during 2016: 
 First amendment of the 2016 Annual Work Plan and Budget to include in the call 
2016 the leftover budget from call 2015 
 Amendment of the Specific Criteria for the selection of new Scientific Committee 
members; 
 Funding of indirect actions pursuant to the 2015.2 Call for proposals 
 Adoption of the Annual Activity Report 2015 
 Adoption Call for new Scientific Committee member 
 Adoption the  of the Mission Charter of the Internal Audit Service of the European 
Commission in relation to bodies having legal personality set up by a basic act and 
entrusted with the implementation of a public private partnership 
 Decision on the setting up a Staff Committee 
 Adoption of the BBI JU Work Plan and Budget for 2017 
With gaining autonomy to implement its own budget the BBI JU adopted its Internal 
Control Framework in September 2015103 based on the 16 standards laid down by the 
European Commission for its own departments104 in order to provide reasonable 
assurance to the Governing Board regarding the achievement of its objectives. This 
framework involves all the measures taken to ensure that:  
 
 Operational activities are effective and efficient - the BBI JU meets its objectives 
defined in the Annual Work Plan using the adequate human and financial 
resources and avoiding misuse. 
 Legal and regulatory requirements are met – the annual reports state that BBI JU 
operates fully in accordance with all legal and regulatory requirements. The 
managing board is supported in this statement by the commission legal advice.  
 Reporting is reliable – programme office management produces regular, reliable 
and easily accessible management information on financial management, use of 
resources and progress on the achievement of operational objectives.  
 Assets and information are safeguarded - programme office management take the 
necessary measures to ensure the completeness and preserve the integrity of the 
data on which management decisions are taken and reports are issued.  
The annual activity reports105 state that all programme office management processes 
and functions meet these four objectives of the Internal Control Framework above, 
meaning that the largest possible preventive, detective and corrective controls are in 
place. The legal and regulatory framework is defined by the European Commission with a 
special note made during interview of anti-trust legislation compliance for industrial 
members through BIC.106 
 
                                                 
103 BBI JU Internal Control Standards (ICSs)  
104 Ares(2014)1329924 - 28/04/2014 Simplified & Reduced Internal Control Requirements 
105 BBI JU Annual Activity Report 2014, 2015 
106 Interview with Marcel Wubbolts 
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7.4.1.4 What are the contractual arrangements between all partners and their 
respective commitments? 
Contractual arrangements between public and private partners and their respective 
commitments were set out in Council Regulation 560/2014107 with as members the 
Union, represented by the Commission, and the Bio-based Industries Consortium Aisbl 
(the ‘BIC’). 
 The commitments of BIC are: Membership of the BBI Joint Undertaking and 
acceptance of statutes contained in the regulation above by means of a letter of 
endorsement. 
 An agreement to pursue the research activities in the area of the BBI Joint 
Undertaking within a structure well adapted to the nature of a public-private 
partnership. 
 Those contributions from the members other than the Union should not be limited 
to the administrative costs of the BBI Joint Undertaking and to the co-financing 
required to carry out research and innovation actions supported by the BBI Joint 
Undertaking. Their contributions should also cover to additional activities. In order 
to get a proper overview of the leverage effect of those additional activities, they 
should represent contributions to the broader BBI Initiative. 
 The members of the BBI Joint Undertaking other than the Union shall make, or 
arrange for their constituent entities to make, a total contribution of at least EUR 
2 730 000 000 over the duration consisting both of contributions to the BBI JU 
and in kind contributions of at least EUR 1 755 000 000 consisting of the costs 
incurred by them in implementing additional activities outside the work plan of the 
BBI Joint Undertaking contributing to the objectives of the BBI Initiative. 
 To report each year by 31 January to the Governing Board of the BBI Joint 
Undertaking on the value of the contributions above made in each of the previous 
financial years and to also inform the States Representatives Group in a timely 
manner.  
The commitments of the Commission are:  
 Formulation and adoption of regulations pertaining to and founding membership 
of the BBI JU  
 Financial contribution to the BBI Joint Undertaking, including EFTA appropriations, 
to cover administrative costs and operational costs shall be up to EUR 975 000 
000. The contribution of the Union to be paid from the appropriations in the 
general budget of the Union allocated to the Specific Programme, implementing 
Horizon 2020, established by Decision 743/2013/EU, in accordance with point (c) 
(iv) of Article 58(1) and Articles 60 and 61 of Regulation (EU, Euratom) No 
966/2012 for bodies referred to in Article 209 of that Regulation. This may be 
terminated, proportionally reduced or suspended or may trigger the winding-up 
procedure if members or their constituent entities do not contribute, contribute 
only partially or contribute late with regard to their respective contributions. 
 The Commission shall by 30 June 2017 carry out, with the assistance of 
independent experts, an interim evaluation of the BBI Joint Undertaking. The 
Commission shall prepare a report on that evaluation, which shall include 
conclusions of the evaluation and observations by the Commission. The 
Commission shall send that report to the European Parliament and to the Council 
by 31 December 2017.  
 Within six months after the winding-up of the BBI Joint Undertaking, but no later 
than two years after the triggering of the winding-up procedure referred to in 
                                                 
107 COUNCIL REGULATION (EU) No 560/2014 of 6 May 2014 establishing the Bio-based Industries Joint 
Undertaking 
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Article 20 of the Statutes,  the Commission shall conduct a final evaluation of the 
BBI Joint Undertaking. The results of that final evaluation shall be presented to 
the European Parliament and to the Council. 
 The Commission was responsible for the establishment and initial operation of the 
BBI Joint Undertaking until it was believed to have the operational capacity to 
implement its own budget. The Commission designated a Commission official 
(Barend Verachtert – Interim Executive Director until 30 September 2015) to act 
as interim Executive Director and exercise the duties assigned to the Executive 
Director until with gaining autonomy to implement its own budget the BBI JU 
Governing Board appointed the Executive Director (Philippe Mengal - Executive 
Director from 1 October 2015). 
 The Commission may also assign a limited number of its officials to the BBI JU on 
an interim basis.  
 
The tasks assigned to the BBI JU in this regulation were: 
 Ensure the establishment and sustainable management of the BBI Initiative; 
 Mobilize the public and private sector resources needed; 
 Establish and develop close and long-term cooperation between the Union, 
industry and the other stakeholders; 
 Ensure the efficiency of the BBI Initiative; 
 Reach the critical mass of research effort to embark on a long-term programme; 
 Monitor progress towards the achievement of the objectives of the BBI Joint 
Undertaking; 
 Provide financial support to research and innovation indirect actions mainly 
through grants; 
 Engage in information, communication, exploitation and dissemination activities 
by applying mutatis mutandis Article 28 of Regulation (EU) No 1291/2013, 
including making the detailed information on results from calls for proposals 
available and accessible in a common Horizon 2020 e-database; 
 Liaise with a broad range of stakeholders including research organizations and 
universities; 
 Any other task needed to achieve the objectives set out in Article 2 of this 
Regulation* 
On gaining autonomy to implement its budget, the BBI JU adopted its Internal Control 
Framework in September 2015.108 This was based on the 16 standards laid down by the 
European Commission for its own departments109 in order to provide reasonable 
assurance to the Governing Board regarding the achievement of its objectives.  
The actions, responsibilities and requirements of the Governing Board, executive director, 
scientific committee, state representative group are similarly set out in Council 
Regulation 560/2014.110 
 
7.4.1.5 Are the definitions of roles and responsibilities clear for each of the 
partners? 
Roles and responsibilities for public and private partners as described in the proposal 
for a council regulation on the bio-based industries joint undertaking.111 
                                                 
108 BBI JU Internal Control Standards (ICSs)  
109 Ares(2014)1329924 - 28/04/2014 Simplified & Reduced Internal Control Requirements 
110 COUNCIL REGULATION (EU) No 560/2014 of 6 May 2014 establishing the Bio-based Industries Joint 
Undertaking 
111 Commission, 2013, Proposal for a COUNCIL REGULATION on the Bio-Based Industries Joint Undertaking. “It 
will be founded by the EU, represented by the European Commission, and the Biobased Industries Consortium 
(BIC). The activities of the BBI JU will be jointly funded by its founders. The Commission and BIC will contribute 
in equal parts to the running costs of the BBI JU. The research and demonstration activities will be funded 
through contributions by the BIC member companies with monetary and non-monetary resources (staff, 
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In this document the roles, responsibilities and contributions of partners were clearly set 
out and then detailed further in Council Regulation 560/2014112, which defines the rules 
for organization and operation objectives.  
From the interview with BIC’s representatives, it emerged that the roles and 
responsibilities of the private member of BBI JU are fully clear. BIC representatives 
provided a frank analysis of the problems encountered so far (i.e. delivery of financial 
contributions at program level and delay in reporting IKOP and IKAA) and presented a 
critical overview of the options available for overcoming such difficulties. It was pointed 
out that BBI JU will run till 2024 and, conversely, industry has still a considerable 
amount of time for delivery its contribution to BBI JU. On that respect, it was pointed 
out that the bureaucracy (e.g. certification of in kind contributions) connected to the 
complex financial rules set by BBI JU represents a heavy burden for some industries.   
In addition, during the interviews with some project coordinators from industry it 
became evident that at the time of the drafting of the proposal they found difficult to 
understand the nature and of expected direct or in kind private contributions, since the 
concepts are described and formulated using quite specific terminology. Overall, there 
are clear indications that it would be advisable to search for best practices aiming at the 
simplification of procedures for certification and reporting of industry contributions. 
The interviewed recognized and highlighted the supportive attitude and helpfulness of 
BBI JU staff. At the same time, the point was raised that proposals preparation requires 
extended reading and analysis work of documents and guidelines that must be turned 
into practice in a short period.  
 
7.4.1.6 Do the partners share the same visions and have clearly defined 
objectives? 
A number of documents and official communications report the visions of the partners at 
the time of the establishment of BBI JU.  
 
The vision of the European Commission 
 
 The Commission Communication of 13 February 2012 entitled ‘Innovating for 
Sustainable Growth: A Bioeconomy for Europe’113, and in particular its Action Plan, 
calls for a public-private partnership to support the establishment of sustainable 
and competitive bio-based industries and value chains in Europe. The 
Communication aims to integrate better biomass producing and processing 
sectors in order to reconcile food security and natural resource scarcity and 
environmental objectives with the use of biomass for industrial and energy 
purposes supporting the move towards a more sustainable and post-petroleum 
society. 
 The Commission Communication of 10 October 2012 entitled ‘A Stronger 
European Industry for Growth and Economic Recovery’114 confirms the strategic 
importance of bio-based industries for the future competitiveness of Europe, as 
identified in the Commission Communication of 21 December 2007 entitled ‘A lead 
market initiative for Europe’, and stresses the need for the BBI Initiative. 
                                                                                                                                                        
equipment, consumables, etc.), and monetary resources from the EU. The level of EU resources will vary, in 
line with Horizon 2020rules, depending on the type of activity considered. 
112 COUNCIL REGULATION (EU) No 560/2014 of 6 May 2014 establishing the Bio-based Industries Joint 
Undertaking 
113 http://ec.europa.eu/research/bioeconomy/pdf/bioeconomycommunicationstrategy_b5_brochure_web.pdf 
114 COMMUNICATION FROM THE COMMISSION TO THE EUROPEAN PARLIAMENT, THE COUNCIL, THE EUROPEAN 
ECONOMIC AND SOCIAL COMMITTEE AND THE COMMITTEE OF THE REGIONS A Stronger European Industry for 
Growth and Economic Recovery http://eur-
lex.europa.eu/LexUriServ/LexUriServ.do?uri=COM:2012:0582:FIN:EN:PDF 
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 The Council Regulation 560/2014 sets out that:  
o ‘Bio-based Industries and their value chains are facing complex and 
substantial technology and innovation challenges. As a nascent sector, bio-
based industries have to overcome the dispersion of technical competences 
and the limited publicly available data on real resource availability in order 
to build sustainable and competitive value chains. In order to tackle those 
challenges, critical mass has to be achieved in a focused and coherent way 
at European level in terms of scale of activity, excellence, and potential for 
innovation.’  
o ‘The BBI Initiative should mitigate the different types of market failures 
that discourage private investment into pre- competitive research, 
demonstration and deployment activities for bio-based industries in 
Europe. In particular, it should ascertain the availability of reliable biomass 
supply taking into account other competing social and environmental 
demands, and support the development of advanced processing 
technologies, large scale demonstration activities and policy instruments, 
thus reducing the risk for private research and innovation investment in 
the development of sustainable and competitive bio-based products and 
biofuels.’ 
o ‘The BBI Initiative should be a public-private partnership aiming at 
increasing investment in the development of a sustainable bio-based 
industry sector in Europe. It should provide environmental and 
socioeconomic benefits for European citizens, increase the competitiveness 
of Europe and contribute to establishing Europe as a key player in 
research, demonstration and the deployment of advanced bio-based 
products and biofuels’ 
o ‘The objective of the BBI Initiative is to implement a programme of 
research and innovation activities in Europe that will assess the availability 
of renewable biological resources that can be used for the production of 
bio-based materials, and on that basis support the establishment of 
sustainable bio-based value chains. Those activities should be carried out 
through collaboration between stakeholders along the entire bio-based 
value chains, including primary production and processing industries, 
consumer brands, SMEs, research and technology centers and universities.’ 
 
 
The vision of the Bio-based Industries Consortium (the ‘BIC’)  
 
BIC developed a vision paper and a Strategic Innovation and Research Agenda 
(SIRA), based on consultation with public and private stakeholders. The SIRA  sets out 
technological and innovation challenges that need to be overcome in order to develop 
sustainable and competitive bio-based industries in Europe and identifies research, 
demonstration and deployment activities to be carried out by a Joint Technology 
Initiative on Bio-based Industries (the ‘BBI Initiative’). 
 
Bio-based Industries vision set out by BIC was:  
 In 2030 the European bio-based economy will be flourishing, with biorefineries 
playing a key role in the re-industrialization of rural Europe. Based on demands of 
a more conscious and resource efficient society and market, versatile biomass 
supply chains will feed full-scale, integrated biorefineries and sustainably process 
biomass into a spectrum of marketable products and energy. 
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Bio-based Industries objectives for 2030 set out by BIC were: 
 
 Reindustrialize Europe by creating a new rural infrastructure of biorefineries; 
 Diversify farmer’s income and provide them with additional margins by up to 40% 
by using available residues 
 Enable 30% of overall chemical production to become bio-based. For high added 
value chemicals and polymers (specialties and fine chemicals), the proportion is 
more than 50%, while less than 10% of bulk commodity chemicals are derived 
from renewable feedstock 
 Supply 25% of Europe’s transport energy needs by sustainable advanced biofuels 
 Support the European market for bio-based fiber and polymers such as viscose, 
carbon fibers, nano-cellulose derivatives and bioplastics to grow rapidly. 
Traditional fiber products such as paper remain 100% bio-based to create more 
value out of the same resources 
 Realize a new generation of bio-based materials and composites produced in 
biorefineries, allowing the production of better-performing components for 
industries including automotive, construction and packaging. 
 The aim of the PPP proposed by BIC in their vision document is that the 
development of value chains and industries resulting from the initial investments 
will generate at least EUR5 for each public euro spent115. 
 
The BIC website116 sets out their current vision and strategy:117 BIC’s vision is to 
accelerate the innovation and market uptake of bio-based products and to position 
Europe as a world-leading, competitive bio-based economy where the basic building 
blocks for chemicals, materials and advanced biofuels are derived from renewable 
biological resources. 
BIC will focus on those sectors of the economy that supply and use only renewable 
biological resources, and produce bio-based materials, goods and fuels, traversing the 
entire value-chain from field to biorefinery to end consumer. 
To create a society, less dependent on fossil fuels, where economic growth is decoupled 
from resource depletion, BIC and its members are building an economy based on: 
 
 Local sourcing 
 Local production 
 Job creation 
 Rural development 
 Sustainability 
 Efficient use of resources 
  
Common vision of BIC and the Union 
This Commission initiated but industry-led initiative developed a joint vision on how 
Europe might reach a substantial bio-based economy building on the work done under 
the seventh EU framework programme for research, member states’ national bio-based 
economy policies and national clusters’ activities. In their vision, the founding partners 
committed to invest more than EUR2.8 billion in research and innovation efforts between 
2014 and 2020. Demonstration and flagship plants were explicitly mentioned as playing a 
key role. This industry commitment was intended to be leveraged as additional partners 
                                                 
115 BIC Vision document BIC_BBI_Vision_web.pdf available at http://biconsortium.eu/library/bic-documents  
Section 1.1 PPP initiative backed by a committed consortium ‘…The aim of the PPP is to have this investment 
matched by an equal amount of public funding. Furthermore, the development of value chains and industries 
resulting from the initial investments will generate at least EUR5 for each public euro spent.’ 
116 http://biconsortium.eu/ 
117 Biobased Industries Consortium  (2012) The Biobased Industries Vision Accelerating Innovations and Market 
Uptake  of bio based products 
http://biconsortium.eu/sites/biconsortium.eu/files/downloads/BIC_BBI_Vision_web.pdf 
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join, national strategies come into force and research programs bring in the scientific, 
academic and research communities and funding sources such as national agencies, 
research institutions, private foundations or venture capital firms. They expected this to 
double, at least, the initial investment of the Founding Members. 
BBI JU’s mission is to implement this Strategic Innovation and Research Agenda 
(SIRA) developed by the Bio-based Industry Consortium (BIC) and endorsed by the 
European Commission on behalf of the European Union (EU). BBI JU operates its 
programme as the catalyst to enable the EU and industry to align their strategy and 
vision while respecting the principles of openness, transparency and excellence required 
for funding under the Horizon 2020 framework programme, through the annual Calls for 
proposals organised by BBI JU. 
More details on the envisioned total EUR 3.7 billion BBI JU budget and on the financial 
commitments of the Partners are reported in section 7.3. Their combined financial 
contributions are required to support the large-scale commercialization of high-
quality bio-based products, through investment in innovative manufacturing facilities and 
processes, as well as in biorefining research and demonstration projects. 
Indeed, interviews with project leaders118 highlighted the effectiveness of the BBI JU in 
bringing together project participants, in leading to more coherent and ambitious 
projects, in de-risking investments, in supporting and creating immediate jobs.  
 
7.4.1.7 Do long-term commitments exist from all partners, including a balanced 
contribution from all partners? 
 
The analysis of the contributions delivered by EC and BIC to BBI JU so far has been 
discussed in section 7.3.2.3, which also analysed the difficulties inherited from the start-
up phase of the organisation. Measures have been designed and agreed by BBI JU 
members to address and solve these issue and specific monitoring actions will be 
required to assess their effectiveness. 
Concerning the long-term commitment and contribution of the BBI JU members (i.e. EU 
and BIC), the unclear definition of rules for the delivery of the financial (in cash) 
contribution to operational costs by BIC led to a consistent lack of financial contribution 
from industry.  The BIC was expected to deliver around EUR 17.5 million financial 
contributions (in cash) to operational costs per year at programme level in 2014, 2015 
and 2016 to be on track to deliver at least EUR 182.5 million over the duration of the BBI 
JU initiative. However, only EUR 0.75 million was delivered by BIC at programme level in 
2016 (see Table 21), and nothing in 2014 and 2015. This corresponds to a cumulated 
non-delivery of financial (in cash) contribution to operational costs in the order 
of EUR 50 million for the period 2014-2016. 
At the same time, about EUR 10.37 million have been committed at project level (EUR 
2.2 million: through calls 2014, 2015; EUR 8.17 million through calls 2016),  although 
this contribution is not counted towards the target of EUR 182 500 000 reported in Article 
12(4) of the BBI JU Statutes.119  
The group of experts tried to understand the different factors at the basis of the ‘in cash 
contribution issue’, by interviewing relevant actors of BIC, BBI and EC. All agreed that 
there was some inaccuracy in the definition of the delivery mode and in the acceptance 
of the BBI JU Statutes where the financial (in cash) contribution to operational costs is 
mentioned in Article 12(4): the consequences of such clause were underestimated.  
                                                 
118 See Annex 6 
119 According to AAR 2015 « In the course of the year 2015, no in cash contribution has been delivered by BIC 
to the operational budget of BBI JU. However, following the signature in 2015 of Grant Agreements related to 
the call 2014, it is expected that an amount of EUR 2 010 000 of financial contribution will be delivered by BIC 
members in the coming years, directly into call 2014 projects. Under the current legal framework of the BBI JU, 
the financial contribution delivered at project level is not counted towards the target of EUR 182 500 000 
provided for in Article 12(4) of the BBI JU Statutes”.  
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The possibility to deliver part of the private contribution in cash was introduced 
specifically in the BBI JU Statutes, whereas it is not present in the regulations of the 
other JUs.120 The option was specifically conceived for those industrial sectors – typically 
the pulp and paper sector - that have scarce in house R&I facilities. Consequently, such 
type of partners could not deliver IKOP at a significant extent. Therefore, the industrial 
partners belonging to those sectors could have contributed financially in cash.  
However, BIC members soon realized that financial contribution at programme level 
is commercially unviable, because doing so would not offer them any guaranteed benefit 
in exchange (e.g. results of the projects and related intellectual property rights). In 
addition to this, taking into account the open and transparent nature of the BBI calls for 
proposals, financial contributions delivered at programme level could benefit competitors 
participating in projects funded by the BBI JU.  
Thus, BIC proposed an alternative mode for delivering the financial (in cash) 
contribution: the possibility for its members to deliver it at project level. This delivery 
mode would encourage BIC members’ financial participation, because it would allow them 
to have access to the results of the projects that are restricted to project participants 
only.  
As reported in section 7.3, the European Commission proposed an amendment to the 
Council Regulation (EU) No 560/2014 establishing BBI JU and, finally, the amendment 
process is ongoing.121 
On that respect, a Task Force was established in April 2016 to discuss possible ways of 
implementing the amendment and how to organize future Calls for proposals dedicated 
to attracting in-cash contributions at project level.  
In particular, it is necessary to understand how this amendment will be implemented to 
deliver actually the expected contribution at project level, particularly in respect to article 
9.5 of the Rules of Participation in Horizon 2020.122  
In the meantime, the European Commission applied Article 4(5) of the BBI Regulation123 
and on March 1st 2016, the Chair of the Governing Board was informed by European 
Commission about the Partial suspension of the Union contribution to the Bio-
based Industries Joint Undertaking operational costs for 2017. In line with article 
4.5 of Council Regulation 560/2014 establishing the BBI JU, the EC has taken the steps 
to suspend EUR 50 million out of the planned EUR 131 million EC contributions 
to BBI JU operational costs in 2017, leading to a EUR 81 million contributions in 
2017.  
This partial suspension and move of budget to later stages in principle would leave 
BIC the possibility of still honouring its in-cash commitments in the course of the 
initiative.  
However, from the interviews carried out by the group of experts emerged that BIC 
considers quite difficult that the industrial partners can deliver the total due ‘in cash 
contribution’ within the time left before the end of the programme.   
Conversely, some additional measures will be required in order to solve the problem of 
the unbalanced contributions of EC vs BIC.  
                                                 
120 Only IMI JU conceives the possibility that private partners contribute in cash to the implementation of 
activities, although at both programme and project level. 
121  The Commission adopted the proposal at the end of February 2017. Proposal  of 22.2.2017 for a COUNCIL 
REGULATION amending the COUNCIL REGULATION (EU) No 560/2014 of 6 May 2014 establishing the Bio-
based Industries Joint Undertaking.   2017/0024.    
122 Regulation (Eu) No 1290/2013 Of The European Parliament And of The Council 
123 Article 4(5) of the regulation: “The Commission may terminate, proportionally reduce or suspend the Union’s 
financial contribution to the BBI Joint Undertaking or trigger the winding-up if those members or their 
constituent entities do not contribute, contribute only partially or contribute late with regard to the 
contributions.”  
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Nevertheless, as mentioned in section 7.3.2.3, it was pointed out that BBI JU will run till 
2024 and, conversely, industry has still a considerable amount of time for delivery 
considerable contributions to BBI JU under different forms. 
When analysing the possible impact of the lack of private financial contribution  to 
operational costs on the successful implementation of the BBI JU program and the 
achievement of its objectives, it must be underlined that    BBI JU implements activities 
through collaboration of stakeholders along the entire bio-based value chains, including 
collaboration with SMEs, research and technology centres and universities.  
In fact, the financial contribution expected from BIC was assigned to be invested in 
Research and Innovation Actions, where the main beneficiaries are academia and SMEs.  
Therefore, the difficulties encountered by BIC in delivering the financial (in cash) 
contribution might have a direct adverse effect on final important drivers of innovation 
and beneficiaries (i.e. academia and SMEs) which are deprived of a source of financing.  
In addition, the delivery of a financial contribution by the private partner is aimed at 
securing a leverage effect of contributions made by the Union, in financial terms, 
although the leverage effect is determined by a group of various factors as commented in 
section 7.5.  
 
 
7.4.2 Operational effectiveness 
 
7.4.2.1 To what extent does the BBI JU operate according to the legal 
framework establishing it? 
The organisation, structure, decision making and reporting of the BBI JU as described in 
7.4.1.3, 7.4.1.4 and 7.4.1.5 are in line with the establishing legal framework.  
Concerning the financial commitments set in the Council Regulation (EU) No 560/2014, 
sections 7.3 and 7.4.1.7 comment in detail the difficulties encountered by the industrial 
partner to implement the articles concerning the financial (in cash) contribution to 
operational activities and measures undertaken to overcome such problems. 
 
Access to BBI JU projects’ results by the Partners 
The rules concerning the access to BBI JU projects’ results are the same as for other JUs 
operating under Horizon 2020   and they can be summarized as follows: The Commission 
has a right to access results retained by the JUs, and in this respect, there are 
sufficient legal safeguards in place to ensure proper use and protection of 
confidential data accessed by the Commission. Article 49(1) of the Horizon 2020   
Rules of Participation (RfP)124 gives the Union's institutions the right to enjoy access to 
the results of a participant that has received Union funding for the duly justified purpose 
of developing, implementing and monitoring Union policies or programmes; such access 
is limited to non-commercial and non-competitive use.  
This right is embedded into the JU Model Grant Agreements (MGAs) in Article 31(5) 
as the obligation by beneficiaries to grant to the JUs and to the Union 
institutions access to project results for policy purposes.  
Any breach of this obligation by the beneficiaries could lead to a reduction of the grant or 
other sanctions (Article 31(7) MGA).125 
                                                 
124 Extract from Article 49 RfP: Access rights for the Union and the Member States  
1. The Union institutions, bodies, offices or agencies shall, for the duly justified purpose of developing, 
implementing and monitoring Union policies or programmes, enjoy access rights solely to the results of a 
participant that has received Union funding. Such access rights are limited to non-commercial and non-
competitive use.  Such access shall be granted on a royalty-free basis. 
125 Article 36(1) in previous versions of the MGA also allowed the disclosure of confidential information by the JU 
to the EU institutions, but under two cumulative conditions, namely: (a) that this is necessary to implement the 
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Since beneficiaries have an obligation under Article 31(5) MGA to provide access to 
results to the Commission, this would mean that information on results provided by 
beneficiaries to the JUs should also be accessible to the Commission for the purpose of 
developing, implementing and monitoring policy.126  
However, the JUs' confidentiality obligations cannot constitute grounds to restrict the 
Commission's access to results. Article 36(1) MGA (current wording introduced in version 
3 MGA) expressly states that the JU may share confidential information with the Union 
institutions, and there are no additional legal conditions attached. 127 
It is also noted that the Commission does not automatically make available to other 
Union bodies or Member States information that comes into its possession concerning 
results of Union-funded actions; it does so upon request and provided that two specific 
conditions are cumulatively fulfilled (namely, the information concerned is relevant to 
public policy and the participants have not provided sound and sufficient reasons for 
withholding the information concerned - see Article 4 RfP). Again, the recipients of such 
information are also obliged to treat it as confidential. 
It must be underlined that the access to project results by the EC is of primary 
importance for policy development and for maximizing the synergies with the different 
initiatives aiming at the growth of the bio-based sector and the Bioeconomy as a whole. 
Therefore, any impediment to the application of the rules and regulations reported above 
should be removed. 
 
7.4.2.2 To what extent has the JU led to improved management of the 
programme and better services to the stakeholders and addressees as 
compared to the alternative options. 
As set out in the Impact assessment128 three alternative options for action in delivering 
services to stakeholders were considered: 
 Business as usual  
 Contractual PPP 
 Institutional PPP 
 In detail (quoting from the impact assessment) these are: 
Option 1 – Business as Usual 
                                                                                                                                                        
Agreement or safeguard the EU’s financial interests and (b) that the recipients of the information are bound by 
an obligation of confidentiality. Regarding the first condition, it can be argued that the need to protect the EU’s 
financial interests includes the need for the officers in charge to be aware of research and innovation that is 
taking/has taken place to avoid that a programme or policy targets research which already is or has been 
funded by the EU. As regards the second requirement, this is also fulfilled since, as stated in point 3 above, the 
Commission and its staff are under a general duty to maintain confidentiality. In any case, for confidentiality 
issues related to projects which were concluded prior to the introduction of version 3 MGA, it should be ensured 
that only staff who needs the confidential information to safeguard the EU’s financial interests will has access to 
confidential information disclosed under these grant agreements (to note that both of the abovementioned 
conditions also applied regarding any disclosure to Commission staff in the Horizon 2020 general model grant 
agreements before version 3).  
126 In the opinion of EC Legal Service, on the basis of the principle of sincere cooperation, the JUs, as indirect 
management structures established by the EU and managing Union funds, cannot justifiably refuse such access. 
Such a refusal would be ultimately ineffective because the Commission has the right to place request for the 
same information directly with the beneficiary. In this respect, the EC would also not see any justification for 
beneficiaries to oppose that information on results collected by the JUs is transmitted to the Commission as 
long as the same rules and standards apply with respect to the confidentiality of the data.  
127 The Commission is under a general duty to maintain confidentiality under Article 3 RfP and Article 20 of the 
respective Delegation Agreements signed between the Commission and the JUs. Furthermore, Commission staff 
(according to the Staff Regulations and the Conditions of Employment) has an obligation to refrain from any 
unauthorised disclosure of information received in the line of duty. 
128 Commission Staff Working Document Executive Summary Of The Impact Assessment Accompanying The 
Document Proposal For A Council Regulation On The Bio-Based Industries Joint Undertaking. SWD/2013/0248 
Final. 
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The ‘Business as Usual’ option (BAU) is based on Horizon 2020 only (‘zero 
option’). 
This implies a continuation of the Collaborative Research model applicable under 
FP7, integrating Horizon 2020 improvements (e.g. more emphasis on demonstration). 
Projects will be carried out jointly by several partners in accordance with the 
conditions and rules for participation set out by Horizon 2020. 
Option 2 – Contractual PPP 
The ‘Contractual PPP’ option (c-PPP) implies a contractual agreement between the 
European Commission and the private partners, who are organized in a dedicated 
industry group. This option gives a stronger advisory role to the industry group, 
which proposes a SIRA. As under BAU, standard Horizon 2020 rules and 
procedures fully apply, also with regard to the preparation of the (bi-) annual 
work programme, which are subject to approval by the Member States in the 
Programme Committee. 
Option 3 – Institutional PPP 
The ‘Institutional PPP’ option (i-PPP) involves the creation of a Joint Technology 
Initiative (JTI) established as a Community body under Article 187 of the Treaty 
on the Functioning of the EU (TFEU). It is foreseen under Article 19 of Horizon 
2020 when justified by the scope of the objectives pursued and the scale of the 
resources required. 
As a Community body, the JTI has a dedicated administrative structure with a 
governance system of its own, the so-called Joint Undertaking (JU). The JU is 
constituted by the European Commission and the private partners, who are 
organized in a dedicated industry group. It is in charge of programming and 
implementing the JTI's activities. Funding rules derogating from the general 
Horizon 2020 rules can be defined where necessary.  
The outcomes of the selected i-PPP option were intended to: 
 Allow for a long term EU and industrial budget commitment, providing industrial 
partners with a stable long-term perspective and an opportunity to adopt a long-
term strategic innovation and research agenda (SIRA) 
 Offer industry with a stable framework and the opportunity to adopt a long-term 
strategic vision 
 Provide greater scope for financial contributions by the industry as funding rules 
derogating from the general Horizon 2020 rules can be defined where necessary 
 Fund projects that contribute to a strategic long-term objective 
 Put more emphasis on demonstration activities (TRLs 4 to 8), paving the way for 
industry to deploy and commercialize the results 
 Attract substantial industrial participation (typically at least 25% in research 
projects; more than 75% for demonstration projects) 
 
The potential impacts of the actions of the three options were considered in the impact 
assessment (Table 23) 
 
Table 23: Potential impacts of the three options 
 
Criteria Business as 
usual  
c-PPP i=PPP 
Input 
parameters 
Critical mass of 
resources and 
leverage effect 
on R&I 
= + ++ 
Critical mass of 
participants 
= + ++ 
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and addressing 
fragmentation 
Efficiency of the 
governance 
structure 
= = + 
Coherence with 
member state 
and regional 
programme 
= = + 
Innovation 
impacts 
= + ++ 
Output 
parameters 
Environmental 
impact 
= + ++ 
Economic 
impact 
= + ++ 
Social impact = + ++ 
Addressing the 
technological 
and innovation 
challenges 
= + ++ 
 
At the current status of these parameters and impact of the i-PPP, the input 
parameters are: 
 
 Critical mass and leverage effect on R&I – as reflected in KPIs the programme has 
seen active engagement from across value chain and success in flagship projects, 
value chains and new products. 
 Critical mass of participants and overcoming fragmentation – as reflected in KPIs 
the projects have demonstrated a great number of new discussions and 
partnerships. 
 Innovation impacts – the development of flagship biorefineries and move toward 
higher TRL levels e.g. development of products rather than concepts appears from 
KPIs to be progressing well. 
 Efficiency of governance structure – there have been issues over interpretation 
and contributions so while over long run this may offer advantages over other 
modes of intervention this cannot be yet confirmed. 
 Coherence with member state programmes – while more member states now 
have bio economy strategies and are consulted and informed regarding the BBI JU 
it cannot be said that the development of these strategies or coherence is better 
than might have been though other modes of intervention.  
Output parameters are: 
 
 Environmental, economic and social impacts: While the use of bio based material 
may result in reduced environmental impact, increased resource efficiency, 
support of agriculture and rural economy, job and value creation (these are all set 
out in the overall vision) there appears to be no meaningful information on the 
expected impacts and on the success of the pipeline of projects and products.  
 While the move toward higher commercialization status/TRL level is evident, the 
actual impact of this is not yet clear or reflected in the KPIs. 
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The progress on implementing the objectives outlined under Section 3 and the SIRA 
is monitored by using three levels of quantitative and qualitative Key Performance 
Indicators: 
 
 KPIs ‘Level 1’ address the contribution to accomplishment of the general 
objectives of the JTI with a vision to 2020 and 2030 (outcome and impact). These 
objectives will, however, not be direct results of the PPP; 
  KPIs ‘Level 2’  aim at monitoring the progress of JTI, measuring how the specific 
operational objectives/results are met by 2020 (output and outcome), with 
milestones end of 2016 and 2018; 
 KPIs ‘Level 3’ allow monitoring the success of each project to be funded under the 
JTI.  
 
The overall objective is to: 
Contribute a more resource efficient and sustainable low-carbon economy and 
increasing economic growth and employment, in particular in rural areas, by 
developing sustainable and competitive bio-based industries in Europe, based on 
advanced biorefineries that source their biomass sustainably 
 
 The specific objectives (bullet) and associated operational objectives/results 
envisaged (sub bullet) are that the BBI JU will: Validate at demo scale new 
chemical building blocks from European biomass 
o By 2020: 5 new building blocks (to be increased to 10 by 2030) 
 Develop new bio-based materials 
o By 2020: 50 new bio-based materials 
 Demonstrate consumer products from bio-based chemicals and materials 
o By 2020: 30 new consumer products 
 Establish new bio-based value chains that integrate players along the whole value 
chain 
o By 2020: 10 new bio-based value chains 
 Set up flagship biorefinery plants producing cost-competitive bio-based materials, 
chemicals and fuels from the PPP 
o By 2020: At least 5 flagship biorefinery plants (at least one per bio-based 
value chain, see above) 
 Create new cross-sector interconnections in Bioeconomy clusters 
o By 2020: 36 new cross sector interconnections 
 Support cooperation projects through cross-industry clusters 
o By 2020: >200 projects 
The technology readiness level for different activities is set out and it is clearly 
anticipated that specific objectives 2, 3, 4 and 5 does not imply that these products and 
value chains progress up to TRL 8 (namely, demonstrated but not yet commercial). 
The association between level 1 and 2 KPIs and the process for monitoring has been 
developed over the duration of the BBI JU:129 
 Feb 2016, a first draft of KPI questionnaire was discussed with representatives 
from the 10 Call 2014 projects 
 2016: Consultation processes among the BBI JU advisory bodies, the SC and SRG 
(State Representatives Group). 
 By November 2016, BBI revised the KPI questionnaire, based on received input & 
changing framework (revised SIRA).  
All projects will be asked to report on KPIs on an annual basis by questionnaire. For 
2016 (first year in effect) 36 running projects were asked to complete questionnaire 
reporting on both tier 1 and 2 KPIs. 
                                                 
129 Presentation supplied by BBI  JU Programme Office (May 2017) 
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While the KPI survey is voluntary and completion not a requirement of the grant 
agreement all but 2 projects provided input. These non-respondents were at the time of 
reporting in the process of grant agreement amendment or suspension. This process is 
now complete for these 2 projects and they along with additional projects started in 
current year will be included in the 2017 survey. 
KPI level 2 section asked whether projects could be expected to contribute to: 
 Socioeconomic impact 
 Environmental impact 
 Health and safety 
 Standards, regulations and policies 
 Other 
The questionnaire requested a description and where possible a quantitative estimate 
of items such as knowledge creation, jobs, valorisation of marginal land etc. All projects 
responding reported that they expect, if successful, to make a positive impact in more 
than one area of impact with 85% projects (29) reporting that they will have a scientific 
impact, 74% (25) will have regional & local impact, 71% of projects (24) will create new 
jobs. Of them, Flagships and DEMO projects reported an overall stronger socio-economic 
impact, especially regarding job creation and regional impact.  
Regarding the economic impact, 71% of the projects reported they will have an impact 
on the creation of new skilled jobs, among them all Flagships, 80% of the DEMOs, 67% 
of the RIAs and 33% of the CSAs. 
On environmental impact, all project reported to have positive environmental impact n 
more than one area: e.g. 71% projects (24) expect to contribute to the production bio-
based products with lower GHG emissions versus fossil-based alternatives (all Flagships, 
90% of the Demos and 67% of the RIAs). 
Some projects, especially Flagships and DEMOs, provided some quantitative data on the 
estimated creation of jobs.  
Although positive, this is not quantitative and relies on the assumption that projects 
are successful. While the projects can be said to be contributing toward the overall vision 
it is not possible to evaluate to what extent. Reliable data can only be collected from the 
(final) project reports of the projects. More in depth analysis of the socio-economic and 
environmental impact has been noted as an action point for coming years. 
While we can see progress against the operational KPIs, we cannot compare the activity 
and results against the highly positive expectation of impact on output parameters under 
BBI JU since, presently, we do not have quantitative data on the expected results  
Although limited data on employment effects are available and a number of 
methodological challenges exist due to the time lag between projects and the creation of 
new temporary and permanent jobs, an attempt was made in section 7.5 to estimate 
direct employment effects (689 staff employed) from the available quantitative data on 9 
running of projects.130  
There are still a number of associated issues to be resolved, such as the unknown 
difference between the employment status of these people before and after the project. 
No comparison is being made with the situation in other projects outside of BBI. Based 
on the figure mentioned above, we can make a rough estimate that across the 65 
running projects almost 5000 people are employed. A disclaimer needs to be pointed out 
here that any conclusions have its limitations until actual statistical data on direct and 
indirect employments effects are collected systematically from the project partners.   
 
7.4.2.3 What is the overall satisfaction of beneficiaries with the services 
provided by the BBI JU? 
 
                                                 
130 Email communication from BBI JU Programme office (May 2017) 
 78 
Project coordinator questionnaire131 
 
A questionnaire to assess the performance of all JUs was carried out with modifications in 
consultation with the BBI to reflect the specificities of the BBI JU (e.g. no project has yet 
gone through the reporting and payment phase, so the questions relating to this aspect 
where removed). 
This survey was launched on 13th February 2017 and was addressed to BBI JU project 
coordinators of the 36 ongoing projects and to those of the projects resulting from 2016 
call, still under the process of grant agreement preparation, making a total of 63 
coordinators. The response rate, with 40 respondents, was the highest among all JUs. 
The questionnaire addressed the following aspects:  
  
a. Information on the respondents 
b. Application process 
c. Grant Finalization Phase 
d. Communication and interaction 
e. Overall performance of the BBI JU 
f. Level of satisfaction with the content of the programme.  
A document was prepared summarizing the most relevant quantitative aspects resulting 
from the questionnaire. Responses were highly positive across every aspect and the 
survey supports the general conclusion that applicants see the programme positively. A 
very high proportion of the respondents are BIC members but there appeared to be no 
significant difference between respondent affiliation and how the programme was 
perceived. 
Further feedback during interviews with project coordinators132 highlighted the 
helpfulness, support and constructive discussion with BBI JU staff in answering calls and 
ongoing management of projects. Points were raised about the volume of information 
which project coordinators have to read and assimilate in order to be able to respond to 
calls and concerns over reporting especially in contributions and quantitative answers on 
outcomes. 
 
Public consultation 
 
In 2017, the BBI carried out a public consultation133 as an online questionnaire to assess 
the effectiveness of the BBI JU.  The BBI received 144 responses. Of the 144 
respondents, 95 had applied for BBI JU funding (outcome of these applications not 
given), while 49 have not. Of the 144 respondents, 67 are directly involved with BBI JU, 
while 77 are not. 
While the responses received were highly positive that the BBI JU makes positive 
contributions toward the vision of a more sustainable bio based industry the low number 
of respondents who neither are applicants nor directly involved in the BBI JU mean this 
cannot be read as a general public consultation or representative of either any wider 
industry or society. 
Relating to KPIs the substantial majority of respondents agreed with statements 
presented that: 
 BBI JU contributes to economic growth and job creation in the EU. 
 The BBI JU contributes to the climate change mitigation by reducing the CO2 
derived from the use of fossil-based products. 
                                                 
131 Annex 3 
132 Expert interviws with selected project coordinators 20 -27 June 2017 
133 Annex 5 
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 The BBI JU contributes to a more sustainable and efficient use of resources, 
including the recycling, reuse and valorisation of organic residues. 
 The BBI JU contributes to the strengthening of a circular economy in Europe. 
Responses relating to website showed lower level of agreement with statements 
presented. About 2/3 of respondents agreed that: 
 The BBI JU website provides easy and effective access to information to the 
public. 
 The BBI JU website provides effective access to information and sufficient 
guidance to interested organizations facilitating their participation in proposals.  
The answers around statements on participation and communication were much more 
ambivalent: 
 The current way of defining topics for the calls of proposals is open and inclusive. 
(63% strongly agree/agree). 
 That BBI JU organizes a sound and fair proposal evaluation system based on both 
scientific and technological excellence and industrial relevance. 51% strongly 
agree/agree, 43% no opinion/no answer, and 6% strongly disagree/disagree. 
 The communication of the evaluation results and the feedback provided to the 
applicants is effective and meaningful. 52% strongly agree/agree, 42% no opinion 
/ no answer, 6% disagree (no strongly disagree responses). 
The communication of the evaluation results and the feedback provided to the 
applicants is effective and meaningful. 52% strongly agree/agree, 42% no opinion / no 
answer, 6% disagree (no strongly disagree responses) Questions relating to Level 1 KPIs 
showed respondents supported the statements presented but these were split between 
broad and emphatic agreement. The majority (>70%) of respondents: 
 Agreed that the scientific priorities addressed by the BBI JU are set in Strategic 
Innovation and Research Agenda (SIRA). Is this document optimal for defining the 
scope of research and innovation followed by the BBI JU?   
Respondents also agreed that the BBI JU as somewhat effective or very effective in: 
 Supporting the development and implementation of pre-competitive research and 
of innovation activities of strategic importance to the Unions in the Bioeconomy 
sector 
 Increasing the number of new cross-sector interconnections in BBI projects 
 Developing new bio-based value chains 
 Developing new bio-based building blocks 
 Developing the bio-based materials 
 Developing new bio-based consumer products 
 Increasing the numbers of flagship biorefinery plants started based on BBI 
demonstration projects 
 Developing necessary technologies to fill in the gap in the bio-based value chains 
This relatively mild expression of support was surprising given the great number of 
applicants to or participants in BBI JU who were included in the respondents. 
The survey presented the points below as being the major benefits of participating in a 
BBI JU project with >80% agreeing: 
 Direct financial support for innovative research and development 
 Greater visibility across Europe/Reputation 
 Greater understanding of the bio-based products development process 
 Enhanced access to new markets, business opportunities and funding sources 
 Inclusion in open innovation networks, with direct contact to leading researchers 
in universities and the industry 
73% of the respondents also indicated that BBI JU projects have resulted in specific 
scientific and/or technological successes, despite the early phases of the running 
projects. 
Respondents were less supportive on the question ‘To what extent are the activities of 
the BBI JU coherent with other activities of the Horizon 2020 programme?’  This question 
still saw respondents agree but their answers were split over the two degrees of 
agreement: 40% very coherent, 35% somewhat coherent. 
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Applicants to BBI JU calls agreed that: 
 The application procedure for funding was straightforward and simple, although 
there is room for improvement. Nonetheless, 13% strongly disagreed or disagreed 
on this point. 
 The administrative burden for preparing the proposal was acceptable, with again a 
significant minority of 16% that expressed disagreement. 
The question related to the budget (You consider that the BBI JU overall budget - public 
and private - in relation to its objectives and expected outcomes) led to a mixed picture: 
56% of respondents find the budget appropriate, 26% too low and therefore it should be 
increased, 1% too high and therefore it should be partly used for other types of research 
and innovation actions in this area, 20% expressed no opinion, whereas 5% gave no 
answer. 
 
7.4.2.4 Operational efficiency 
Timely execution of the functions 
As described in the annual reports (see Table 26), time to inform, time to grant, and time 
to pay have been within target. 
 
 
Table 26: Time to grant according to AAR 2016 
Call  EVALUATION  GRANTS  PAYMENTS  
2014  Time to inform 
(TTI) all applicants: 
146 calendar days 
(target < 153 
calendar days) 
Redress after 
evaluation: 0 cases  
Time to grant 
(TTG): 240.8 
calendar days 
(target TTG < 243 
calendar days)  
Time to pay (pre-
financing): 14.3 
calendar days 
(target 30 days) 
2015.1   TTI all applicants: 
86 calendar days 
(target 153 
calendar days)  
Redress after 
evaluation: 0 cases  
227 days (target 
243 days) 
66% on time with 
an average of 16 
days  (target 30 
days) 
2015.2 141 days (target 
153 days) 
239 days (target 
243 days) 
23 days (100%) 
(target 30 days) 
2016 99 days (target 153 
days) 
GA signatures 
target: 8 May 2017 
(target 243 days) 
PF to be paid in 
2017 (after 
reference date) 
Cost-efficiency of the management and control arrangements. 
Management efficiency for this purpose is defined as the ratio between inputs (staff) and 
outputs (the budget managed by the Joint Undertaking). The analysis will cover i) the 
ratio between the administrative and operational budget (%) and ii) budget ‘per head’ 
(million EUR). In addition, calculation of the average project management cost per 
running project has to be calculated.  
Table 27: Administrative and management budget (in Euro). Execution by the 
BBI JU134 
                                                 
134 With the EC executing the budget of the BBI JU on its behalf during its pre-autonomy phase (2014 – Oct. 
2015). 
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Year 
Total 
actual 
spending 
(budget 
execution, 
in 
commitme
nt 
appropriati
ons) 
 
Administrative 
(Titles 1+2) 
actual 
spending  (budg
et execution, in 
commitment 
appropriations) 
 
Operational 
(Title 3) 
actual 
spending  (bu
dget 
execution, in 
commitment 
appropriation
s)135 
% 
Admi
n 
Number 
of total 
running 
projects 
at the 
end of 
the 
year 
Admin 
cost/pr
oject 
2014 50,338,515 684,807 49,653,708 1.4% 0 - 
2015 180,961,163 1,924,189 179,036,974 1.1% 10 192,419 
2016 188,326,847 3,255,914 185,070,933136 1.7% 36 90,442 
Total  5 864 910     
 
 
Administrative and management budget137 is modest and proportionate (Table 27) 
compared to the value and scale of the projects under management. Contributions 
committed to the Administrative Costs are EUR 5,864,910. Detail of budget execution 
of commitment and payment appropriations are reported in annual reports for the 
periods 2015 and 2016138 (tables 27-30). The discrepancy between headline figures in 
table 27 and detail below was ascribed to the moment at which the report on accounts is 
prepared (estimated versus final execution). 
Detailed budget execution is reported below, as presented in the annual reports and in 
the reference for the Court of Auditors. It is publicly available. 
 
Table 28: Commitment appropriations 2015 
Expenditure Budget EUR Executed EUR %  
Title 1 – staff 
expenditure 
1500100 616231 41.07% 
Salaries and allowances 1243200 553628 44.53% 
Expenditure relating to staff 
recruitment 
158300 19061 12.04% 
Mission expenses 60000 9402 15.67% 
Socio-medical infrastructure 33600 31640 94.17% 
Receptions, events and 
representation 
5000 2500 50.00% 
                                                 
135 Budget execution excludes here the appropriations that were committed by BBI JU for the call for proposals 
during the examined year but that were decommitted (became temporarily unused) later on because the total 
of this call's GAs amounts was in the end smaller than the call's size.. 
136 This executed figure includes reactivations of unused commitment appropriations from 2014 (EUR 1.8 million) and 2015 
(EUR 26.0 million) 
137 As extracted from data made available by the EC to the group of experts by May 2017. 
138 Received by email from BBI JU staff 
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Title 2 – Infrastructure 
and operating 
expenditure 
1532200 1307958 85.36% 
Rental of buildings and 
associated costs 
263000 263023 100.00% 
Information, communication 
technology and data 
processing 
158300 127645 80.63% 
Moveable property and 
associated costs 
25000 20201 80.80% 
Current administrative 
expenditure 
16100 15411 95.72% 
Postage/telecommunications 9700 3912 40.32% 
Meeting expenses 100300 28812 28.73% 
R&D support, evaluations 
and reviews 
759800 75988 100% 
Information and publishing 190000 89154 46.92% 
Studies 10000 0 0.00% 
Title 3 – Operational 
expenditure 
206390497 180390497 87.40% 
Total 209422797 182314686 87.06% 
 
Table 29: Payment appropriations 2015 
 
Expenditure Budget EUR Executed 
EUR 
%  
Title 1 – staff 
expenditure 
1500100 569965 41.07% 
Salaries and allowances 1243200 541627 43.57% 
Expenditure relating to staff 
recruitment 
158300 13908 8.78% 
Mission expenses 60000 6635 11.05% 
Socio-medical infrastructure 
(including training) 
33600 5747 17.10% 
Receptions, events and 
representation 
5000 2048 40.96% 
Title 2 – Infrastructure 
and operating 
expenditure 
1532200 157464 34.80% 
Rental of buildings and 
associated costs 
265000 263023 99.25% 
Information, communication 
technology and data 
processing 
158300 87868 55.51% 
Moveable property and 
associated costs 
70000 20201 28.86% 
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Current administrative 
expenditure 
16100 1776 11.03% 
Postage/telecommunications 9700 - 0.00% 
Meeting expenses 75300 28279 37.56% 
Running costs in connection 
with operational 
expenditure 
- - 0.00% 
Information and publishing 150000 66447 44.30% 
Studies 5000 - 0.00% 
R&D support, evaluations 
and reviews 
782800 - 0.00% 
Title 3 – operational 
expenditure 
18042892 17713972 98.18% 
Total 21075192 18817377 89.29% 
 
Table 30: Commitment appropriations 2016 
 
Expenditure Budget 
EUR 
Executed 
EUR 
%  Carry over 
to 2017 
EUR 
Available 
for 
future 
use EUR 
Title 1 – staff 
expenditure 
3357069 1807295 53.84% 88635 1549774 
Salaries and allowances 2953523 1555009 52.65% 14529 1398514 
Expenditure relating to staff 
recruitment 
150400 114945 76.43% 28000 35455 
Mission expenses 118200 54593 46.19% 4117 63607 
Socio-medical infrastructure 
(including Training) 
114091 74948 65.69% 41786 39143 
Receptions, events and 
representation 
20855 7800 37.40% 204 13055 
Title 2 – Infrastructure 
and operating 
expenditure 
1943753 1448619 74.53% 244323 495134 
Rental of buildings and 
associated costs 
273131 263035 96.30% - 10096 
Information, communication 
technology and data 
processing 
172860 150692 87.18% 45937 22168 
Moveable property and 
associated costs 
75300 64218 85.28% 6000 11082 
Current administrative 
expenditure 
17100 8439 49.35% 2300 8661 
Postage/telecommunications 20400 15850 77.70% 6931 4550 
Expenditure on formal 
meetings 
72900 37094 50.88%  35806 
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External communication 
information and publishing 
462500 366388 79.22% 149015 96112 
Studies 121500 34140 28.10% 34140 87360 
Experts contracts and 
evaluations 
728011 508763 69.88% - 219248 
Title 3 – Operation 
expenditure 
188995048 185602886 98.21% 335085603 3392162 
Previous years’ calls -   149525760  
Addition to call 2015.2 341071  0.00%  341071 
Call 2016 188653977 185602866 98.38% 185556843 3051111 
Total 194295870 188858800 97.20 335415561 5437070 
 
Table 31: Payment appropriations 2016 
 
Expenditure  Amended 
Budget 
EUR 
Executed 
budget 
EUR 
%  Available 
for future 
use EUR 
Title 1 – staff 
expenditure 
3338335 1747743 52.35% 1590592 
Salaries and allowances 2991168 1549151 51.79% 1442017 
Expenditure relating to staff 
recruitment 
106139 95585 90.06% 10554 
Mission expenses 141913 52501 37.00% 89412 
Socio-medical infrastructure 
(including Training) 
91133 61525 67.51% 29608 
Receptions, events and 
representation 
7982 7881 98.73% 101 
Title 2 – Infrastructure 
and operating 
expenditure 
2065831 1309625 63.39% 756206 
Rental of buildings and 
associated costs 
381871 263035 68.88% 118836 
Information, communication 
technology and data 
processing 
184095 177599 96.47% 6496 
Moveable property and 
associated costs 
135081 58218 43.10% 76863 
Current administrative 
expenditure 
33174 19773 59.60% 13401 
Postage/telecommunications 26757 12831 47.95% 13926 
Expenditure on formal 
meetings 
98665 37094 37.60% 61571 
External communication 
information and publishing 
384177 232312 60.47% 151.865 
Studies 94000 - 0.00% 94000 
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Experts contracts and 
evaluations 
728011 508763 69.88% 219248 
Title 3 – Operation 
expenditure 
61792021 61792021 100.00% 0 
Previous years’ calls 61792021 61792021 100.00% 0 
Addition to call 2015.2 0    
Call 2016 0    
Total  67196187 64849389 96.51% 2346798 
 
 
7.4.3 To what extent does the BBI JU ensure the visibility of the EU as part of 
programme promoter? 
The Model Grant Agreement139 sets out clearly the general obligation for funded projects 
to disseminate results, process, format and requirements for access and availability for 
doing so across written materials and publications. In this it is made clear how 
information on EU funding should be included in such dissemination e.g. obligation and 
right to use the BBI JU, EU and Bio-based Industries Consortium (BIC) emblems. For 
publications it is required that bibliographic metadata must be in a standard format and 
must include all of the following: the terms ‘Bio-based Industries’; ‘European Union (EU)’ 
and ‘Horizon 2020’; the name of the action, acronym and grant number; 
The BBI website140 is a principal portal for visibility of the programme. The effectiveness 
of this site was discussed in section 7.4.2.3 above but further traffic analysis was carried 
out using Google Analytics (period 1 August 2016 and 23 January 201). This showed 
39,540 visits (22,246 unique visitors) with 107,570 page views (pages per visit 2.72, 
session duration 2 min 40s, 56.95% returning visits). 
The homepage was the most visited page of the site, followed by pages on calls for 
proposals, job vacancies and information about the BBI JU. The visibility of the EU is 
ensured by prominent positioning of the EU both in text and graphics throughout the site 
and links to European Commission Bioeconomy pages. The EU flag features on every 
page of the site. 
 
Table 24: Performance of BBI JU web site 
 
Page Page 
Views 
Uniqu
e 
Page 
Views 
Avg. 
Time 
on 
Page 
(min
) 
Entrance
s 
Bounc
e Rate 
%Exit 
http://www.bbi-europe.eu/ 28,06
2 
20,714 01:42 19,519 43.39
% 
43.52
% 
http://www.bbi-
europe.eu/projects 
6,359 3,522 00:40 645 35.77
% 
13.51
% 
http://www.bbi- 6,246 4,874 01:18 1,169 60.07 35.11
                                                 
 
 
140 https://bbi-europe.eu/ 
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europe.eu/about/about-bbi % % 
http://www.bbi-
europe.eu/participate/calls-
proposals-2016 
3,825 3,224 03:58 1,258 64.29
% 
58.75
% 
http://www.bbi-
europe.eu/jobs 
3,353 2,984 01:54 710 85.77
% 
62.87
% 
http://www.bbi-
europe.eu/participate/calls-
proposals 
3,334 2,754 00:53 1,563 28.57
% 
27.83
% 
http://www.bbi-
europe.eu/participate/calls-
proposals-2017 
3,010 1,985 02:22 1,134 30.90
% 
47.08
% 
http://www.bbi-
europe.eu/participate/participa
te 
2,399 1,743 00:45 128 51.56
% 
15.96
% 
http://www.bbi-
europe.eu/about/scientific-
committee 
2,160 1,826 04:30 1,346 41.48
% 
61.06
% 
http://www.bbi-
europe.eu/about/vacancies 
1,750 1,524 01:38 856 81.49
% 
69.60
% 
 
Most of the visitors to the site in this period came from EU countries, most notably 
Belgium, Italy, Spain and Germany. These countries also had a larger number of page 
views per visit than average. The large share of traffic generated from Belgium may be 
attributed to visits by staff and other affiliated parties of the European institutions. There 
were only two non-EU countries in the top 10 list: the United States and Russia. Both of 
them had a smaller than average number of pages viewed per visit. 
It was also noted that users from Germany viewed more pages per visit compared to the 
average of the site. 
 
Table 25: Visitors of BBI JU web site per Country. 
 
 
80+ Events are listed in the BBI JU events page with about half of these organised by the 
BBI JU as information days, webinars and briefing sessions. Across these events, the 
position of the EU as programme promoter is prominent and clear. 
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7.5 Question 5: EU added value and leverage effect 
The BBI JU added value to the EU from 2014 to 2016 is manifested by contributions in 
the areas of European research and innovation, industry and economy as well as society 
and environment. Structuring and mobilizing these three value domains in the EU has 
been one of the main success factors starting from the setup phase of BBI JU. This has 
taken up momentum by members of the EU Commission, BIC, BBI, the BBI Scientific 
Committee and the BBI State Representatives Group. They acted as ambassadors for the 
program by interfacing top-down and bottom-up approaches towards the creation of 
coherent and robust bio-based industries in their respective communities.  
 
Figure 11: The three value domains contributing to the Overall Added Value to 
the EU 
 
 
 
 
In research and innovation, a number of new projects, collaborations and value chains 
have been demonstrated already and led to 6 grant agreements for flagship projects, 
among others. While it is too early to assess the added value of BBI JU in terms of 
research and innovation outputs and impacts on society at large, added value can be 
preliminarily assessed through results of participant surveys and preliminary data on the 
leverage effect. The overall leverage effect comprises of the direct as well as indirect 
leverage effect. As it is too early to assess the indirect leverage effect, only the direct 
leverage effect is here considered, which is the sum of the operational and the additional 
leverage effects (see also section 7.5.3). 
 
7.5.1 Changes that can be reasonably attributed to an EU intervention 
In addition to the quantified leverage effect, an important added value of BBI JU is, 
according to the results of the participants' survey141, the encouragement of 
entrepreneurship and pioneer spirit in Europe. This leads towards increasing 
interdisciplinary valorisation of biomass-derived raw materials, e.g. from the agro- and 
wood sector to higher added value products than traditional products and bringing those 
to large scale demonstration and to the market.  
In order to assess the long term contribution of BBI JU in terms of economic, social 
and environmental beneficial impact it would be useful to have access to quantitative 
data reporting the sum total and weighted total technical risk  of commercial realisation 
                                                 
141 Survey questionnaire of Bio-Based Industries Joint Undertaking (BBI JU) project coordinators: Summary of 
the results, February 2017 
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of the projects funded. The de-risking effect of BBI JU in this regard is significant and has 
led to industry-driven projects, which would not have been possible without BBI JU. This 
has become evident from the interviews with BBI project coordinators.  
Although a stakeholder survey102 could be biased (considering that a part of its 
respondents benefit financially from the BBI JU) the results have shown that 73.6% of 
the participants disagree with the view that the industry would have been able to 
overcome the barriers which hinder innovation and drive up costs in the bio-based sector 
at national level and without the involvement of the EU. In the same survey, 94.4% 
agree with the EU cooperating with industry in the context of a public-private partnership 
so that the bio-based research brings better results to the society and the market in 
Europe. The added value of this public-private partnership is seen in a better use of the 
available funding (77.7%), integration of European research (81.9%), more cross-border 
collaboration (77.0%), more cross-sector/interdisciplinary collaboration (79.9%), quicker 
adoption of standards (68.7%) and last but not least, better availability of research 
results (74.3%) and encouragement of companies to share expertise (73.6%).  
The concrete efforts towards strengthening the EU competitiveness by setting up the 
BBI JU and accelerate the discovery, development and delivery of bio-based products 
have already begun to change perceptions and thinking along established and new value 
chains within Europe and outside Europe. Historically, the chemical industry developed 
over a very long period with new unit operations, processes, markets and by exploiting 
various fractions of fossil raw materials. Presently, the same chemical sector is trying to 
evolve towards a bio based chemical and material industry.  
As the different stakeholders and statistical data on bio-based industries are fragmented 
in Europe, the real added value of BBI JU is largely in the acceleration of bringing 
together different sectors and industries. Together they provide not only revitalization 
along existing value chains but also lead to the creation of new value chains, with 
different partners working together within a single project. As manufacturing, refining 
and final product providing companies start working together to satisfy real world 
customer demands with biobased products, also with other sectors and researchers, 
Bioeconomy has started to become more visible. In a stakeholder survey,142 87.5% of 
the participants consider that BBI JU contributes to economic growth and job creation in 
the EU. Although individual project partners have reported direct effects on the creation 
of new jobs due to BBI JU, there is no systematic annual reporting of the direct and 
indirect effects on the number of new jobs created by the different activities of BBI JU. In 
order to assess the direct and indirect impact of BBI JU projects on job creation, a 
preliminary statistical analysis has been done for the 9 BBI JU projects resulting from call 
2014, which indicates 689 staff employed, with a gender distribution of 58% male staff 
and 42% female staff. Assuming that 2014 statistics for 9 BBI projects can be 
extrapolated to the total of 65 BBI projects, the creation of about 5000 directly related 
jobs can be estimated. As the creation of direct and indirect new jobs, both temporary 
and permanent, is taking place over extended periods of time, a standardized and 
constant reporting over the years is needed and can give actual quantitative data to 
judge the long-term effect on employment in EU member states. While such a 
standardized and constant reporting can be easily introduced on the level of project 
coordinators for the duration of projects, it is more challenging to continue after the 
completion of projects  
An even higher number as 93% judge that BBI JU contributes to the transition from a 
fossil- based to a bio-based economy. Further effects of the BBI JU are seen in the 
contributions to the climate change mitigation by reducing the CO2 derived from the use 
of fossil-based products (91% of the participants), to a more sustainable and efficient 
use of resources, including the recycling, reuse and valorisation of organic residues 
(91.6% of the participants) and to the strengthening of a circular economy in Europe 
(91.7%).  
   
                                                 
142 Survey questionnaire of Bio-Based Industries Joint Undertaking (BBI JU) project coordinators: Summary of 
the results, February 2017 
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7.5.2 Assessment of the scale of resources involved  
The overall expected contributions are set in the Council regulation for the whole 
duration of the BBI JU. Relative to the number of projects, project participants and vision 
the scale of resources deployed is not unreasonable (see also section 7.4 on project 
management). As discussed earlier in section 7.3 and 7.4, there have been challenges 
with the delivery of financial contributions from the industry to cover operational costs 
and an amendment to the Council Regulation143 has been proposed to enable delivery at 
project level instead of the original approach of program level in-cash contributions. 
 The years 2014-2016 have clearly been the start-up phase of the BBI JU, with the public 
and private partners having to match their pace towards a common and harmonized 
growth. The resources contributed from the public and private sectors have provided 
important and concerted signals for catalysing and derisking pioneering developments 
within the EU in a decentralized way, which would not have been possible without the 
BBI JU. This represents an important EU added value, not only for the future of BBI JU, 
but also for attracting and creating additional investments and growth in biobased 
industries, both around the BBI project locations as well as for the regions and states of 
the EU in general. The resources committed to Flagship, DEMO and RIA projects provide 
the critical mass to drive the creation, improvement and revitalization of value chains, 
ultimately leading to the launch of new products and supply chains on the market.   
The overall contributions delivered so far are summarized in Table 32, with progress 
percentages compared to overall target levels, whereas Table 33 reports the types of 
contribution, cost and contributor. There is a challenge in measuring and comparing 
these contributions, as some are based on global commitments made by the EU towards 
the BBI JU (i.e. EU contributions), others on contributions committed at the time of 
signature of grant agreements (i.e. industry in kind contribution to operational activities) 
and some on actual realized delivery. This explains why the progress percentage of the 
EU contribution is currently higher than for the industry contributions. As soon as the GB 
adopts the BBI JU budget for a given year, the contribution of the EU to BBI JU in 
commitments for the examined year is considered as having been made available by the 
EU to the BBI JU. Therefore, it is not because the BBI JU would only use part of this 
commitment appropriations during the examined year that this implies that the EU 
contribution should be considered as equal to this part only. The EU contribution is equal 
to what has been voted in the BBI JU budget. Indeed, on its side, the EC commits during 
the examined year the full contribution mentioned in such budget (so that this 
commitment in EC book can be consumed in subsequent years by money transfers to the 
BBI JU that the JU will use to pre-finance projects). The only ‘money transfers from the 
EU and the JU are for payment appropriations, not for commitment appropriations. 
Payment appropriations are considered as being made available by the EU as soon as the 
BBI JU budget is adopted. 
 Table 32: Progress of contributions by 31/12/2016 
 
 Overall Contributions 2014-
2016  (Euro) [in brackets: 
target] 
Progress 
towards 
target (%) 
 
EU contributions committed 
through the voted budgets 
towards the BBI JU 
 
418 289 253 + 4 143 617  =  
422 432 870 
[≤ 975 000 000] 
44 % 
Industry in cash  750 000 0.4 %  
                                                 
143
 The Commission adopted the proposal at the end of February 2017. Proposal of 22.2.2017 for a COUNCIL 
REGULATION amending the COUNCIL REGULATION (EU) No 560/2014 of 6 May 2014 establishing the Bio-
based Industries Joint Undertaking.   2017/0024 
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[≥ 182 500 000] 
Industry additional activities    
(2014-2015) 
(2016) 
291 482 000.00 
185 863 000.00144 
[≥ 1 755 000 000] 
 
17 % 
11 % 
Industry in kind (operational 
activities in signed GAs) 
     114 621 657.20 
[no target given] 
    n.a. 
Industry to administrative costs 3 766 201.00 
[ ≤ 29 250 000.00] 
13 % 
Industry total 596 482 858.20 
[2 730 000 000] 
    22 % 
 
Table 33: Progress of contributions 2014-2016 per type of contribution, cost 
and contributors 
Type of Contributions Contributions 
2014-2016 (Euro) 
Progress 
(%) 
EU Contributions committed to the operational 
costs committed in individual grant agreements. 
418 289 253.00  
EU Contributions committed to the Administrative 
Costs 
    4 143 617   
Total EU Contributions committed 421 932 870.00 44% 
Industry Financial Contributions to the 
Administrative Costs 
3 766 201.00  
Industry Financial Contributions to the Operational 
Costs 
750 000.00  
Total Industry Financial Contributions 4 516 201.00  
Industry in kind contribution for Additional 
Activities (2014-2015) 
291 482 000.00 17% 
Industry in kind contribution for Additional 
Activities (2016) 6 
185 863000.00  
Industry in kind (operational activities in signed 
GAs) 
114 621 657.20 14% 
Total Industry Contributions 596 482 858.20  22% 
Total PPP Contributions 1 018 415 728.20   
 
                                                 
144 As anticipated by BIC in June 2017. The actual amount should be updated once the Governing Board is 
officially informed about the amount covered by the IKAA Report 2016 (certified value). 
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7.5.3 Assessment of the BBI JU's ability to leverage additional investments in 
research and innovation 
The direct leverage effect, i.e. the scale of overall contributions made by the industry 
compared to the EU contribution, is one of the main direct components of EU added 
value. Target level for the leverage effect in the Council regulation is 2.8.145  
It must be underlined, that the target leverage effect of BBI JU is the highest among the 
seven JUs operation under Horizon 2020.146 
The major problem encountered by the group of experts was the delay in receiving 
information on IKAA delivered in 2016. Therefore, the group of experts could not take 
into account any private contribution to additional activities related to 2016 for the 
calculation of the leverage effect, since the corresponding IKAA plan had not been 
approved at the time this evaluation was carried out. However, in June 2017 BIC 
anticipated an amount of certified IKAA for 2016 equal to EUR 185.863 million, which, 
however, was not accounted in the calculation reported herein. 
Based on the in-kind and financial (in cash) contributions to operational costs only of 
calls 2014 to 2015 as well as on the signed grant agreements of calls 2014-2015, the 
operational leverage by 31 December 2016 is 0.50.  
Operational leverage = (114 621 657 + 750 000) / 228 690 682 = 0.504 
which accounts the industrial in-kind and financial (‘in cash) contributions to operational 
costs declared in the signed agreements.  
It must be noted that the grants from call 2016 have been signed only in May 2017, 
whereas the calculations of leverage take into account the cut-off date of 31 December 
2016, which means that only grant agreements from calls 2014 and 2015 are taken into 
account.  
When considering the reported contributions to additional activities (certified value) - not 
the IKAA plan – delivered in 2014 and 2015 the additional leverage effect by 31 
December 2016 is 1.275.  
Additional leverage = 291 482 000 / 228 690 682 = 1.275 
                                                 
145 Under the Horizon 2020 indicators, leverage in an Art. 187 PPP is defined as the total amount of funds 
leveraged through the initiative, including additional activities, divided by the EU contribution, and it requires 
knowing the funding made by the private actors. To guarantee a similar approach in the seven Interim 
evaluation reports, it is proposed to calculate the leverage effect on the basis of two possible contributions: 
Total leverage  =  Operational leverage  + Additional leverage 
The Operational leverage only refers to Private contributions to the activities mentioned in a signed GA for an 
indirect action (e.g. a project or CSA) receiving EC contribution. It can be calculated on the basis of committed 
eligible IKOP, of non-eligible overheads which have been certified (also part of the IKOP) and of established 
Private Financial Contributions to the operations (allowed for IMI 2 and BBI). 
                                           ∑ IKOP of private partners in signed GA (+Private FC)  
Operational leverage =   -------------------------------------------------------------------------- 
                                                  ∑ EU contribution (∗) committed in the signed GA 
In the case of CS2, S2R, FCH and BBI, the Regulation allows an additional term: 
 
                                                              ∑ IKAA of members    
Additional leverage =   ------------------------------------------------------------------------- 
                                              ∑ EU contribution (∗) committed in the signed GA   
 (*) EU contribution as committed in the GA. For ECSEL it makes sense to consider alternative leverages which 
take a joint public contribution of EU and Participating States 
 
146 Target leverage effects of the seven Jus according to the respective legal acts. FCH2: 0.57; CS2: 1.25; 
IMI2: 1; BBI: 2.8; ECSEL: 2.4; S2R: 1.04; SESAR: 1.41 
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Therefore, the global leverage effect by 31 December 2016 is 1.779. 
Total leverage = 0.504 + 1.275 = 1.779 
The lower leverage effect (1.779) as compared to the target of 2.8 set in the Council 
Regulation is clearly connected to the delay in the communication of the certified IKAA. 
Therefore, the actual leverage effect should be re-calculated and made public once the 
IKAA plan for 2016 is approved by the Governing Board, since the announced 2016 IKAA 
(EUR 185.863 million), would significantly affect the quantification of the additional and, 
more importantly, the total leverage effect. Indeed, based on the certified IKAA for 2016 
the additional leverage effect would be 2.1 while the global leverage effect would become 
2.6.   
Notably, taking into account only data for 2014-2015, i.e.                                                                                                                                                                                                                 
only projects awarded from the call 2014, the leverage effect appears to be 6.53. This 
considerably high value is based on a total EU contribution of EUR 49 653 707, as 
committed in the grant agreements, a total IKOP of private partners of EUR 32 819 114 
for the projects of calls for proposals 2014 in signed grant agreements, a total private 
financial contribution of EUR 0 and a total private IKAA of EUR 291 482 000.    
The financial contribution committed by BIC by end 2016 should have been EUR 52.5 
million (according to the financial statement annexed to the BBI proposal where on page 
47 financial contributions are foreseen of  EUR 17.5 million for each of the years 2014-
2016).  
Appropriate monitoring measures should be implemented for collecting comprehensive 
evidence of the actual private and public contributions to BBI JU delivered so far as well 
as of the contribution expected from the two members over the next years.  
 
7.6 Question 6: Coherence 
 
Coordination of the programming activities is necessary for ensuring coherence of BBI JU 
respect to the other parts of Horizon 2020. However, the broad nature of the challenges 
addressed by Horizon 2020 implies that some intersections exist at the level of topics 
and calls published by the various programmes. That complements the approaches and 
the specific perspectives of each initiative active within the frame of Horizon 2020. 
7.6.1. Internal coherence of the actions  
Budget distribution in SC2, LEIT and BBI 
Objectives of BBI JU are in line but also complementary with other parts of Horizon 2020 
in particular ‘Societal Challenge 2: food security, sustainable agriculture and forestry, 
marine, maritime and inland water research and the bio-economy’ (SC2) and 
‘Nanotechnologies, Advanced Materials, Biotechnology and Advanced Manufacturing and 
Processing’ part of LEIT programme (LEIT) which finance BBI JU. 85% (EUR 828.75 
million) of EC contribution in BBI comes from SC2 and 15% (EUR 146.25 million) from 
LEIT programme.  
The development of sustainable bio-based economy requires an integrated approach and 
an array of instruments addressing various research and innovation needs. Horizon 2020 
work programmes put in play a wide range of instruments such as research and 
innovation activities, demonstration and flagship projects, SME instrument and 
coordination and support actions. The use of those instruments varies between different 
parts of the programme. While SC2 and LEIT keep on supporting research and innovation 
activities related to bio-economy, BBI aims to strengthen the bio-based industry sector 
and it mainly finances the projects with much higher technology readiness level and 
market potential compared to SC2 and LEIT.  
This is reflected in the distribution of EC funds per different type of action presented in 
Figure 12. Majority of contribution in SC2 and LEIT is dedicated to research and 
innovation activities (RIA), while majority of BBI funds goes to innovation actions (IA), 
namely to demonstration (DEMO) and flagship (FLAG) projects. 
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As discussed in section 7.2.7 the distribution of funds per beneficiary type also 
significantly differs in SC2, LEIT and BBI (se Fig. 3). The majority of the EC funding in 
BBI (70.7%), goes to private entities, while in SC2 to academia (HES: 27%) and 
research organisations (33.1%).  
 
Figure 12: Distribution of contribution in LEIT KET Biotechnology, SC2 
(including SME instrument) and BBI by project type. 
 
 
Source: BBI: CORDA analysis (cut-off May 2017); SC2; DG RTD, unit F.1. Statistics on 
SC2 programme including SME instrument, (cut-off January 2017); LEIT KET 
Biotechnology: DG RTD, unit D 2. Statistics on SC2 programme including SME 
instrument, (cut-off January 2017);  
 
Coherence with SC2 
 
BBI JU is currently a main programme supporting the development of the bio-based 
industry – within the greater framework of the bio-economy – and it represents a major 
investment in this area. It covers the whole value chain from the development of 
innovative feedstock, its conversion in next generation biorefineries, and supporting 
markets for bio-based products; its emphasis is placed on the development and 
demonstration of next generation biorefineries.  
Though, SC2 still complements the BBI activities in this area. In the years, 2014-2016 
two bio-economy related SC2 calls were launched: 
 
1) Sustainable and Inclusive Bioeconomy (HORIZON 2020  -ISIB-
2014/2015) with the budget of EUR 86.5 million;  
 
Majority of projects funded under this call were ERA-NETs and CSAs. ERA-NETs 
addressed the challenges such as sustainable and resilient agriculture, sustainable 
livestock production, biomarkers for nutrition and health and monitoring and mitigation 
of agricultural and forestry greenhouse gases (GHG). These areas are beyond the scope 
of BBI. On the other hand CSA calls proposed a variety of topics which were supposed to 
foster public engagement in Bioeconomy, reach end users and policy makers, bridge 
research and innovation gaps and overall prepare various stakeholders groups and 
member states for the launch of BBI. A few RIAs funded under ISIB addressed the issues 
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of forest management practices; enhanced governance and social innovation for growth 
in rural areas and provision of public goods by EU agriculture and forestry. These topics 
are also complementary and coherent with those covered under BBI. One early (2014) 
topic shows slight thematic overlap with BBI: 
- ISIB-05-2014: Renewable oil crops as a source of bio-based products 
 
2) Bio-based innovation for sustainable goods and services (HORIZON 2020 
-BB-2016/17) with the indicative budget of EUR 37.5 million. 
BB 2016/17 was a call with very modest budget and 8 topics open for funding. Three of 
them were CSAs supporting the regional dimension of bio-based industries; mutual 
learning for bio-based products and strategies for improving the Bioeconomy knowledge 
of public. There was one IA topic for Plant Molecular Factory and three RIAs for 
sustainability schemes for bio economy, statistical data collection method on bio-based 
industries and finally one project for tree breeding strategies for resilient forest 
production systems. 
The activities proposed in the ISIB and BB calls are complementary to those undertaken 
by the BBI JU and target the supply side (upstream) of the biomass to bioproducts value 
chain through the development of innovative feedstock, research and innovation on next 
generation biorefineries using CO2 as direct feedstock, and supporting markets for bio-
based products (downstream).  
The ISIB and BB calls also integrate crosscutting activities, such as communication, 
technology transfer and dissemination activities, seeking to foster citizens' engagement 
and promote participative governance of the Bioeconomy, respecting a Responsible 
Research and Innovation; and supporting National Contact Points for SC2. These calls 
also support actions seeking to bridge the activities and projects under different pillars of 
Horizon 2020, and help the uptake of research results along the innovation chain.  
 
Coherence with LEIT Biotechnology 
 
Leadership in enabling and industrial technologies (LEIT) part of Horizon 2020 focuses on 
new opportunities for industrial leadership in Key Enabling Technologies (KETs), ICT and 
Space.  
Biotechnology is considered a key enabling technology and it is supported under 
‘Nanotechnologies, Advanced Materials, Biotechnology and Advanced Manufacturing and 
Processing’ part of LEIT programme. 
In the years, 2014-2016 two LEIT calls addressing biotechnology were launched: 
 
1) Call for Biotechnology HORIZON 2020 -BIOTEC-2014/2015 with a budget 
of around EUR 88 million.147  
 
The main themes of this call were: 
 
- ‘Cutting-edge biotechnologies as future innovation drivers’ : within these theme 
the call for synthetic biology and bioinformatics were launched and two RIA 
projects were founded 
-  ‘Innovative and competitive platform technologies’ : one open call on 
metagenomics (RIA) 
- ‘Biotechnology-based industrial processes driving competitiveness and 
sustainability’: under this theme two IA and one SME projects were funded. The 
topics were very close to the ones proposed under BBI programme, namely: 
o BIOTEC 3 – 2014: Widening industrial application of enzymatic processes 
                                                 
147 EC (2016): Maximising the impact of KET Biotechnology” Workshop report. November 2016. 
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o BIOTEC 4 – 2014: Downstream processes unlocking biotechnological 
transformations (TRL5-7) => similar issues are covered by many BBI projects 
o BIOTEC 5 – 2014/2015: SME-boosting biotechnology-based industrial 
processes driving competitiveness and sustainability => SMEs have good 
participation and receive a good share of funding in BBI  
 
2) Call for Biotechnology HORIZON 2020 -BIOTEC-2016/2017 with a budget 
of around EUR 95 million148. 
 
- ‘Cutting-edge biotechnologies as future innovation driver’  and ‘Innovative and 
competitive platform technologies’ , further contributed to developing new 
technological platforms related to biocatalysis and bio design. Three RIA calls 
covered the system biology, microbial platforms for CO2 reuse and new plant 
breeding techniques. These topics are coherent and complementary to BBI 
activities. 
- ERA- NET project with a goal to better align current EU and national biotechnology 
initiatives and to improve synergies and coherence of current research funding 
activities was launched under this call; two CSA projects, one on ‘biotechnology 
foresights and identifying gaps and high-value opportunities for the EU industry’  
and the second one on ‘enhancing and demonstrating the impact of KET 
Biotechnology projects’  are very complementary to BBI projects and the results 
of those projects could also be taken into consideration while designing future BBI 
calls. 
- under ‘Biotechnology-based industrial processes’  theme, the calls addressed the 
challenges such as improving resource efficiencies and overall process 
sustainability, as well as improving product yields, recovery and quality in this 
area. The calls: 
o BIOTEC-02-2016: Bioconversion of non-agricultural waste into biomolecules for 
industrial applications (RIA); and  
o BIOTEC-06-2017: Optimization of biocatalysis and downstream processing for 
the sustainable production of high value-added platform chemicals (IA) show 
some overlap with the calls launched under BBI. Attention should be paid to 
ensure the complementarity of the approaches, since it is in the remit of the 
KET Biotechnology to focus on the optimization of the biotechnological process. 
 
Interestingly, many projects funded under BIOTEC calls address very important challenge 
of biopharmaceuticals (e.g. vaccine) production and downstream processing (e.g. 
nextBioPharmDSP and DiViNe, MycoSynVac). These projects are of high value, as such 
topics are not covered at all under 2014-16 BBI calls. On the other hand, there are a few 
projects that cover the themes which are already well addressed under BBI, e.g. 
FALCON ‘Fuel and chemicals from lignin through enzymatic and chemical conversion’, 
VOLATILE ‘Biowaste derived volatile fatty acid platform for biopolymers, bioactive 
compounds and chemical building blocks’ and DAFIA ‘Biomacromolecules from municipal 
solid bio-waste fractions and fish waste for high added value applications’. The calls 
under ‘Biotechnology-based industrial processes driving competitiveness and 
sustainability’ challenge should be better aligned with BBI. 
 
Coherence with other parts of LEIT  
Eco-Design and New Sustainable Business Models 
 
These activities focus on new concepts and methodologies for knowledge-based, 
specialised production, which can fulfil the requirements of sustainability, globalised 
value chains, changing markets, and emerging and future industries. They are not 
                                                 
148 EC (2016): Maximising the impact of KET Biotechnology” Workshop report. November 2016. 
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focused on the bio-based industries, but the selected projects may cover that area as 
well. 
Example of the calls complementary to BBI:  
NMBP-21-2016: ERA-NET on manufacturing technologies supporting industry and 
particularly SMEs in the global competition 
NMBP-22-2017: Business models and industrial strategies supporting novel supply chains 
for innovative product-services 
 
Coherence with crosscutting activities149  
Industry 2020 in the Circular Economy call (HORIZON 2020 -IND-CE-2016/17) 
 
The objective of this part of the call is to foster economic, social and environmental 
prosperity – ‘living well, within the limits of our planet’. A systemic approach to eco-
innovation is intended to promote new modes of production and consumption, triggering 
a disruptive transformation for a resource efficient society. 
Many open topics launched under this call are highly complementary and coherent with 
BBI objectives, e.g.: 
o CIRC-01-2016-2017: Systemic, eco-innovative approaches for the circular 
economy: large-scale demonstration projects 
o CIRC-03-2016: Smart Specialization for systemic eco-innovation/circular 
economy 
o CIRC-05-2016: Unlocking the potential of urban organic waste 
BBI could try to establish synergies with this part of the programme as well as 
collaborations with selected projects if they are relevant to BBI activities. 
 
Coherence with SC5 'Climate action, environment, resource efficiency and raw materials' 
The objective of the Societal Challenge 'Climate action, environment, resource efficiency 
and raw materials' (SC5) is to achieve a resource – and water – efficient and climate 
change resilient economy and society, the protection and sustainable management of 
natural resources and ecosystems, and a sustainable supply and use of raw materials, in 
order to meet the needs of a growing global population within the sustainable limits of 
the planet's natural resources and eco-systems. 
 
The objectives of the call – Waste: A Resource to Recycle, Reuse and Recover Raw 
Materials Towards a near-zero waste society (HORIZON 2020  -WASTE-
2014/2015) are highly complementary to those of BBI, especially to Value Chain 4: 
‘From waste problems to economic opportunities by realizing sustainable technologies to 
convert waste into valuable products.  
Many topic are well aligned and coherent with BBI and here the synergies and 
collaborations should be sought, e.g.  
WASTE-1-2014: Moving towards a circular economy through industrial symbiosis 
WASTE-4-2014/2015: Towards near-zero waste at European and global level 
WASTE-5-2014: Preparing and promoting innovation procurement for resource efficiency 
WASTE-6-2015: Promoting eco-innovative waste management and prevention as part of 
sustainable urban development, 
While in the others show some overlapping goals and activities, e.g.: 
WASTE-2-2014: A systems approach for the reduction, recycling and reuse of food waste  
                                                 
149 Horizon 2020. Work Programme 2016-16. Cross-cutting activities. 
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WASTE-7-2015: Ensuring sustainable use of agricultural waste, co-products and 
byproducts 
Evidently, BBI is closely linked with SC5 with many complementary objectives and 
activities; therefore, BBI should establish close collaborations with this part of the 
programme. Such linkage should be of benefit of both parts of the programme and 
should serve the society and foster further development of Bioeconomy. 
 
Coherence with other Public Private Partnerships (PPP) – SPIRE 
 
SPIRE (Sustainable Process Industry through Resource and Energy Efficiency) is a Public 
Private Partnership (PPP) between the process industry and the European Commission 
aiming for optimal valorisation and utilization of existing, alternative and renewable 
feedstock. In this last regard, this relates very closely to the BBI JU. The six components 
of SPIRE include: 
 Feed: Increased energy and resource efficiency through optimal valorisation and 
smarter use and management of existing, alternative and renewable feedstock. 
 Process: Solutions for more efficient processing and energy systems for the process 
industry, including industrial symbiosis (e.g. cross-sectorial application of 
technologies). 
 Applications: New processes and materials for market applications that boost 
energy and resource efficiency throughout the value chains. 
 Waste2Resource: Avoidance, valorisation and re-use of waste streams within and 
across sectors, including recycling of post-consumer waste streams and new 
business models with the ambition to closing the loop. 
 Horizontal: Accelerated deployment of the R&D&I opportunities identified within 
SPIRE through e.g. robust sustainability evaluation tools, skills and 
 Education programmes, as well as enhanced sharing of knowledge and best 
practices. 
 Outreach: Reach out to industry (especially SMEs), policy makers, investors and 
citizens to support the realization of impact through awareness, stimulating societal 
responsible behaviour. 
It is in the first and third aspects that particular attention should be paid especially in sub 
key action KA 1.4: Advancing the role of sustainable biomass/renewables as industrial 
raw material to avoid overlap or duplication and that potential for economic impact, jobs 
and carbon footprint savings are not counted twice. 
During the last experts’ meeting with EC and BBI JU (May 2017), it was pointed out that 
Joint BBI and SPIRE Working Group was established in June 2016. The goal of this group 
is to search for synergies and collaborations between the two partnerships and to avoid 
redundancies in the work programmes and projects. Formal group’s meetings are held 
twice a year. In addition, upon need, the informal meetings are organized. The work of 
the group should help in addressing before mentioned concern. 
 
Coherence with European Technology Platform Suschem 
SusChem is an industry led stakeholder organization launched in 2004 as a European 
Commission supported initiative to revitalize and inspire European chemistry and 
industrial biotechnology research, development and innovation in a sustainable way. 
SusChem is organized as a European Technology Platform (ETP) with the aim to develop 
a long-term R&D agenda for implementation at national and European level.  
SusChem was founded by six European bodies to represent the main stakeholders from 
academia and industry in the chemical sciences sector: 
 Cefic – European Chemical Industry Council 
 DECHEMA – German Society for Chemical Engineering and Biotechnology 
 ESAB – European Federation of Biotechnology Section of Applied Biocatalysis 
 EuropaBio – the European Association for Bioindustries 
 GDCh – the German Chemical Society 
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 RSC – Royal Society of Chemistry (UK) 
Priorities of SusChem are: 
 significantly cut emissions of carbon dioxide and other pollutants 
 develop sustainable and renewable energy sources 
 find alternatives to scarce raw materials 
 embrace the concept of a circular economy and increase our recycling and reuse of 
waste 
 ensure the quality of our water supplies 
 improve our quality of life without compromising that of future generations 
SusChem is focused on the move toward a sustainable low-carbon economy and now has 
a supporting network of National Technology Platforms in 14 European countries. These 
platforms work on national sustainable chemistry initiatives, support national 
engagement in EU collaborative projects and programmes and contribute to transnational 
collaborations. SusChem has played a significant role in developing, implementing and 
coordinating the European Public-Private Research and Innovation Partnerships, both the 
Biobased Industries Joint Undertaking (BBI JU) (as its associated BIC member) and the 
Sustainable Process Industry through Resource and Energy Efficiency (SPIRE). 
SusChem’s working group in this area analyses the current and future programmes of 
these two PPPs to identify areas of complementarity and common interest and to develop 
opportunities for new programme content that will be implemented by the two PPPs. The 
working group also identifies project content for biobased materials applications and 
biotechnological processes that are implemented via SusChem’s own Innovation and 
Research Agenda (SIRA). SusChem is also invited to the meetings of before mentioned 
Joint BBI and SPIRE Working Group. 
 
 7.6.2 External coherence of the actions  
Coherence and alignment with initiatives and strategies addressing Bioeconomy 
 
Although it must be noted that bio-based industry represents only one segment of the 
wide scenario of the Bioeconomy, BBI JU appears well aligned and coherent with different 
national and macro-regional strategies addressing Bioeconomy.  That was evident from a 
number of interviews and from presentations made available by the Member State 
Representative during specific events aiming at promoting both BBI JU but also at 
illustrating the Bioeconomy situation in different member states.150 
Some of the member states have their own Bioeconomy strategies. The focus of the 
strategies is however in some countries in a wider context, including also green economy 
or other renewable resources than biomass. Some countries have only regional 
strategies, like Belgium. Under half of the member states, altogether 12 member states 
or associated countries currently have a dedicated Bioeconomy strategy or position 
paper: Austria, Denmark, Finland, France, Germany, Iceland, Ireland, Italy, the 
Netherlands, Norway, Spain, Sweden and UK.  
Maps showing the countries with Bioeconomy strategies before and after setting up BBI 
JU are shown below in Figure 13. The focus areas of the national Bioeconomy strategies 
vary to some extent, but they all share a common trait of having a strong focus on 
promoting research and innovation in the area of Bioeconomy. This is generally well in 
line with the targets of BBI JU. 
Figure 13. Countries with Bioeconomy strategies before (left) and after (right) 
setting up BBI JU. Member states in dark blue, Member states and associated 
countries with Bioeconomy strategies in green. 
                                                 
150 ECOMONDO 2016, 9 November 2016, Rimini. https://www.bbi-
europe.eu/events/ecomondo-2016-green-technologies-expo-italy 
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BBI JU appears to have a relevant impact and leverage effect by mobilizing national 
and macro regional stakeholders in the field of Bioeconomy. Three different MS (Italy, 
France, and Spain) developed a national Bioeconomy strategy, which, according to the 
interviews with some of the stakeholders involved, would not have happened without the 
aggregating and mobilizing effect of BBI JU.  
More specifically, as the development of National Bioeconomy Strategies requires the 
involvement of a number of different ministries and policies, the role of industry is 
essential to interface and promote this type of broad initiatives. 
The SRG chair has underlined that the positive action of BBI JU can be already perceived 
from the response of different MS to surveys and consultations. At the starting of BBI JU, 
only five Countries were considerably responsive regarding the Bioeconomy issue, whereas 
nowadays most of European Countries are expressing their active interest towards 
Bioeconomy and BBI JU as well. 
This has been cross-fertilized also by the initiatives organized by BBI JU at national level 
(e.g. launching of WP, informative days) and by the coordinated action of the MS 
representatives. 
Furthermore, the Chair of the SRG provided the indication that BBI JU has a remarkable 
potential for boosting Bioeconomy not only at National but also at Macro-Regional level. 
Such positive impact has been observed during the launch of PRIMA initiative,151 which 
was promoted also thanks to the coordinated actions of some Member State 
Representatives inside BBI JU. The general objective of PRIMA is to reinforce cooperation 
in Research and Innovation in Mediterranean countries in order to contribute to the 
challenges of sustainable food production and water provision in the Mediterranean 
region. As reported in the Strategic Research and Innovation Agenda (SRIA) of the 
PRIMA initiative, Bioeconomy is among the policies in synergy with PRIMA priorities.152 
Following the positive experience of PRIMA, a similar initiative is about to be launched for 
Northern European Countries. One positive consequence of such initiatives is the 
involvement of partners from non-EU Countries, sharing common problems in the context 
of primary production that might also lead to an increased attention of non-EU 
stakeholders towards BBI JU initiative. Indeed, as reported in section 7.2, the 
participation of non-EU partners to BBI JU calls has been, so far, insufficient. 
The activities of BBI JU are also coherent with a series of initiatives on going throughout 
Europe. 
 
Coherence with industrial initiatives and platforms 
                                                 
151 https://ec.europa.eu/research/environment/index.cfm?pg=prima 
152 http://4prima.org/sites/default/files/publication/PRIMA%20SRIA.pdf 
National bio economy strategies before setting up BBI JU (until 2013)
National bio economy strategies after setting up BBI JU (after 2013)
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Since BIC’s mission is to build innovative bio-based value chains by developing new 
biorefining technologies, optimizing feedstock use and creating a favourable business and 
policy climate to accelerate market acceptance of bio-based products, BIC was among 
the promoters and the founder members of the European Bioeconomy Alliance (EUBA)153 
inaugurated February 2015. This organization includes: 
 BIC - Bio-based Industries Consortium 
 CEFS - European Association of Sugar Producers  
 CEPF - Confederation of European Forest Owners  
 CEPI - Confederation of European Paper Industries 
 COPA - COGECA - European Farmers and European agro-cooperatives  
 ePURE - European Renewable Ethanol Producers Association 
 EuropaBio - The European Association for Bioindustries  
 EUBP - European Bioplastics  
 FEDIOL - The EU Vegetable Oil & Proteinmeal Industry 
 FTP - Forest-based Sector Technology Platform  
 PFP - Primary Food Processors 
 Starch Europe - European Starch Industry Association 
 
As a further stakeholder group of which BIC are a founder member EUBA’s aim is to 
bring into the mainstream and realise the potential of the Bioeconomy in Europe 
advocating for a favourable and coherent policy and investment framework, with a 
common vision154: 
 The production and use of renewable resources as feedstock for making 
innovative, value-added everyday products and materials 
 The commitment to maximise the unused potential of European renewable 
resources to encourage the production of bio-based products and materials ‘Made 
in Europe’  
 Resource efficiency and sustainability as driving business principles 
 
  
                                                 
153 http://bioeconomyalliance.eu/ 
154 http://bioeconomyalliance.eu/about-bioeconomy 
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7.7 Evaluation question 7: Synthesis, conclusions and recommendations 
 
7.7.1 Relevance   
BBI Joint Undertaking was initiated first to attract consistent private investment, promote 
R&I along whole value chains, avoid fragmentation and duplication and improve 
coordination in innovation activities of bio-based industries. The impact assessment 
concluded that a strong EU effort is critical to ensuring long-term investments while 
mitigating their inherent risks. Moreover, reaching critical mass is needed to bring the 
right partners to the table and resolve the technological and innovation problems that the 
bio-based industries face, particularly in the areas of demonstration and deployment. On 
that respect, the institutional PPP was selected among the three policy options especially 
for its capacity to mobilise greater project resources due to the significant contribution by 
industry.  
The specific tasks given to BBI JU in the Council regulation are well aligned with these 
initial long-term objectives of the BBI JU, which are still highly relevant in order to keep 
EU competitive and at the forefront of the global Bioeconomy development. The 
motivations for the selection of i-PPP as a policy option are also still relevant, since the 
objective of mobilizing investments from industry remains crucial. Although it is still too 
early to assess the overall effectiveness of i-PPP in meeting these goals, significant 
amounts of industry investment have already been mobilized, as described earlier in 
sections 7.4 and 7.5.  
Based on the interviews carried out before the setting up of BBI JU, the competitive 
position of Europe in BBI technologies was challenged by many of the demo size facilities 
being implemented in US and Asia. Well aligned with this initial challenge, BBI intends to 
solve one of the key focus areas of BBI that was to de-risk demonstration and 
commercialization of BBI technologies. The interviewees carried out within the context of 
this mid-term evaluation also largely agreed that the main positive effect of BBI JU 
derives from the value chain driven cooperation across sectors (‘the structuring effect’), 
which helps scale up the technologies towards market applications. BBI JU is valuable 
especially for the long-term effect of bringing technologies to market and it represents an 
important signal effect for boosting the long-term development of the emerging BBI. 
After setting up the BBI JU the sectors active in BIC have evolved to include also, for 
example, the food industry and increasing amount of brand owners. Consequently, BBI 
technologies can be developed to match better the market requirements when a wider 
array of downstream sectors is closely involved in the development work.  
In capital-intensive bio-based industries, technology commercialization takes time since 
it needs to be done with a staged approach. On that respect, flagship projects are the 
main instrument that is expected to bring the key BBI technologies to demonstration in 
the short term, to commercialization in the medium term and to market replication in the 
long term.  
Taking into account technological developments that have occurred in the recent years, 
the conversion of carbon dioxide into chemicals and fuels production appears as 
emerging trends and first commercial facilities have already established. If carbon 
dioxide based chemicals and fuels will be produced in techno, economical feasible routes 
in the future it is likely that those applications will grow rapidly and they will indirectly 
affect the competitiveness of the BBI technologies. In addition, digitalization is a trend 
that is transforming whole sectors and industries and needs to be considered also as a 
direct or indirect aspect affecting the competitiveness of BBI technologies. 
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7.7.2 Implementation (open, transparent, effective and efficient)  
The analysis presented in this report concerns the calls launched and implemented by 
BBI JU during the period 2014-2016. In this period, the project grants were allocated via 
four calls for proposals.  
The total EC contribution (in commitment appropriations) to BBI JU operational 
expenditure over 2014-2016 amounted to EUR 418.29 million and the total financial 
contribution committed by BIC at programme level amounted to EUR 0.75 million. EUR 
414.29 million were subsequently committed by the BBI JU in individual projects selected 
for funding. Moreover,  in the signed Grant Agreements there was a global commitment 
by the private partners of EUR 114,621,657.2 for in kind contributions to operational 
activities (IKOP). 
BBI JU selected 65 projects for funding: 6 Coordination and Support Actions (BBI-CSA), 
26 Innovation Actions (IA), 20 Demonstration Actions (BBI-IA-DEMO), 6 Flagship Actions 
(BBI-IA-FLAG) and 33 Research and Innovation Actions (BBI-RIA). In terms of funding, 
72.7% of the contribution was dedicated to Innovation Actions (39.5% to DEMO and 
33.2% to FLAG projects) while 25.9% went to RIAs and 1.4% to CSAs. Notably, Strategic 
Innovation and Research Agenda (SIRA) for Bio-Based Industries consortium (2013)155 
had earmarked 30% for DEMO, 34.75% for FLAG, 30% for RIA and 3.25% for CSA. 
Currently, the share of budget dedicated to DEMO projects is significantly higher than 
originally planned. This should be taken into consideration in the future work plans that 
should deserve more attention to RIA and CSA projects. 
The geographical distribution of funds in BBI resembles those in the SC2 calls and in LEIT 
KET Biotechnology programme, where the majority of EC funding (84%) goes to EU15. 
This is also connected to a big discrepancy between the success rates of EU15 (32.6%) 
and EU13 (19.7%). Although EU13 receives a much lower share of the contribution than 
EU15, it scores better in BBI (7.9%) than in SC2 (5.5%) and in LEIT KET Biotechnology 
programme (7.2%).  
The countries with the highest funding received and numbers of participations are 
Germany Italy, Netherlands, France and Spain. Notably, these Member States have 
already developed and adopted some kind of national bio-economy strategies at national 
level. 
The pattern of budget distribution per beneficiary type significantly differs from that in 
SC2 and in LEIT. The majority of the EC funding in BBI (70.7%) goes to private sector. 
In LEIT Biotechnology and SC2, academia and research organisations receive the major 
part of the budget. HES and REC combined receive 55.2 and 60.1% in LEIT KET 
Biotechnology and SC2, respectively, while in BBI only 26.8%. BBI calls have a very 
good SME participation (35.4%) with 219 of the total 618 beneficiaries involved in BBI 
funded projects. 
So far six flagship projects were launched, three in VC1, one in VC2 and two in VC3. So 
far, the distribution of projects and funds according to value chain seems to be somewhat 
                                                 
155 Bio-based Industries Consortium (2013). Strategic Innovation and Research Agenda (SIRA). Bio-based and Renewable 
Industries for Development and Growth in Europe.  
Recommendations 
 
 To continue focus on de-risking bringing new bio-based value chains to market 
 To include increasingly brand owners and sectors at the interface with 
consumers with synergies with the existing ones 
 To respond to important emerging trends through future calls that could 
consider conversion of biogenic CO2 into chemicals and materials as well as 
digitalization (including big-data analysis and exploitation) as one aspect in 
Bioeconomy value chains.  
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unbalanced.  Lignocellulose, forest-based and agro-based value chains existed before BBI 
and thus it is not surprising that they present the highest technology readiness level and 
launching of the flagship projects in those areas was possible. Efforts should be made to 
support the development of technologies in new value chains and flagship projects in new 
value chains should be launched. On that respect, new value chains have emerged, such 
as aquatic biomass and this shows flexibility and responsiveness of BBI towards 
customers and market needs. At the same time, the integrated energy, pulp and 
chemicals biorefineries value chain (VC5) has apparently decreased its strategic 
relevance within BBI JU, taking account of the activities being financed in other parts of 
Horizon 2020, in particular to maximise synergies and avoid overlaps with SC2 ‘Energy’. 
Furthermore, the 2016 work programmes have moved from the biomass ‘push’ approach 
and the traditional value chains, towards a new focus: the creation of biomass demand 
connected to ‘market pull’. This approach is reflected in the high number of ‘across VC’ 
call topics funded by 2016 calls. 
Concerning the openness, BBI has done great efforts in communicating the BBI JU and 
its calls to stakeholders in the EU through its events, meetings and website. The nature 
of BBI calls is fully open to the participation of any stakeholder. Although the success 
rate of proposals having BIC coordinators and BIC partners is higher than for non-BIC 
coordinators and non-BIC partners, the actual numbers of non-BIC coordinators and non-
BIC partners in the selected proposals are much higher, with the exception of non-BIC 
coordinators in call 2015.1. 
 
 
Recommendations 
 
• CSA projects have still received lower than planned share of the funds (1.4% 
compared to planned 3.25% in SIRA). This could be used as an opportunity: 
future CSA projects could support market analysis for bio-based products and 
processes and thus support ‘market pull’.  
• Constant monitoring and analysis of the bio-based markets is of high 
importance for the development of the future calls.  
•   The results of CSA projects funded under SC2 should be taken into 
consideration in the planning of future BBI calls 
• Efforts should be made to support development of completely new value chains 
and cross-value chains products and processes. Towards the end of the BBI 
programme, more DEMO and especially FLAG projects demonstrating the 
feasibility and economic viability of completely new bio-based value chains 
should be launched. 
• In the future BBI calls should complement rather than repeat emerging trends 
covered in LEIT BIOTEC or exploit the results of LEIT BIOTEC to move to higher 
TRL and greater involvement of the industry. 
• To improve the participation of EU-13 MS and Third Countries through a more 
open programming strategy, which should take into account potentials for 
growth at macro regional level, also in synergy with other EU initiatives (e.g. 
Smart Specialisation Strategies, S3). 
•    To analyse cases of success in terms of national participation and deliver ‘best 
practices’ for Member States, offering also mentoring support. 
•   To identify win-win strategies for a larger involvement of Third Countries while 
ensuring the protection of EU industry’s interests. 
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7.7.3: Main achievements and effectiveness of implementation  
BBI JU has become operational on 26 October 2015. The number of running projects has 
steadily grown from 10 projects in 2014 to 36 at the end of 2016, and has reached 65 
ongoing projects by May 2017. 
Well-chosen and highly relevant value chains of the BBI JU very well address the 
objectives of the BBI Initiative. Although value chain 5 appears to have decreased its 
strategic relevance, cross-sectoral growth opportunities enabled the creation of new 
value chains. The development of business models to integrate economic actors along 
the whole value chain - namely from supply of biomass to biorefinery plants to 
consumers of bio-based materials, chemicals and fuels - is an achievement. This includes 
creating new cross-sector interconnections and supporting cross-industry clusters. 
The performance of BBI JU against three main Horizon 2020 KPIs – time to inform (TTI), 
time to grant (TTG) and time to pay (TTP) pre-financing – operates efficiently. The 20% 
target for SMEs has been surpassed, with a 29.1% of contribution delivered to SMEs 
taking part in funded projects, which clearly demonstrates that the BBI JU programme is 
contributing to the development of the bio-based SMEs landscape in Europe. The private 
sector participation in the funding allocated is very pronounced, with 70.7% of the 
overall contribution given to private for profit entities (PRC), which is a cornerstone of 
the BBI JU. This leads to a pronounced participation of industry and SMEs well above the 
target, whereas higher education institutions received only 10.8% of the allocated 
contributions despite a large mobilization.  
BBI JU has started in 2014-2016 to attract and motivate the participation of the best 
European players in the areas of the selected value chains, as demonstrated by the fact 
that non-BIC members make up the majority of participants and coordinators in the 
selected proposals. This demonstrates the openness of the BBI JU, while the higher 
success rate of BIC-members versus non-BIC members indicates that BIC-membership 
provides an advantage in terms of proposal preparation.    
Overall, the BBI JU has created a stimulating research and innovation environment in 
Europe since, according to the grant agreements signed so far,  the financed projects will 
deliver 146 new cross-sector interconnections, 82 new value chains, 46 new bio-chemical 
building blocks, 106 new bio-based materials, 51 new bio-based ‘consumer products’. 
Moreover, 6 grant agreements for flagships projects were already signed so far by 22 
June 2017. Consequently, six out of the seven Key Performance Indicators (KPIs) specific 
for BBI JU are reported well above the targets (projected figures) and the seventh KPI is 
well on track. Future analysis should include quantitative comparison between actual 
achievements reported by projects and the targets set in the regulations for each KPI. On 
that respect, the high TRL levels of demonstration and flagship projects justify, to some 
extent, the high level of confidentiality applied to most data and intellectual property 
produced within BBI JU projects. Nevertheless, for building in the EU a long-term 
innovation space from fundamental to applied research supporting such advanced 
industrial projects and for avoiding and overcoming fragmentation, disconnection and 
duplication, it is important that the relevant EC directorates have clearly regulated and 
prompt access to the projects’ deliverables, in compliance with the relevant regulations. 
This will be crucial for implementing any mechanism aiming at better coordinating all 
initiatives dedicated to the growth of European Bioeconomy and also searching for 
further leveraging effects in the science and technology as well as the geographic 
dimensions, e.g. at the regional and macro-regional levels. Moreover, it important to 
benchmark and monitor the effectiveness of such initiatives in promoting and supporting 
EU leadership in this emerging sector and in implementing continuous process 
improvements at all levels. 
Concerning the effectiveness in living up financial and managerial responsibilities, the 
available documents as well the interview of BBI JU stakeholders, indicate that during the 
organization of BBI JU regulation there was an underestimation of the necessity to 
establish clear criteria and suitable instruments for delivery and reporting the 
contributions of the industry. Such inaccuracy in the definition of clear rules led to an 
incomplete and fragmented picture of the actual financial and in kind contributions of the 
industry to BBI JU, as commented in 7.7.4 and 7.7.5.  
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7.7.4: Performance: mission and governance, operational effectiveness, 
operational efficiency 
As already mentioned, flagship projects represent an actual achievement of BBI JU, with 
collaborations throughout the value chain towards consumer products. Nevertheless, the 
link between the operational KPIs and overall goal of the BBI JU is not completely cleat at 
this stage of the programme, since it is not evident how these actions and strategies will 
translate into the economic, social and environmental benefits envisioned by BBI JU and 
its supporting partners. The revision of a KPI survey is a positive step in demonstrating 
this link but the qualitative nature of responses leaves ambiguity. Strengthening this link, 
reporting real achievements in contrast to expected outcomes and adding quantitative 
data could improve the management of programme, identify new opportunities and show 
to a wider audience of stakeholders the value of the BBI JU. In particular, the 
consultation that was carried out to monitor the progress against the KPIs involved only 
marginally respondents not directly involved in the BBI JU as applicants or beneficiaries. 
There is no demonstration that government, brand owner, NGO or consumers responded 
in sufficient numbers to demonstrate that the full value chain was represented or that the 
program is perceived as delivering real value for these stakeholders. 
Although feedstock owners and several value chain players are well represented, the 
downstream value chain to market requires the strengthening of the position of brand 
owners and public bodies in defining challenges and, conversely, calls.  
Concerning the long-term commitment and contribution of the BBI JU members (i.e. EU 
and BIC), the unclear definition of rules for the delivery of the financial (in cash) 
contribution to operational costs by BIC led to a consistent lack of financial contribution 
from BIC.  Although some measures have been designed to address and solve this issue, 
at the time of this evaluation it is not completely clear whether they will be fully effective 
in rebalancing the situation in terms of contributions from the two Partners, as also 
underlined by some BBI JU stakeholders. Therefore, the implementations of such 
measures will require specific monitoring actions.  
Moreover, the delay in the approval of clear guidelines for reporting IKOP and for 
planning IKAA prevented the group of experts to have access to complete data, reflecting 
Recommendations 
 
• To monitor further progress of BBI JU by an annual comparison between BBI-
specific KPIs projected, achieved and accumulated in the corresponding year. 
• To increase the involvement of educational and research institutions in BBI JU 
programs and projects in medium to long-term precompetitive industrial 
innovation topics to be defined by all stakeholders.     
• To search for best practices aiming also at the simplification of certification 
procedure for IKOP and for the reporting of IKAA. 
•  To improve coordination among all EU initiatives boosting the Bioeconomy and 
maximize their effect by i) assuring prompt access to project deliverables by the 
EC and ii) catching the emerging trends in innovation for promoting long term 
competitiveness, also by a procedure involving associated public research 
partners of BIC in the programming activities at an early stage. 
•    To monitor the practice developed between EC, BBI JU and BIC services with 
regard to the planning of additional activities, with the objective of delivering an 
updated picture of the actual private vs public contribution to BBI JU. 
•   To avoid programming strategies aiming at short term benefit of BIC’s specific 
sectors but rather invest resources in topics able to create wider and long 
lasting benefits both at multi-sectorial and macro-regional levels.   
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the actual in kind contributions delivered by industry so far. Therefore, some monitoring 
actions are advisable on annual basis. 
 
 
7.7.5:  EU added value and leverage effect 
The main success factor of BBI JU in 2014-2016 has been the structuring and mobilizing 
action on research and innovation, industry and economy as well as society and 
environment in the EU. The interviews with BBI JU project coordinators made evident 
that the consortia of projects with TRL > 7-8 would have not taken place without the 
support of BBI JU. Conversely, the industrial investments in additional actions (IKAA) 
would not have delivered. Notably, the different elements of the bio-based industry are 
fragmented in Europe. Therefore, the significant added value of BBI JU is largely in this 
acceleration of bringing together different sectors and industries towards the creation of 
new value chains, with different partners working together within a single project. The 
expected consequence is a revitalization of rural areas in different European regions, 
which can benefit from the already existing value chains but also from the novel ones. On 
that respect, members of the BBI, BIC, the BBI Scientific Committee and the BBI State 
Representatives Group have acted as ambassadors for the initiative in their respective 
communities, thus providing momentum.  
One further effect of BBI JU is that the bio-based industry has started to become more 
visible since researchers, manufacturing, refining and brand owners have started working 
together to satisfy real world customer demands with bio-based products. In a survey, 
87.5% of the participants considered that BBI JU contributes to economic growth and job 
creation in the EU. In order to assess the direct and indirect impact of BBI JU projects on 
job creation, statistics of the staff employed have been extracted from the reports 
provided by the BBI projects selected from call 2014. The number of staff employed by 9 
BBI JU projects was 689, with a gender distribution of 58% male staff and 42% female 
staff. Depending on the respective bio-based value chain, this will also lead to a number 
of indirectly related jobs. As the creation of direct and indirect new jobs, both temporary 
and permanent, is taking place over extended periods of time, a standardized and 
constant reporting over the years, also after the completion of projects, can give an 
actual quantification of the long-term effect on employment in EU member states. 
Therefore, a systematic annual reporting of the direct and indirect effects on the number 
of new jobs created by the different activities of BBI JU needs to be established.  
In the same survey mentioned above, an even higher proportion of respondents (93%) 
judged that BBI JU contributes to the transition from a fossil-based to a bio-based 
Recommendations 
 
• To strengthen the whole value chain approach by a greater participation of end 
users and customers. 
• To monitor the effectiveness of the measures implemented for solving the 
problems related to industrial financial contributions to operational costs and 
consider possible complementary measures to assure a balanced contribution of 
the Public and Private members to BBI JU. 
•  To start planning different scenarios in case the operational budget, which was 
originally  approved at the time of BBI JU set up, is not fully spent by the end of 
the initiative.  
• To monitor the effectiveness of the guidelines for reporting and certification of 
IKOP and IKAA.  
•To deliver reports that provide comprehensive description of the actual private 
and public contributions to BBI JU delivered so far as well as the detailed plan 
for the delivery of the contribution of the two Partners over the next years.  
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economy. Together with the expected contributions to climate change mitigation by 
reducing the CO2 derived from the use of fossil-based products (91% of respondents), 
this further strengthens the global impulse of the BBI JU.   
The leverage effect is one of the main quantitative components of EU added value, with 
the target level for the leverage effect of BBI JU set to 2.8.  Notably, this is the highest 
leverage target value among the seven JUs operating under Horizon 2020. Based on the 
in-kind and financial (in cash) contributions to operational costs of calls 2014-15 the 
operational leverage by 31 December 2016 is 0.50. Taking into account the available 
contributions to additional activities in 2014 and 2015, the additional leverage effect is 
1.275. Therefore, the global leverage effect by 31 December 2016 is 1.779. The lower 
global leverage effect (1.779) as compared to the target of 2.8 set in the Council 
regulation is clearly connected to the delay in reporting the certified values for 2016 
IKAA, since the corresponding IKAA plan had not been approved at the time of this 
interim evaluation. Consequently, the actual leverage effect should be re-calculated and 
published once the IKAA plan for 2016 is approved by the Governing Board and the IKAA 
report 2016 has been certified. BIC has announced an amount of IKAA for 2016 equal to 
EUR 185.863 million. Based on the certified IKAA for 2016 the additional leverage effect 
would be 2.1 while the global leverage effect would become 2.6. 
As part of the mobilizing and structuring effect, intensifying private sector commitment 
by in-kind contributions, additional activities and by attracting additional investments 
needs to be continued as key tasks to ensure a balanced contributions from the BBI JU 
members. 
 
7.7.6: Coherence 
The objectives and activities covered under BBI JU are coherent and well-coordinated 
with the parts of the Horizon 2020 financing it: SC2 and LEIT ‘Biotechnology’. While SC2 
and LEIT Biotechnology keep on supporting research and innovation activities related to 
the whole Bioeconomy, BBI aims to strengthen the bio-based industry sector. It mainly 
finances projects with much higher technology readiness levels and market potential than 
SC2 and LEIT. This is reflected in the distribution of EC funds per different type of action. 
Recommendations 
 
• To introduce a systematic and constant annual reporting of the direct and 
indirect effects on the number of new jobs created by the different activities of 
BBI JU. This must be established on project coordinator level for the duration of 
BBI JU projects along with reporting tools for systematic reporting on long-term 
follow-up. 
• To increase and intensify private sector commitment by in-kind contributions and 
contributions to additional activities.  
•    To re-calculate the actual leverage effect once the IKAA plan for 2016 is 
adopted by the GB and the IKAA report 2016 has been certified. 
• To build up metrics and statistical data on the bio-based industries in the EU 
with annual reporting on economic growth   
• To catalyse the growth of novel sustainable value chains able to connect bio-
based excellent science to bio-based industry    
•   To set up a task force within the EC for maximizing the structural effect at 
National, Regional and Macro regional level, also by analysing BBI JU project 
deliverables (in compliance with all confidentiality rules) 
• To reach out to EU member states and regions with rural or deindustrialized 
areas for catalysing revitalisation through bio-based industries   
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Majority of EC contribution in SC2 and LEIT is dedicated to research and innovation 
activities (RIA), while majority of BBI funds goes to innovation actions (IA), namely to 
demonstration (DEMO) and flagship (FLAG) projects.  
Apparently, there is some overlap of BBI calls with the topics under LEIT theme:’ 
Biotechnology-based industrial processes driving competitiveness and sustainability’ and 
the BBI calls should be better aligned with this part of LEIT programme. There is much 
less coordination with the other parts of Horizon 2020 such as SC5 'Climate action, 
environment, resource efficiency and raw materials' or Circular Economy (crosscutting 
activities). For example, the objectives of the ‘Waste Call’ (HORIZON 2020 -WASTE-
2014/2015) are highly complementary to those of BBI, especially to Value Chain 4, and 
some synergies and joint actions could be considered. The same applies to the Circular 
Economy call (HORIZON 2020 -IND-CE-2016/17). 
Many topics covered by the recent Bioeconomy-related calls (ISIB-2014/2015 and BB-
2016/17) have been targeting the downstream side of the value chain and aimed at 
increasing public awareness and supporting markets’ development. They also integrate 
crosscutting activities, such as communication, technology transfer and dissemination 
activities. Many CSA projects were funded under those calls, which is very positive since 
the output of such projects could be used as input for future BBI JU calls. On the other 
hand, in BBI only 6 CSA projects with a total budget of EUR 5.85 million were funded 
(1.4% of total BBI JU contribution), although the SIRA earmarks 3.25% for those 
projects.  
Finally, the objectives and activities financed by BBI are closely linked to those of SPIRE 
(Sustainable Process Industry through Resource and Energy Efficiency) PPP.  Notably, a 
joint BBI and SPIRE Working Group were established in June 2016 with the aim of 
developing synergies and collaborations and avoiding redundancies between the two 
partnerships. 
 
 
  
Recommendations 
 
 To finance more CSAs projects in the following BBI JU work programmes 
 To publish more topics for RIA, in order to enlarge the participation of  REC and 
HES  
 To cover emerging trends, such as synthetic biology and platform technologies 
(e.g. bioinformatics),  in the future BBI work programmes  
 To coordinate programming activities of BBI JU, SC2 and LEIT in order to 
guarantee complementary in terms of financial support for all beneficiary types 
and to achieve a balanced share of contribution dedicated to REC and HES. 
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ANNEX 1: EXPERT GROUP SHORT BIOGRAPHIES 
Dr Roland WOHLGEMUTH (male, Swiss), Chair  
 
Roland Wohlgemuth is an active and distinguished expert from the industrial sector 
(Sigma – Aldrich). He studied chemistry and biology at the University of Basel in 
Switzerland and obtained his Ph.D. with Prof. Joachim Seelig in 1979 at the Biocenter of 
the University of Basel. He did postdoctoral work at the Lawrence Berkeley Laboratory 
and UC Berkeley with a Swiss National Science Foundation Award in 1980 and a US 
Department of Energy employment with Prof. Melvin Calvin from 1981-1983. From 1983 
on Roland Wohlgemuth  has been working at Fluka, which in 1989 became part of the 
Sigma-Aldrich corporation, which in November 2015 has become member of the Merck 
Group. His main interests are in industrial innovation at the biology-chemistry interface, 
biocatalysis and biotransformations, glycobiology, metabolomics and bioanalytical 
technologies. He is author of several important scientific publications with focus on 
biotechnological/bioprocesses, enzymatic methods, and industrial applications. He has 
been involved in evaluations of projects under FP7 KBBE programme.  
Professor Lucia GARDOSSI (female, Italian), Rapporteur 
 
Prof. Gardossi is an active and distinguished scientist employed by University of Trieste, 
Italy. Her speciality is organic chemistry, biotransformation/bioprocesses, enzyme 
science, bioinformatics etc. She has been assisting the European Commission as an 
expert member of several committees linked with the area biotechnologies and bio-based 
industries, and generally bioeconomy, such as being a member of the Advisory Group of 
H2020 Societal Challenge 2, participating in workshops on Enabling Technologies 
(biotechnology), and especially on industrial biotechnology. She has ample experience in 
EU-funded programmes as coordinator of projects under FP7, as well as in the projects 
financed by private and public sources. She has been active in past project-level 
evaluations (FP7 KBBE programme, People Marie Curie actions, research programmes 
from IT, CH, FR, HU, as well as for several scientific journals). She is an author of an 
extensive body of scientific literature (90+ articles) and author of four European and 
Italian patents. Prof. Gardossi's professional experience includes engagements at private 
bio-based industry (DSM, SPRIN, Poly-Tech companies).  
 
Dr Alistair REID (male, British), Member 
Dr Reid has a Ph.D. in Chemistry from Durham University and is an expert from private 
industry (Akzo Nobel Group) with a focus on renewable new materials, value chains, 
sustainability assessment, R&D strategy etc. He started his employment at Akzo Nobel in 
2002, occupying various positions with increasing responsibility, including being active as 
a scientist (unit Marine and Protective Coatings, Akzo Nobel International Paints), 
research chemist (Technology Centre – Powder Coatings, Akzo Nobel Powder Costings), 
Community of Practice Leader (Akzo Research, Development and Innovation), Project 
Leader (R&D&I and Sourcing, White Biotech Strategy, Akzo Nobel Supply Chain) and 
since 2012, as Manager Innovation Partnerships and Bio-based Materials (Akzo Nobel 
Supply Chain, Research and Development). He is active on the UK Innovate Industrial 
Biotechnology panels, and as reviewer of EU funded calls related to Biotechnology and 
sustainability.  
Tiina PURSULA (female, Finnish), Member 
Tiina Pursula obtained her MSc degree at Helsinki University of Technology in 1997. She 
was a research scientist at the Finnish VTT Technical research centre (1997 – 1998) and 
held several positions eg. as a Senior Scientist and Research Engineer at the KCL Science 
and Consulting (1998 – 2007, focus on biorefineries and wood processing). Between 
2007 and 2008 she become the Research Director at KCL Science and Consulting, 
moving to a consultancy Gaia Consulting Oy since 2008, where she has the position of 
Business Director. The focus of her work is Bio-based economy, and in this capacity she 
has been active in the EU evaluation of projects under FP7 KBBE programme, as well as 
participated in the Expert group in preparation of the EU Bioeconomy Strategy (2011). 
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She was a member of the Ex-post expert group evaluating FP7 KBBE Biotechnology 
programme (2014), and at present is a member of the Horizon 2020 Societal Challenge 2 
(Bioeconomy) Mid-term evaluation group (focusing on bio-based area, including BBI JU).  
Professor Erick VANDAMME (male, Belgian), Member until 31 January 2017 
Professor Vandamme received M.Sc. (1967), Ph.D. (1972) and D.Sc. degrees (1976) at 
Ghent University in molecular biology, fermentation science and industrial biotechnology, 
respectively. He has been a postdoctoral fellow at the Sir William Dunn School of 
Pathology, Oxford University, UK (1973), at the Massachusetts Institute of Technology 
(MIT), Cambridge, Massachusetts, USA, (where he obtained the MIT-Certificate in 
Fermentation Technology (1974-1975)), and at Queen Elisabeth College (now King’s 
College), University of London, UK (1976). Since 2008, he is Emeritus Senior Full 
Professor at the Laboratory of Industrial Biotechnology and Biocatalysis, Department of 
Biochemical and Microbial Technology, Faculty of Bioscience Engineering, Ghent 
University, Belgium. He has acted as director of this department for over 20 years. He 
was Visiting Scientist at the Weizmann Institute of Science, Rehovot, Israel (1980) and 
Visiting/Invited Professor at several universities in Europe, UK, North and Central 
America, South-East Asia, China, Japan, S. Korea, South-Africa and Australia. He is (co)-
author of over 430 research papers and review articles (SCI: > 3300 ; h-index: 23) in 
the field of antibiotic, bacteriocin, enzyme, fine and bulk chemical fermentations and 
bioconversion processes (i.e. speciality (oligo)sugars, chiral synthons) and  holds several 
patents. He has received several scientific awards (national and international) including 
the S. Waksman Outstanding Educator Award (USA) and is an Elected Fellow of the 
American Academy of Microbiology (USA) and of the Society for Industrial Microbiology 
and Biotechnology (SIMB). He received the degree of Doctor Honoris causa at the 
Technical University of Lodz, Poland (2008), and at Hubei University of Technology, China 
and at South Central University of Nationalities, Wuhan, China (2007). He is serving on 
the Editorial Boards of several scientific journals and learned societies. 
 
Dr Danuta CICHOCKA (female, Polish), Member 
Dr Cichocka has obtained her MSc in 2004 in Environmental Protection at the Warsaw 
University (Warsaw, Poland) and her PhD in Environmental Microbiology in 2008 at the 
Freiberg Technical University/Helmholtz Centre for Environmental Research (Leipzig, 
Germany). She followed her career as a post-doctoral researcher at the Catholic 
University of Leuven (Belgium) (2008-2009) and between 2009 and 2012 was a 
Research Programme officer at the European Commission, Research and Innovation 
Directorate General, at the biotechnologies programme responsible for the FP7 projects 
related to environmental biotechnology and 'emerging trends in biotechnology' areas. 
Since 2012 Dr Cichocka is a senior researcher at the University of Applied Sciences and 
Arts Northwestern Switzerland, at the School for Life Sciences, at the Institute for 
Ecopreneurship (Muttenz, Switzerland). Dr Cichocka is author or co-author of several 
peer-review journals, book chapters and conference presentations.  
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ANNEX 2:  LIST OF ACRONYMS 
AAR  Annual Activity Report  
AWP Annual Work Plan 
BBI JU  Bio-Based Industries Joint Undertaking 
BIC  Bio-based Industries Consortium 
CAS Common Audit Service 
CSA  Coordination and Support Action 
CSC  Common Support Centre 
DEMOS-IA Innovation Action for demonstrators 
DG AGRI Directorate-General Agriculture & Rural Development 
DG GROW Directorate-General Internal Markets, Industry, Entrepreneurship and SMEs 
DG RTD  Directorate-General Research and Innovation 
EC  European Commission 
ECA European Court of Auditors 
EESC  European Economic and Social Committee 
EFTA European Free Trade Association 
FR Financial Regulation of the European Union 
EFIB European Forum for Industrial Biotechnology and the Bioeconomy 
ETP              European Technology Platform  
GAP  Grant Agreement preparation 
GB   Governing Board of BBI JU 
H2020  Horizon 2020 
IA Impact Assessment  
IAS Internal Audit Service 
IAs  Innovation Actions 
ICF  Internal Control Framework 
ICS Internal Control Standard 
ICT Information and communication technology 
IFIB Italian Forum on Industrial Biotechnology and Bioeconomy 
IKAA In-kind contributions to additional activities 
IKOP In-kind contributions to operational costs 
JTI               Joint Technology Initiative  
JU Joint Undertaking 
KPIs  Key Performances Indicators 
LEIT              Leadership in enabling and industrial technologies 
LMI              Lead Market Initiative 
LISO Local Informatics Security Officer 
MGA             Model Grant Agreement 
NCPs National Contact Points for Horizon 2020 
PA Payments  
PPP Public-Private Partnership 
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REA   Research Executive Agency 
RfP  Rules for Participation in Horizon 2020 
RIA   Research and Innovation Actions 
R&D  Research and Development 
SC   Scientific Committee of BBI JU 
SC2/3/5        Societal Challenge 
SIRA   Strategic Innovation and Research Agenda 
SOP  Standard Operating Procedures  
SLA  Services Legal Agreement 
SMART Specific, Measurable, Accepted, Realistic and Time-related 
SMEs   Small and Medium-Size Enterprises 
SRG   States Representatives Group of BBI JU 
SPIRE  Sustainable Process Industry through Resource and Energy Efficiency 
SWD            Staff Working Document 
TL   Task Leader 
TTG   Time to Grant 
TTI   Time to Inform 
TTP  Time to Pay 
EG  Expert Group 
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ANNEX 3: KEY CRITERIA USED FOR THE EVALUATION   
 
The evaluation is and evidence-based judgement of the extent to which BBI JU has met 
the following criteria, as defined by the Better Regulation Guidelines:156  
a) Effectiveness:  
Analysis of the progress made towards achieving the objectives of the intervention, 
looking for evidence of why, whether or how these changes are linked to the EU 
intervention. Besides evaluating if the intervention is on track, the analysis should seek 
to identify the factors driving or hindering progress and how they are linked (or not) to 
the EU intervention. 
Effectiveness analysis considers how successful EU action has been in achieving or 
progressing towards its objectives. The evaluation should form an opinion on the 
progress made to date and the role of the EU action in delivering the observed changes. 
If the objectives (general, specific, operational) have not been achieved or things are not 
on track, an assessment should be made of the extent to which progress has fallen short 
of the target and what factors have influenced why something was successful or why it 
has not yet been achieved. Consideration should also be given to whether the objectives 
can still be achieved on time or with what delay. The analysis should also try to identify if 
any unexpected or unintended effects have occurred. 
Typical examples of effectiveness questions are: 
- To what extent have the objectives been achieved? 
- What have been the (quantitative and qualitative) effects of the intervention? 
- To what extent do the observed effects correspond to the objectives? 
- To what extent can these changes/effects be credited to the intervention? 
- What factors influenced the achievements observed? 
- To what extent did different factors influence the achievements observed? 
- For spending programmes, did anti-fraud measures allow for the prevention and timely 
detection of fraud? 
 
b) Efficiency 
The evaluation should always look closely at both the costs and benefits of the EU 
intervention as they accrue to different stakeholders, identifying what factors are driving 
these costs/benefits and how these factors relate to the EU intervention. The answer to 
this question should provide evidence on the actual costs and benefits, making it clear 
what can be linked to the EU intervention and what cannot. Efficiency analysis is a key 
input to policy making, helping both policy makers and stakeholders to draw conclusions 
on whether the costs of the EU intervention are proportionate to the benefits. 
Efficiency considers the relationship between the resources used by an intervention and 
the changes generated by the intervention (which may be positive or negative). 
Differences in the way an intervention is approached and conducted can have a 
significant influence on the effects, making it interesting to consider whether other 
choices (e.g. as demonstrated via different MS) achieved the same benefits at less cost 
(or greater benefits at the same cost). 
Efficiency analysis can differ depending on the type of intervention being evaluated. 
                                                 
156 Commission Staff Working Document “Better Regulation Guidelines”, may 19 2015. http://ec.europa.eu/smart-
regulation/guidelines/docs/swd_br_guidelines_en.pdf 
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Typical efficiency analysis will include an examination of administrative and regulatory 
burden74 and look at aspects of simplification – these are important for ALL evaluations, 
but particularly those identified under the REFIT programme. Where appropriate, 
evaluation findings should pin-point areas where there is potential to reduce inefficiencies 
particularly regulatory burden and simplify the intervention. 
The full efforts to support and perform an intervention can be broken into different 
categories such as: staff, purchases made, time and/or money spent, fixed costs, 
running costs, etc. These costs can be associated to different aspects of an intervention 
and judged against the benefits achieved. 
Good evaluations should make strong efforts to go beyond a qualitative description of the 
different costs and benefits of the EU intervention and seek to quantify them. While 
assessing costs and benefits may be (methodologically) easier for spending programmes, 
such assessment in policy areas may be a challenge since obtaining robust, good quality 
data is difficult, particularly across Member States which may have implemented 
legislation in a variety of different manners. 
Typical examples of efficiency questions are the following: 
- To what extent has the intervention been cost effective? 
- To what extent are the costs involved justified, given the changes/effects which have 
been achieved? 
- To what extent are the costs proportionate to the benefits achieved? What factors are 
influencing any particular discrepancies? 
- What factors influenced the efficiency with which the achievements observed was 
attained? 
- How affordable were the costs borne by different stakeholder groups, given the benefits 
they received? 
- If there are significant differences in costs (or benefits) between Member States, what 
is causing them? 
 
c) Relevance 
The evaluation must look at the objectives of the EU intervention being evaluated and 
see how well they (still) match the (current) needs and problems. The answer to this 
question should identify if there is any mismatch between the objectives of the 
intervention and the (current) needs or problems. This is key information that will assist 
policy makers in deciding whether to continue, change or stop an intervention. 
Relevance looks at the relationship between the needs and problems in society and the 
objectives of the intervention. Things change over time - certain objectives may be met 
or superseded; needs and problems change, new ones arise. Relevance analysis is very 
important – because if an intervention does not help to address present needs or 
problems then it does not matter how effective, efficient or coherent it is – it is no longer 
appropriate. This is why there is a strong link between relevance analysis and the criteria 
of EU added value – which assesses whether action continues to be justified at the EU 
level. 
Typical examples of relevance questions 
- To what extent is the intervention still relevant? 
- To what extent have the (original) objectives proven to have been appropriate for the 
intervention in question? 
- How well do the (original) objectives (still) correspond to the needs within the EU? 
- How well adapted is the intervention to subsequent technological or scientific advances? 
(N.B. could include issues related to the specify policy here e.g. social, environmental) 
- How relevant is the EU intervention to EU citizens? 
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d) Coherence: The evaluation should look at how well the intervention works: i) 
internally and ii) with other EU interventions. 
The answer to this question should provide evidence of where and how EU interventions 
are working well together (e.g. to achieve common objectives or as complementary 
actions) or point to areas where there are tensions (e.g. objectives which are potentially 
contradictory, or approaches which are causing inefficiencies). 
There are many different actors involved in many different interventions, both inside and 
outside the EU. Even small changes in how one intervention is designed or implemented 
can trigger improvements or inconsistencies with other on-going actions. The evaluation 
of coherence involves looking at a how well or not different actions work together. 
Checking internal coherence means looking at how the various internal components of an 
EU intervention operate together to achieve its objectives. Similar issues can arise 
externally at different levels: for example, between interventions within the same policy 
field (e.g. a specific intervention on drinking water and wider EU water policy) or in areas 
which may have to work together (e.g. water policy and chemicals policy, or chemicals 
and health and safety). At its widest, external coherence can look at compliance with 
international agreements/declarations (for example EU labour market initiatives might be 
looking into coherence with ILO conventions). 
The focus on coherence may vary depending on the type of evaluation and is particularly 
important in Fitness Checks, where coherence analysis will look for evidence of synergies 
or inconsistencies between actions in a related field which are expected to work together. 
Even when evaluating an individual intervention, it can be important to check coherence 
with (a limited number of) other interventions. 
Typical examples of coherence questions: 
- To what extent is this intervention coherent with other interventions which have similar 
objectives? 
- To what extent is the intervention coherent internally? 
- To what extent is the intervention coherent with wider EU policy? 
- To what extent is the intervention coherent with international obligations? 
 
e) Added value 
The evaluation should consider arguments about the value resulting from EU 
interventions that is additional to the value that would have resulted from interventions 
initiated at regional or national levels by both public authorities and the private sector. 
The answer to this question should, where applicable, respond to the subsidiarity analysis 
conducted in any related IA. For spending programmes, EU added value may result from 
different factors e.g. co-ordination gains, improved legal certainty, greater effectiveness 
or complementarity. The analysis of EU added value is often limited to the qualitative, 
given the stated difficulties to identify a counter-factual. 
EU-added value76 looks for changes which it can reasonably be argued are due to EU 
intervention, rather than any other factors. In many ways, the evaluation of EU added 
value brings together the findings of the other criteria, presenting the arguments on 
causality and drawing conclusions, based on the evidence to hand, about the 
performance of the EU intervention and whether it is still justified. 
The sources and nature of this additional value vary from intervention to intervention. It 
is, in particular, useful to distinguish the European added value of an EU policy measure 
in general (like an EU regulation to foster the single market) and that of an EU spending 
programme per se. In both cases, European added value may be the results of different 
factors: coordination gains, legal certainty, greater effectiveness, complementarities etc. 
In all cases, measurement is a challenge and the final judgement on whether expected 
added value would justify an EU intervention is ultimately the result of a political process. 
In areas where the EU has exclusive competence, the appropriate answer to the question 
of EU added value may simply involve re-stating the reasons why the EU has exclusive 
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competence or may already be answered by the efficiency and effectiveness analysis. 
Sometimes it may be necessary to question if the assumption of exclusive competence 
still holds or whether the needs have changed (see also common tool on subsidiarity/EU 
added value). In such instances, the evaluation may focus more strongly on 
consideration of the relevance and efficiency of the intervention. Where there is little 
evidence of the EU added value of an intervention, consideration should be given to its 
repeal. 
Typical examples of EU added value questions:  
- What is the additional value resulting from the EU intervention(s), compared to what 
could be achieved by Member States at national and/or regional levels?  
- To what extent do the issues addressed by the intervention continue to require action 
at EU level? 
- What would be the most likely consequences of stopping or withdrawing the existing EU 
intervention? 
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ANNEX 4:  PROJECT COORDINATOR QUESTIONNAIRE 
 
a. Information on the respondents 
The total number of respondents is 40. Most of them are private industry (including 
SMEs) (40%), followed of public bodies (27.5%), Private, not-for-profit sector (17.5%) 
and academia (12.5%). Among them, 72.5 % are BIC members. 
 
 Chart: Coordinators’ type of organization 
 
The most important channels for information on BBI opportunities were reported to be: 
European Commission website (indicated by 60% of the respondents), BIC (40%), 
EU/BBI info days (32.5%), NCP (32.5%), among others. 
The answers indicate that most of the researcher teams are based in Germany (15%), 
Netherlands (15%), Spain (15%), France (12.5%) and Italy (10%). 
 
 
Chart: Countries where the research team is located as reported by 
Coordinators. 
 
0% 10% 20% 30% 40% 50%
Private industry contributing/having
contributed in-kind to BBI project(s)
Academia (University or higher education
institution)
Private, not-for-profit sector, e.g. research
foundation
Public or government sector, e.g. research
performing organisation
Private industry (including SMEs)
benefitting/having benefitted from BBI JU…
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Belgium
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Germany
Netherlands
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b. Application process 
The overall satisfaction with the overall application process is very high, with 92% 
reporting satisfaction with the clarity of the information and the transparency of the 
evaluation process 
The respondents report that they agree that the information is easy to find (92%) and 
clear (80%); that the requirements for application process were reasonable and 
proportionate (90%); the evaluation process was clear and transparent (90%) and the IT 
tools friendly (82%). 67.5 % of them indicate they knew how to contact when preparing 
and submitting the application. 
 
Chart: Coordinators satisfaction with the application process 
 
The timelines of the processes were very positively assessed: 82.5 % agree with the time 
period from the call deadline to the time the outcome of the proposal was announced to 
you; 87.5% are satisfied with the time period from the announcement of your proposal’s 
outcome to the time you signed the grant agreement and 75% agree with overall time 
period from submission of the proposal to signature of the grant agreement. 
 
Chart: Satisfaction with the timing of the processes 
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c. Grant Finalization Phase 
The satisfaction of the coordinators with the BBI staff and processes during the GAP 
phase is very high, being 93% of them satisfied with the BBI JU staff and the clarity of 
the BBI JU requests 
The respondents agree that the BBI JU staff assigned to the project in the grant 
preparation phase were easy to contact and responsive (92.5%), their requests were 
clear (92.5%), the electronic tools were friendly (77.5%) and the process of validating 
the beneficiaries was smooth (67.5%). 
Graph: Satisfaction with the Grant Preparation Phase 
 
d. Communication and interaction 
The respondents are very satisfied with the communication and interaction with the BBI. 
The respondents found very useful or useful the communication through email (95%), 
the telephone contact (70%), and the information available at the website (72.5%) and 
the face-to-face contact (62.5%). 
The respondents consider very important/slightly important the following aspects when 
dealing with the BBI JU: Clarity about the JU's procedures (75%/25%), Accessibility and 
clarity of information provided by the JU (77.5%/22.5%), The JU's willingness to help 
you and provide personal attention (72.5%/ 20%), The willingness to help, courtesy and 
cooperation of the JU's employees (75%/17.5%) and the JU's ability to perform the 
service promptly, accurately and transparently (62.5%/37.5%). 
77.5 % of the respondents would definitely consider applying again for a BBI JU grant 
and 22.5% would possibly do it. 
e. Overall performance of the BBI JU 
The overall satisfaction of the coordinators with the BBI is 100%, being 50% of them 
very satisfied and 50% satisfied 
 f. Level of satisfaction with the content of the programme 
The satisfaction of the respondents with the BBI JU programme content in respect to its 
relevance for the European bio-based industry and society is 97%: 67.5 % of the 
coordinators report to be very satisfied or 27.5% satisfied. 
In response to the question How satisfied are you with the BBI JU programme content in 
respect to its state-of the-art?, 62.5 % indicated they were very satisfied and 35% 
slightly satisfied. 
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Chart:  Overall satisfaction with the BBI JU 
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ANNEX 5: PUBLIC CONSULTATION QUESTIONNAIRE 
 
All 144 respondents answered Questions E1-E3 relating to the application process despite 
many not actually applying for funding resulting in artificially low agreement rates. 
Response rates from the 95 who made an application give a more accurate response to 
the process.   
The responses summarized (those applicants and non-applicants responded in similar 
proportion so are not broken out separately): 
Level 1 KPIs 
Do you consider that BBI JU contributes to economic growth and job creation in the EU? 
 87.5% strongly agree/agree 
Do you consider that the BBI JU contributes to the transition from a fossil- based to a 
bio-based economy? 
 93% strongly agree/agree 
Do you think that the BBI JU contributes to the climate change mitigation by reducing the 
CO2 derived from the use of fossil-based products? 
 91% strongly agree/agree 
Do you think that the BBI JU contributes to a more sustainable and efficient use of 
resources, including the recycling, reuse and valorisation of organic residues? 
 92% strongly agree/agree 
Do you think that the BBI JU contributes to the strengthening of a circular economy in 
Europe? 
 92% strongly agree/agree 
Website, management and organisation of the BBI JU 
Do you consider that the BBI JU website provides the general public and potential 
participants with easy access to information? 
The BBI JU website provides easy and effective access to information to the public 
 78% strongly agree/agree 
The BBI JU website provides easily accessible and sufficient information about its funded 
projects 
 74% strongly agree/agree 
The BBI JU website provides effective access to information and sufficient guidance to 
interested organisations facilitating their participation in proposals 
 65% strongly agree/agree 
Do you consider that the BBI JU encourages the participation of SMEs? 
 75% strongly agree/agree 
Do you consider that the current way of defining topics for the calls of proposals is open 
and inclusive? 
 63% strongly agree/agree 
Do you consider that BBI JU organises a sound and fair proposal evaluation system based 
on both scientific and technological excellence and industrial relevance? 
 51% strongly agree/agree 
 43% no opinion/no answer 
 6% strongly disagree/disagree 
Do you consider that the communication of the evaluation results and the feedback 
provided to the applicants is effective and meaningful? 
 52% strongly agree/agree 
 42% no opinion / no answer 
 6% disagree (no strongly disagree responses) 
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Level 1 KPIs 
The scientific priorities addressed by the BBI JU are set in Strategic Innovation and 
Research Agenda (SIRA). Is this document optimal for defining the scope of research and 
innovation followed by the BBI JU? 
 76% strongly agree/agree 
In your view how effective has BBI JU been in terms of: 
Supporting the development and implementation of pre-competitive research and of 
innovation activities of strategic importance to the Unions in the Bioeconomy sector 
 49% very effective 
 36% somewhat effective 
 3% not at all effective 
 12% no opinion/no answer 
Increasing the number of new cross-sector interconnections in BBI projects 
 52% very effective 
 33% somewhat effective 
 1% not at all effective 
 11% no opinion/no answer (only 141 responses?) 
Developing new bio-based value chains 
 59% very effective 
 32% somewhat effective 
Developing new bio-based building blocks 
 49% very effective 
 32% somewhat effective 
 1% not at all effective 
 17% no opinion/no answer 
Developing the bio-based materials 
 53% very effective 
 28% somewhat effective 
Developing new bio-based consumer products 
 35% very effective 
 45% somewhat effective 
Increasing the numbers of flagship biorefinery plants started based on BBI demonstration 
projects 
 45% very effective 
 26% somewhat effective 
 5% not at all effective 
 23% no opinion/no answer 
Developing necessary technologies to fill in the gap in the bio-based value chains 
 44% very effective 
 33% somewhat effective 
Which would you consider as major benefits of participating in a BBI JU project? 
Direct financial support for innovative research and development 
 95% strongly agree/agree 
Greater visibility across Europe/Reputation 
 86% strongly agree/agree 
Greater understanding of the bio-based products development process 
 88% strongly agree/agree 
Enhanced access to new markets, business opportunities and funding sources 
 83% strongly agree/agree 
Inclusion in open innovation networks, with direct contact to leading researchers in 
universities and the industry 
 88% strongly agree/agree 
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Do you consider that BBI JU projects have resulted in specific scientific and/or 
technological successes? 
 73% yes 
 21% no 
 6% no answer 
To what extent are the activities of the BBI JU coherent with other activities of the 
Horizon 2020 programme? 
 40% very coherent 
 35% somewhat coherent 
 1% not at all coherent 
 25% no opinion/no answer 
 
Application process and budget 
All 144 respondents answered Questions E1-E3, with the results shown in Response rates 
per question spreadsheet supplied – these results include those who did not actually 
apply for funding, therefore give artificially low agreement rates. Response rates from 
the 95 who made an application give a more accurate response to the process.   
When you applied for funding from the BBI JU, did you think that the application 
procedure was straightforward and simple?  
ALL respondents:  
 51% strongly agree/agree 
 8% strongly disagree/disagree 
 3% no opinion 
 38% no answer 
APPLICANT ONLY responses: 
 78% strongly agree/agree 
 13% strongly disagree/disagree 
When you applied for funding, was the administrative burden for preparing the proposal 
within acceptable limits? 
ALL respondents: 
 50% strongly agree/agree 
 10% strongly disagree/disagree 
APPLICANT ONLY responses: 
 75% strongly agree/agree 
 16% strongly disagree/disagree 
Can you make any suggestions for improvements or simplifications to the application 
procedure? 
ALL respondents: 
 14% yes 
 44% no 
 42% no answer 
APPLICANT ONLY responses: 
 21% yes 
 66% no 
 13% no answer 
You consider that the BBI JU overall budget (public and private) in relation to its 
objectives and expected outcomes is: 
 56% appropriate 
 26% too low and therefore should be increased 
 1% too high and therefore it should be partly used for other types of research and 
innovation actions in this area 
 20% no opinion 
 5% no answer 
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ANNEX 6: LIST OF INTERVIEWS WITH BBI JU STAKEHOLDERS   
 
Kevin O’Connor, Chair of the BBI JU Scientific Committee 
  John Bell, Director Bioeconomy, DG RTD/F, European Commission 
Peter Dröll, Director, Industrial Technologies, DG RTD/D,  European Commission 
Jose Manuel Gonzalez Vicente, Chair of the BBI JU States Representative Group 
Philippe Mengal, Executive Director of BBI JU 
Pilar Llorente Ruiz De Azua, Project Officer BBI JU 
Dieter Brigitta, Project Manager, BBI JU 
Marcel Wubbolts, BIC, former Chair of BBI JU Governing Board 
Waldemar Kütt, Head of Unit Strategy, Bioeconomy Directorate, DG RTD/F, European 
Commission 
Barend Verachtert, Head of Unit Agro-food Chain, Bioeconomy Directorate, DG RTD/F, 
European Commission 
Dirk Carrez, Executive Director of BIC 
Carmen de Vicente, Research Programme Officer, Industrial Technologies, DG RTD/D, 
European Commission 
Lieve Hoflack, Project Coordinator, BBI-RIA Project CARBOSURF 
Stefania Pescarolo, Project Coordinator, BBI-Flagship Project BIOSKOH 
Peter Röger, Project Coordinator, BBI-RIA Project VALCHEM 
Javier Brañas Lasala and Antonio Moran, Project Coordinator, BBI-RIA Project NewFert 
Hans Henrik Øvrebø and Jarle Wikeby, Project Coordinator, BBI-Flagship Project EXILVA 
Cecilia Giardi, Project Coordinator, BBI-Flagship Project FIRST2RUN 
Gerald van Engelen, Project Coordinator, BBI-DEMO Project PULP2VALUE 
 
 
 
                                                               
 
 
 
 
 
 
  
 
How to obtain EU publications 
Free publications: 
•  one copy: 
        via EU Bookshop (http://bookshop.europa.eu); 
•  more than one copy or posters/maps: 
        from the European Union’s representations 
(http://ec.europa.eu/represent_en.htm);  
        from the delegations in non-EU countries 
(http://eeas.europa.eu/delegations/index_en.htm);  
        by contacting the Europe Direct service 
(http://europa.eu/europedirect/index_en.htm) or 
        calling 00 800 6 7 8 9 10 11 (freephone number from anywhere in the EU) (*). 
         
        (*) The information given is free, as are most calls (though some operators, phone 
boxes or hotels may charge you). 
Priced publications: 
•  via EU Bookshop (http://bookshop.europa.eu).  
 
 
  
 
The Council Regulation (EU) No 560/2014 establishing the Bio-based Industries Joint 
Undertaking stipulates in Art.11(1) that by 30 June 2017 the Commission shall conduct 
an interim evaluation of the BBI JU with the assistance of independent experts. 
The current interim evaluation of the operation of the BBI JU covers the period from July 
2014 to 31 December 2016. Its main objective is to assess the performance of the BBI 
JU and its progress towards the objectives set out in the Council Regulation (EU) No 
560/2014.  
The evaluation was carried out by a Commission Expert Group registered in the EC 
Register of Expert Groups under Nr E03456, from November 2016 to June 2017.  
 
 
 
Le règlement du Conseil (UE) N° 560/2014 portant établissement de l'entreprise 
commune Bio-industries stipule au paragraphe 1 de l'Article 11 que la Commission 
procède, avec l'aide d'experts indépendants, à une évaluation intermédiaire de 
l’entreprise commune BBI au plus tard le 30 juin 2017. 
L'évaluation intermédiaire actuelle du fonctionnement de l’entreprise commune BBI 
couvre la période allant de juillet 2014 au 31 décembre 2016. Son principal objectif est 
d'évaluer la performance de l’entreprise commune BBI et ses progrès vers les objectifs 
énoncés dans le règlement du Conseil (UE) N° 560/2014. 
L'évaluation a été effectuée par un 'Groupe d'Experts de la Commission' enregistré dans 
le registre des groupes d'experts de la CE sous le N° E03456, de novembre 2016 à juin 
2017. 
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